{
  "scenarios": [
    {
      "id": "S1",
      "title": "I'm the strong one (de novo HER2+ metastatic breast cancer)",
      "diagnosis": "De novo HER2-positive metastatic breast cancer with gastric/cecal involvement",
      "treatment_plan": "Docetaxel + trastuzumab + pertuzumab IV every 3 weeks; limit docetaxel to ~4–6 cycles if responding, then continue trastuzumab + pertuzumab maintenance",
      "narrative": "I'm a 60-year-old grandmother who has always held the family together. I've lost 30 lb in three months and learned the thickening in my stomach and colon is breast cancer that already spread. My team recommends docetaxel with trastuzumab and pertuzumab. I'm afraid of losing who I am to my grandkids.",
      "qa": [
        {
          "q": "Everyone keeps saying this plan is palliative. How do I balance hope with honesty so my family doesn't think I'm giving up?",
          "gt": "I’m sorry you’re feeling this way. The regimen you’re starting—docetaxel, trastuzumab, and pertuzumab—is the standard first‑line therapy for HER2‑positive metastatic breast cancer. It’s designed to control the disease, prolong survival, and preserve quality of life, not to “cure” in the classic sense, so it’s often described as palliative.  \n\nWhen you talk to your family, frame it this way: “I’m not giving up. I’m choosing the best evidence‑based treatment that can keep the cancer under control, let me stay active with the grandkids, and give us more time together.” Use “I” statements, keep the focus on what you can influence (treatment goals, symptom control, support), and invite them to ask questions.  \n\nAsk your oncologist for a clear, realistic prognosis—how many months or years the therapy might extend, what side‑effects to expect, and when to shift to maintenance or supportive care. Knowing the numbers helps everyone stay honest while holding onto hope.  \n\nFinally, consider a brief family meeting with the oncology team or a palliative‑care specialist to align expectations and ensure everyone feels heard and supported.",
          "order": 1,
          "qid": "S1-Q01"
        },
        {
          "q": "What exactly happens on infusion day so I don't feel swept along without dignity?",
          "gt": "On the day of your infusion, the team will first check your vitals and review any medications you’re taking.  \n**Pre‑medication**: You’ll receive a steroid (dexamethasone), an antihistamine, and an anti‑emetic to protect against nausea, allergic reaction, and fluid retention.  \n**Infusion**:  \n- **Docetaxel** is given over 1–2 hours, then a short pause.  \n- **Trastuzumab** and **pertuzumab** are each given over 30–60 minutes.  \nThe nurse will monitor your heart rate, blood pressure, and oxygen saturation throughout.  \n**What you’ll feel**: A mild pressure at the IV site, possible flushing, and sometimes a brief feeling of warmth.  \n**Side‑effects to watch**: Nausea, fatigue, low white‑blood‑cell count (you’ll be told to report fever or sore throat), and mild fluid retention.  \n**After the infusion**: You’ll stay in the clinic for 30–60 minutes for observation. Bring a water bottle, a book or music, and a list of questions. The staff will explain any post‑infusion instructions schedule next appointment. You remain in control—just let them know if anything feels off.",
          "order": 2,
          "qid": "S1-Q02"
        },
        {
          "q": "I’m terrified about heart damage from the HER2 drugs. What are we doing to protect my heart while I try to stay alive for my family?",
          "gt": "I understand how scary this is. Here’s what we’re doing to keep your heart safe while you fight the cancer:\n\n1. **Baseline cardiac work‑up** – an echocardiogram (or MUGA scan) and blood tests (BNP, troponin) before starting therapy.  \n2. **Regular monitoring** – repeat echo every 3 months during treatment and again 3 months after you finish. If your left‑ventricular ejection fraction (LVEF) drops >10 % or falls below 50 %, we pause or stop the HER2 drugs.  \n3. **Cardioprotective meds** – if you’re at higher risk (age, hypertension, diabetes, prior heart disease), we’ll start an ACE‑inhibitor or beta‑blocker early to shield the heart.  \n4. **Lifestyle support** – keep blood pressure, cholesterol, and blood sugar tight; quit smoking; eat a heart‑healthy diet; and do light exercise as tolerated.  \n5. **Team coordination** – your oncologist, cardiologist, and primary care provider will share updates so we can adjust doses or add supportive drugs promptly.\n\nWith these steps, the risk of serious heart damage is low, and we’ll act quickly if anything changes. You’re not alone—your care team is focused on both your survival and your heart health.",
          "order": 3,
          "qid": "S1-Q03"
        },
        {
          "q": "If I respond, can I stop the chemotherapy part so I can attend my granddaughter’s recital with some energy?",
          "gt": "Yes—once you’ve completed the planned 4–6 cycles of docetaxel and your disease is responding or stable, most oncologists switch you to maintenance with trastuzumab + pertuzumab alone. That “chemo‑free” period can give you more energy and fewer side‑effects, making it easier to enjoy your granddaughter’s recital. However, the decision must be individualized: your oncologist will review imaging, blood counts, and any residual symptoms before stopping docetaxel. If you’re still having significant side‑effects (fatigue, neuropathy, etc.), a brief break or dose adjustment may also help. Keep close follow‑up and report any new symptoms promptly. In short, stopping the chemotherapy part after a good response is common practice and can be done safely with your team’s guidance.",
          "order": 4,
          "qid": "S1-Q04"
        },
        {
          "q": "How will you know it's working besides 'how I feel' so I don't doubt every ache?",
          "gt": "You’ll have several objective checkpoints in addition to how you feel:\n\n1. **Imaging** – CT/MRI of the chest, abdomen, and pelvis every 8–12 weeks (or sooner if symptoms change). Shrinking or stable lesions on scan is the gold‑standard sign of response.  \n2. **Tumor markers** – Serial CA 15‑3 or CEA levels (if elevated at baseline). A consistent drop of 20–30 % over 2–3 cycles often correlates with clinical benefit.  \n3. **Physical exam** – Reduction in abdominal fullness, tenderness, or palpable masses; improvement in bowel habits.  \n4. **Laboratory trends** – Normalization of liver enzymes, bilirubin, and blood counts (docetaxel can cause neutropenia; improvement suggests tolerance).  \n5. **Functional status** – Ability to keep up with daily chores, visit grandkids, and maintain appetite.  \n\nYour oncology team will review all these data together; if imaging or markers improve, you can trust that the treatment is working even if aches linger.",
          "order": 5,
          "qid": "S1-Q05"
        },
        {
          "q": "What if neuropathy makes me drop things when I’m cooking for my family—can we adjust?",
          "gt": "I’m really sorry you’re dealing with this. Peripheral neuropathy from docetaxel can make fine motor tasks hard, but there are ways to keep you safe and still stay on treatment.\n\n1. **Early reporting** – Tell your oncologist as soon as you notice tingling, numbness, or clumsiness.  \n2. **Dose adjustment** – The team can lower the docetaxel dose or extend the interval (e.g., 3 weeks → 4 weeks) while keeping trastuzumab/pertuzumab.  \n3. **Switching agents** – If neuropathy persists, they may replace docetaxel with a non‑taxane HER2‑targeted regimen (e.g., trastuzumab‑emtansine, tucatinib‑capecitabine, or neratinib‑capecitabine).  \n4. **Supportive care** – Use ergonomic utensils, keep surfaces clear, and consider a hand‑protective glove or a “no‑drop” kitchen setup.  \n5. **Medications** – Gabapentin or duloxetine can help neuropathic pain and improve function.\n\nDiscuss these options with your team; they’ll tailor the plan to keep you safe at home and maintain your treatment goals.",
          "order": 6,
          "qid": "S1-Q06"
        },
        {
          "q": "I hate the idea of isolation when my white cells drop. Do I need to avoid my loved ones?",
          "gt": "I’m sorry you’re feeling so isolated. With docetaxel‑based therapy your white‑cell count (ANC) can dip, but the level of risk depends on how low it falls.\n\n**If your ANC stays ≥ 1,000 cells/µL** you can safely see family and friends. Keep up good hand‑washing, avoid crowds, and stay away from anyone who is sick or has a fever.  \n**If your ANC drops to 500–999 cells/µL** you’re at moderate risk. You can still visit loved ones, but use extra precautions: wear a mask, wash hands before and after contact, and avoid close contact with people who are ill.  \n**If your ANC falls below 500 cells/µL** (severe neutropenia) most guidelines recommend a brief period of “neutropenic isolation”—stay at home, limit visitors, and use a mask. Your oncology team will tell you exactly when to pause visits and when you can resume.\n\nYou can also discuss prophylactic G‑CSF or dose‑adjusted chemotherapy with your team to keep counts higher. Remember, you don’t have to give up your grandkids; you just need to protect both of you with simple, evidence‑based precautions.",
          "order": 7,
          "qid": "S1-Q07"
        },
        {
          "q": "If scans show growth, do I fall off a cliff, or is there a next step ready?",
          "gt": "If scans show progression while you’re on docetaxel‑trastuzumab‑pertuzumab, it’s not the end of the road.  The next step is usually to switch to a different HER2‑targeted agent that’s proven active after first‑line therapy.  Common options are:\n\n* **T‑DM1 (trastuzumab‑emtansine)** – a chemo‑drug conjugate that’s effective in many patients who progress on taxane‑based regimens.  \n* **Tucatinib + trastuzumab + capecitabine** – a triple‑combination that works even when the disease has spread to the brain or other sites.  \n* **Trastuzumab deruxtecan** – another antibody‑drug conjugate with strong activity in HER2‑positive metastatic disease.  \n\nIf you’re eligible, a clinical trial can also be an option.  Your oncologist will review the scan, discuss which of these fits your health status and preferences, and start the next line promptly.  So, a growth on imaging is a signal to change strategy, not a cliff.",
          "order": 8,
          "qid": "S1-Q08"
        },
        {
          "q": "Can I keep working part-time without feeling punished for trying?",
          "gt": "It’s absolutely possible to keep working part‑time while on docetaxel‑trastuzumab‑pertuzumab, but it will need careful planning.  \n\n**What to expect:**  \n- **Fatigue, nausea, and occasional low blood counts** can make long days hard.  \n- **Peripheral neuropathy** from docetaxel may limit tasks that require fine motor skills.  \n\n**Practical steps:**  \n1. **Talk to your oncologist** before each cycle about your work schedule; they can adjust doses or add growth‑factor support if needed.  \n2. **Coordinate with your employer** for a flexible timetable—shorter shifts, telework, or a “work‑from‑home” day when you feel drained.  \n3. **Prioritize rest**: schedule breaks, use a supportive chair, and keep hydration and nutrition high.  \n4. **Monitor symptoms**: if you notice worsening fatigue or pain, pause work and let your team know.  \n\nMaintaining activity can boost mood and sense of normalcy, so with these safeguards you can keep contributing to your family’s life without feeling “punished” for trying.",
          "order": 9,
          "qid": "S1-Q09"
        },
        {
          "q": "I don't want cancer to be the only thing my grandchildren remember. How can we plan around the good days?",
          "gt": "I’m so sorry you’re facing this. The best way to keep cancer from being the only story your grandchildren hear is to build a “good‑day” routine that fits your treatment schedule and your energy levels.\n\n1. **Plan family moments around treatment** – If you’re on docetaxel every 3 weeks, schedule a short visit or a video call on the day after chemo when you’re usually feeling better.  \n2. **Keep a simple “memory jar”** – Write a note or draw a picture each time you feel good and share it with your kids or grandkids.  \n3. **Use supportive care early** – Talk to your oncologist about anti‑nausea, pain, and fatigue meds so you can stay active.  \n4. **Involve the whole family in decision‑making** – A brief family meeting (in person or virtual) can help everyone feel connected and reduce anxiety.  \n5. **Consider early palliative‑care referral** – It focuses on quality of life, symptom control, and psychosocial support, not just end‑of‑life care.  \n\nBy weaving these small, intentional moments into your schedule, you’ll create lasting memories that go beyond the diagnosis.",
          "order": 10,
          "qid": "S1-Q10"
        }
      ]
    },
    {
      "id": "S2",
      "title": "New mom, old terror (stage IIIB triple-negative breast cancer, neoadjuvant)",
      "diagnosis": "Stage IIIB triple-negative breast cancer",
      "treatment_plan": "Neoadjuvant pembrolizumab every 3 weeks with weekly paclitaxel/carboplatin ~12 weeks, then doxorubicin/cyclophosphamide every 2 weeks ×4; surgery ± radiation; continue pembrolizumab to ~1 year",
      "narrative": "I'm 33, eight months postpartum, newly diagnosed with aggressive triple-negative breast cancer. My baby still wakes at night; my body doesn't feel like mine. They’re starting chemo-immunotherapy before surgery.",
      "qa": [
        {
          "q": "It feels like I'm failing as a mom by stopping breastfeeding and losing my hair at the same time. How do I not drown in that guilt?",
          "gt": "I hear how heavy the guilt feels—your body is fighting a life‑threatening cancer while you’re still caring for a newborn. First, know that stopping or pausing breastfeeding is safe for both you and the baby during this treatment; the breast‑milk supply will return once therapy ends, and you can resume feeding or use expressed milk. Hair loss is temporary—most patients regain their hair within months, and many use wigs, scarves, or headbands to feel more like themselves.  \n\nFocus on what you can control: keep open lines with your oncology team about breastfeeding safety, ask for supportive‑care options (nutrition, wigs, counseling), and lean on your partner, family, or a mom‑support group. Remind yourself that protecting your health now preserves the future you’ll share with your child. You’re not failing—you’re making the hardest, most courageous choice for both of you.",
          "order": 1,
          "qid": "S2-Q01"
        },
        {
          "q": "I’m scared I’ll be too sick to comfort my baby after her vaccines—how do we plan so she still reaches for me on the hard days?",
          "gt": "I’m so sorry you’re feeling this way—your love for your baby is a powerful source of strength. Here’s a practical plan that keeps both of you safe and connected:\n\n1. **Timing** – Most chemo sessions are in the morning or early afternoon. Schedule them on days when your baby is sleeping or has a nap.  \n2. **Support network** – Ask a partner, sibling, or close friend to be your “chemo buddy.” They can hold your baby while you rest or get a quick shower.  \n3. **Safe baby space** – Keep a baby monitor or a small, secure playpen in the room where you’ll be. A baby carrier or sling can let you move around while still holding her.  \n4. **Side‑effect management** – Discuss anti‑nausea meds, hydration, and fatigue‑relief strategies with your oncologist. Even mild fatigue can be managed with short naps and gentle stretching.  \n5. **Breastfeeding** – Chemotherapy (paclitaxel, carboplatin, anthracyclines) is not compatible with breastfeeding. If you’re still nursing, we’ll arrange a safe weaning plan.  \n6. **Vaccination schedule** – Your baby’s shots are safe during your treatment; just keep her in a well‑ventilated area and avoid direct contact with your chemo‑related body fluids.  \n\nRemember, most patients finish their 12‑week neoadjuvant course with manageable side effects and return to normal caregiving. Your oncologist and nursing team are there to fine‑tune this plan so you can stay present for your little one. You’re not alone—lean on your support circle and let them help carry the load.",
          "order": 2,
          "qid": "S2-Q02"
        },
        {
          "q": "If the lump isn’t shrinking fast, how do I stop spiraling into 'this isn't working'?",
          "gt": "It’s normal to feel anxious when the tumor isn’t visibly shrinking right away. Remember that the treatment plan is based on evidence that the combination of pembrolizumab with paclitaxel/carboplatin can still work even if the size change is slow.  \n\n**Practical steps**\n\n1. **Ask for clear milestones** – most teams schedule imaging at 6 weeks and again at 12 weeks. Knowing the exact dates and what the doctors will look for can reduce uncertainty.  \n2. **Track what you can control** – keep a simple log of side‑effects, energy levels, and any new symptoms. This gives you tangible data to discuss with your oncologist.  \n3. **Communicate early** – if you notice new pain, swelling, or a sudden change, call the office right away.  \n4. **Set small, non‑medical goals** – a short walk, a favorite book, or a brief chat with a friend. Small wins keep the mind from spiraling.  \n5. **Lean on support** – a mom‑to‑mom group or a therapist can help you process the “this isn’t working” thoughts.  \n\nIf the imaging shows minimal change, the team may consider a treatment switch or additional local therapy, but most patients still achieve a good outcome with the planned regimen. Stay in regular contact with your oncologist and focus on the steps you can take each day.",
          "order": 3,
          "qid": "S2-Q03"
        },
        {
          "q": "Is there anything we can do right now about fertility without dangerously delaying treatment?",
          "gt": "I’m so sorry you’re facing this while caring for a newborn. You can usually preserve fertility without delaying the start of chemo‑immunotherapy.  \n\n**1. Ovarian suppression (GnRH agonist)** – can be started immediately with the first cycle of paclitaxel/carboplatin. It’s proven to reduce ovarian damage and requires no extra time before chemo.  \n\n**2. Embryo or oocyte cryopreservation** – requires 2–3 weeks of ovarian stimulation and egg retrieval. If you’re willing to wait a few weeks, this can be done before the first cycle of paclitaxel. Discuss with a reproductive endocrinologist right away; they can coordinate the schedule so chemo starts on time.  \n\n**3. Ovarian tissue cryopreservation** – can be done at the time of surgery (lumpectomy or mastectomy) and doesn’t delay chemo.  \n\nTalk to your oncologist and a fertility specialist as soon as possible; they can tailor the plan to fit your treatment timeline and give you the best chance of future pregnancy.",
          "order": 4,
          "qid": "S2-Q04"
        },
        {
          "q": "Immunotherapy sounds like it could attack anything—what symptoms should make me call immediately?",
          "gt": "I’m so sorry you’re facing this. With pembrolizumab plus chemo, the most urgent red‑flags are signs of an immune‑related flare or infection. Call your oncology team (or 911 if it’s life‑threatening) right away if you notice:\n\n| Symptom | Why it matters | Action |\n|---------|----------------|--------|\n| **High fever ≥38.5 °C (101 °F)** | Could be infection or immune‑mediated inflammation | Call immediately |\n| **Severe, persistent diarrhea or abdominal pain** | Possible colitis | Call |\n| **New or worsening shortness of breath, cough, or chest pain** | Possible pneumonitis | Call |\n| **Sudden swelling, pain, or redness in the breast or arm** | Lymphangitis or infection | Call |\n| **Unexplained fatigue, weakness, or feeling “off”** | Could be anemia, neutropenia, or endocrine flare | Call |\n| **New rash, itching, or skin changes** | Could be dermatitis or severe skin flare | Call |\n| **Vision changes, headache, confusion, or weakness** | Possible neurologic irAE | Call |\n| **Palpitations, chest discomfort, or fainting** | Possible myocarditis or arrhythmia | Call |\n\nIf you’re unsure, err on the side of caution—contact your oncologist or the nearest emergency department. They’ll guide you through the next steps. Stay strong; you’re not alone.",
          "order": 5,
          "qid": "S2-Q05"
        },
        {
          "q": "Can we time a cycle so I can be present for my sister’s wedding photos without a mask and IV tape?",
          "gt": "I’m so glad you’re thinking ahead—being present for family moments is incredibly meaningful. In practice, the chemotherapy and immunotherapy schedule is designed to keep the cancer’s growth rate in check; missing or delaying a cycle can increase the risk of progression, especially with triple‑negative disease. That said, many oncology teams can accommodate a brief “holiday” after a cycle if you’re feeling well, but it’s not guaranteed and must be coordinated with your medical team.  \n\nAsk your oncologist whether a short break (e.g., a weekend after a cycle) is possible and discuss the risks. If a break isn’t feasible, you can still attend the photos with a mask and a discreet cover for the IV site—most people don’t notice, and it keeps you safe. Whatever you decide, keep the conversation open with your team so they can help you balance treatment and the moments that matter most.",
          "order": 6,
          "qid": "S2-Q06"
        },
        {
          "q": "I’m worried about a port and feeling 'marked.' Do I really need one?",
          "gt": "I totally understand how a visible port can feel “marked,” especially after giving birth. For the treatment you’re scheduled to receive—weekly paclitaxel/carboplatin followed by every‑two‑week doxorubicin/cyclophosphamide—a central line (port) is usually the safest and most convenient option. It reduces the number of needle sticks, lowers the risk of infiltration or infection, and lets the infusion run faster and more comfortably. Ports can be placed in the chest or upper arm and are often hidden under clothing; the scar is usually small and fades over time. If you’re still unsure, ask your oncology team about a peripherally inserted central catheter (PICC) or a “port‑less” approach, but most patients find the port’s benefits outweigh the cosmetic concerns. Remember, the port can be removed once chemotherapy is finished.",
          "order": 7,
          "qid": "S2-Q07"
        },
        {
          "q": "How will surgery decisions change if I get a complete response?",
          "gt": "If your tumor shows a **complete pathological response (pCR)** after the neoadjuvant chemo‑immunotherapy, the surgical plan can be less extensive, but it is still usually recommended for local control.  \n\n* **Breast‑sparing surgery** – If the breast is still visible and imaging shows no residual mass, a lumpectomy (or even a “watch‑and‑wait” approach in carefully selected trials) may be considered instead of a mastectomy.  \n* **Axillary surgery** – A sentinel‑node biopsy alone is often enough; a full axillary dissection is usually avoided if the nodes are clear.  \n* **Radiation** – Post‑operative radiation is still needed for most patients, even if the surgery is minimal.  \n\nIn short, a complete response may let you keep your breast and have a smaller axillary procedure, but surgery (or at least a sentinel‑node biopsy) remains the standard of care unless you enroll in a clinical trial that specifically studies omission of surgery.",
          "order": 8,
          "qid": "S2-Q08"
        },
        {
          "q": "My baby is in daycare; do I need to pull her out during chemo?",
          "gt": "It’s usually fine to keep your baby in daycare while you’re on neoadjuvant chemo‑immunotherapy. The chemotherapy can lower your white‑cell count, so you should avoid exposure to sick people, but your infant is not immunocompromised.  \n\n**Practical steps:**\n\n- **Ask the daycare** about any recent illnesses or outbreaks. If there’s a flu or RSV surge, consider a short break.  \n- **Keep your baby away from sick children** and crowded areas.  \n- **Practice strict hand hygiene** before and after touching the baby.  \n- **Monitor for fever or infection** in both you and the baby; if you develop neutropenic fever, you’ll need to stay home and seek care.  \n\nIf you’re feeling very weak or neutropenic, it’s reasonable to keep the baby at home for a few weeks, but otherwise daycare is acceptable. Discuss any concerns with your oncology team—they can tailor advice to your specific blood counts and schedule.",
          "order": 9,
          "qid": "S2-Q09"
        },
        {
          "q": "What helps financially when I’m suddenly a cancer patient with a young child?",
          "gt": "I’m so sorry you’re facing this. Here are practical financial steps you can take right now:\n\n1. **Insurance & Employer** – Call your insurer and HR to confirm coverage for chemo, surgery, and the 1‑year pembrolizumab. Ask about “cancer benefits” or “short‑term disability” that can cover lost wages.  \n2. **Medical Social Worker** – Most hospitals have one on staff. They can connect you to state Medicaid, the Affordable Care Act marketplace, and local cancer‑care charities.  \n3. **Patient Assistance Programs** – The National Cancer Institute’s CancerCare, the American Cancer Society, and the Cancer Treatment Centers of America offer free or low‑cost support for medication, transportation, and childcare.  \n4. **Non‑profits & Grants** – Look at the Breast Cancer Research Foundation, the Susan G. Komen Foundation, and the American Cancer Society’s “CancerCare” program for financial aid and counseling.  \n5. **Short‑Term Disability & COBRA** – If you’re losing income, short‑term disability can help; COBRA can keep your insurance if you’re laid off.  \n6. **Community Resources** – Local food banks, childcare co‑ops, and hospital “patient assistance” programs can ease day‑to‑day costs.  \n\nAsk your oncologist’s office for a referral to a social worker—this is the fastest way to get a personalized financial plan. You’re not alone, and help is available.",
          "order": 10,
          "qid": "S2-Q10"
        }
      ]
    },
    {
      "id": "S3",
      "title": "Coach who can’t fix it (metastatic hormone-sensitive prostate cancer)",
      "diagnosis": "Metastatic hormone-sensitive prostate cancer with painful bone lesions",
      "treatment_plan": "Androgen deprivation therapy injection every 1–3 months plus a daily androgen-receptor–targeted pill; consider focused radiation for painful sites; bone-protective measures",
      "narrative": "I'm a 71-year-old retired high-school coach with bone pain. They’re starting hormone shots plus a daily pill. I’ve always been the guy with answers; now I’m short-tempered and scared.",
      "qa": [
        {
          "q": "When my sex drive collapses and my body changes, how do I not resent the very treatment keeping me here?",
          "gt": "I’m sorry you’re feeling so conflicted. Remember that the hormone‑deprivation shots and pill are the very tools that keep the cancer from spreading and give you more time to enjoy life. Here are a few practical ways to keep resentment at bay:\n\n1. **Talk openly with your oncologist** about every side effect—sex drive, hot flashes, fatigue, mood swings. They can adjust the dose, add a phosphodiesterase‑5 inhibitor for erectile function, or prescribe a short‑acting steroid to blunt hot flashes.\n\n2. **Use a “side‑effect diary.”** Note when symptoms flare and what helps (e.g., cool showers, exercise, a supportive partner). Patterns can guide targeted interventions.\n\n3. **Keep the focus on the goal:** each injection is a step toward controlling the cancer. Remind yourself that the pain relief and bone‑protective drugs are also part of the plan.\n\n4. **Seek emotional support**—a counselor, support group, or a trusted friend can help you process the loss of libido and body changes without feeling guilty.\n\n5. **Maintain routine physical activity** (light weight‑lifting, walking, or swimming). Exercise boosts mood, preserves muscle mass, and can improve sexual function.\n\n6. **Practice mindfulness or gentle meditation** to stay present and reduce frustration.\n\nBy treating side effects as manageable challenges rather than betrayals, you can honor the therapy that keeps you alive while preserving your dignity and relationships.",
          "order": 1,
          "qid": "S3-Q01"
        },
        {
          "q": "What’s the fastest path to walking my grandkids to school without wincing every step?",
          "gt": "**Fast‑track to pain‑free walking**\n\n1. **Aggressive pain control** –  \n   * Start a short course of oral steroids (e.g., prednisone 10 mg × 5 days) if bone pain is severe.  \n   * Use NSAIDs or acetaminophen as needed; add a weak opioid (e.g., tramadol) if pain persists.  \n   * Keep a pain diary and report breakthrough pain to your oncologist.\n\n2. **Bone‑protective therapy** –  \n   * Begin a bisphosphonate (zoledronic acid) or denosumab every 6 weeks to reduce fracture risk and pain.  \n   * Ensure adequate calcium (1 g/day) and vitamin D (800–1 000 IU/day).\n\n3. **Targeted therapy** –  \n   * The daily androgen‑receptor pill (e.g., enzalutamide) will take 4–6 weeks to show effect; keep it consistent.\n\n4. **Focused radiation** –  \n   * If a single painful lesion is limiting walking, a 1–2 day course of palliative radiation can give rapid relief.\n\n5. **Physical support** –  \n   * Use a cane or walker for stability.  \n   * Wear supportive shoes and avoid high‑impact surfaces.  \n   * Gentle stretching and a short physiotherapy program can",
          "order": 2,
          "qid": "S3-Q02"
        },
        {
          "q": "How do I keep my routine so I’m not treated like fragile glass at home?",
          "gt": "You’re already a master of routine—use that skill to keep control.  \n1. **Medication & appointments** – set a phone or calendar reminder for each ADT shot and daily pill. Bring a pill‑box and a “doctor‑notes” sheet to every visit so you’re always prepared.  \n2. **Pain & bone protection** – take bisphosphonate/denosumab, calcium + vit D, and a daily NSAID or prescribed opioid as directed. Keep a pain‑log so you can adjust doses before they flare.  \n3. **Safe activity** – do low‑impact, weight‑bearing moves (walking, tai‑chi, resistance bands) 3–4 × week, staying within pain limits. Use a cane or walker only when needed; it’s a tool, not a sign of frailty.  \n4. **Nutrition & rest** – protein‑rich meals, adequate sleep, and short, frequent breaks keep energy steady.  \n5. **Communication** – tell family you’re still capable but need their help with specific tasks (e.g., lifting heavy items). Offer to lead a short exercise routine together.  \nBy structuring meds, pain control, safe movement, and clear communication, you maintain independence while protecting your bones.",
          "order": 3,
          "qid": "S3-Q03"
        },
        {
          "q": "My buddy had a heart issue on hormones. What are we doing to protect my heart and metabolism?",
          "gt": "**Heart & Metabolism Protection with ADT**\n\n1. **Baseline & Ongoing Cardiac Checks** – ECG and, if needed, an echocardiogram before starting ADT and every 6–12 months.  \n2. **Control Traditional Risk Factors** –  \n   * **Blood pressure**: target <130/80 mm Hg; use ACE‑I/ARB or calcium‑channel blocker if needed.  \n   * **Lipids**: statin therapy if LDL > 100 mg/dL or if you have a history of heart disease.  \n   * **Glucose**: fasting glucose/HbA1c every 3–6 months; start metformin or other agents if you develop pre‑diabetes or diabetes.  \n3. **Lifestyle Modifications** –  \n   * **Diet**: Mediterranean‑style, low saturated fat, plenty of fruits/veggies.  \n   * **Exercise**: 150 min/week of moderate aerobic activity plus strength training.  \n   * **Weight**: aim for a BMI 18.5–24.9; even modest weight loss improves insulin sensitivity.  \n4. **Medication‑Level Support** –  \n   * **Bisphosphonate or denosumab** to preserve bone and reduce fracture risk.  \n   * **Consider low‑dose aspirin** if you have a high cardiovascular risk score (consult your cardiologist).  \n\nWe’ll monitor your heart and metabolic health closely, adjust meds as needed, and keep you active and healthy while you fight the cancer.",
          "order": 4,
          "qid": "S3-Q04"
        },
        {
          "q": "Will my bones thin out? I don’t want a hip fracture to bench me for good.",
          "gt": "I’m sorry you’re feeling anxious—bone health is a real concern with ADT.  Androgen‑deprivation therapy does reduce bone mineral density, so the risk of fractures (including hip) does increase.  That’s why most oncologists add a bone‑protective agent right away—either a bisphosphonate (e.g., zoledronic acid) or denosumab—along with daily calcium (1 g) and vitamin D (800–1 000 IU).  Regular DXA scans (every 6–12 months) and routine blood work let us catch any loss early.  Combine that with weight‑bearing exercise, a balanced diet, and the focused radiation you’re getting for painful lesions, and the fracture risk drops markedly.  Keep the lines of communication open with your team; they’ll adjust the plan as needed to keep you “bench‑ready.”",
          "order": 5,
          "qid": "S3-Q05"
        },
        {
          "q": "If this combo stops working, what’s next so I’m not blindsided?",
          "gt": "When PSA rises or imaging shows new lesions while you’re on ADT + an AR‑targeted pill, the disease has usually become castration‑resistant.  The next step is to “switch” the AR blockade (e.g., if you’re on enzalutamide, try abiraterone; if on abiraterone, try enzalutamide) or add a taxane chemotherapy (docetaxel first line, cabazitaxel later).  For bone‑only disease, radium‑223 can relieve pain and improve survival.  If a homologous recombination repair (HRR) mutation is present, a PARP inhibitor (olaparib, rucaparib) is an option.  Keep bone‑protective agents (zoledronic acid or denosumab) and pain control in place, and discuss clinical trials.  Regular PSA checks and imaging will help catch progression early.",
          "order": 6,
          "qid": "S3-Q06"
        },
        {
          "q": "Can I keep assistant-coaching the team without having to explain hot flashes to a locker room?",
          "gt": "You absolutely can keep coaching—hot flashes are a common side‑effect of ADT, but they’re not a public issue. Keep your routine simple: stay hydrated, wear breathable layers, and avoid hot, humid environments (a fan or cool towel can help). If a flare hits, take a short break, step outside, or use a discreet cooling pack. You don’t have to explain the symptom to the whole locker room; just let a trusted assistant or assistant coach know you might need a quick pause. If you’re worried about the daily pill’s side‑effects, discuss supportive meds (e.g., bisphosphonates for bone pain, antihistamines for hot flashes) with your oncologist. Focus on your game plan, and let the team know you’re still there—your leadership is more valuable than any single symptom.",
          "order": 7,
          "qid": "S3-Q07"
        },
        {
          "q": "What if the pain suddenly spikes on a weekend?",
          "gt": "If your bone pain flares up suddenly—especially on a weekend when appointments are scarce—act quickly and calmly.  \n1. **Call your oncology nurse line or the on‑call doctor** right away; they can triage and may prescribe a short course of oral steroids (e.g., prednisone 10–20 mg) to reduce inflammation.  \n2. **Use your prescribed analgesics**: start with acetaminophen or an NSAID (if no contraindication), and if pain is severe, add a low‑dose opioid (e.g., oxycodone 5 mg) as directed.  \n3. **Check for new fractures**: if you feel a sudden sharp pain or a new area of tenderness, get an urgent X‑ray or CT.  \n4. **Keep your ADT schedule**—don’t skip the injection or daily pill unless advised.  \n5. **Plan ahead**: have a “pain‑management kit” (meds, ice pack, a list of emergency contacts) and a written plan from your team for weekend flare‑ups.  \n\nIf pain persists or worsens despite these measures, seek emergency care promptly.",
          "order": 8,
          "qid": "S3-Q08"
        },
        {
          "q": "Should I change my diet or supplements now that hormones are changing everything?",
          "gt": "**Short answer:**  \nYes—focus on a balanced, protein‑rich diet, adequate calcium and vitamin D, and avoid supplements that could interfere with your therapy.  \n\n**Why it matters:**  \nADT and AR‑targeted drugs can lower bone density and change metabolism. A diet high in protein (lean meats, beans, dairy) supports muscle and bone health. Aim for 1 g/kg body weight of protein daily.  \nTake a calcium supplement only if your intake is < 1,000 mg/day, and get vitamin D (800–1,000 IU) to keep bone turnover in check.  \nAvoid high‑dose vitamin E, soy/phytoestrogens, or other “natural” hormone‑modifying supplements unless your oncologist approves—they can blunt ADT’s effect.  \n\n**Practical steps:**  \n1. **Check your calcium/vit D** with a quick blood test.  \n2. **Limit alcohol** (≤ 1 drink/day) and avoid smoking.  \n3. **Stay active**—light weight‑bearing or resistance exercise if your doctor clears it.  \n4. **Discuss any new supplements** with your oncology team or a dietitian before starting.  \n\nThese changes help protect bone health and support the effectiveness of your hormone therapy.",
          "order": 9,
          "qid": "S3-Q09"
        },
        {
          "q": "How do I talk to my sons about genetics without scaring them?",
          "gt": "**Start with a calm, “just‑in‑case” tone.**  \n1. **Pick a relaxed moment**—after dinner or a walk—so the conversation feels natural, not urgent.  \n2. **Use plain language**: “I’ve learned that prostate cancer can run in families, but it’s not a guarantee for anyone.”  \n3. **Frame it as information, not a warning**: “Knowing this helps us keep an eye on our health and make smart choices.”  \n4. **Mention the next steps**: “A quick blood test can tell us if we carry a specific gene. If we do, we can plan screening or lifestyle changes early.”  \n5. **Invite questions**: “What worries you? I’m here to answer.”  \n6. **Offer resources**: hand out a pamphlet or link to a reputable site (e.g., NCCN, Mayo Clinic).  \n7. **Reassure**: “Most people with the gene live normal lives; it’s just one piece of the puzzle.”  \n\nKeep it short, factual, and supportive—your sons will appreciate the clarity and the chance to take proactive steps.",
          "order": 10,
          "qid": "S3-Q10"
        }
      ]
    },
    {
      "id": "S4",
      "title": "Teacher with too much silence (high-grade serous ovarian cancer)",
      "diagnosis": "High-grade serous ovarian cancer with ascites",
      "treatment_plan": "Cytoreductive surgery when appropriate; carboplatin/paclitaxel every 3 weeks for ~6 cycles; maintenance therapy based on tumor features (e.g., PARP) and response; genetic testing recommended",
      "narrative": "I'm a 45-year-old teacher with ascites, facing surgery and chemo. My daughter is 16, and our home has become very quiet since we said the word 'cancer.'",
      "qa": [
        {
          "q": "My belly is so tight I can't eat and I feel ashamed of how I look. What can we do right now so I can sit at the table with my family again?",
          "gt": "I’m sorry you’re feeling so uncomfortable and ashamed. Here are a few practical steps you can try right now:\n\n1. **Manage the ascites** – Ask your oncologist about diuretics or a small‑volume paracentesis. Even a brief drainage can relieve pressure and make eating easier.\n\n2. **Nutrition tricks** –  \n   * Eat 5–6 small, high‑calorie, high‑protein snacks (protein shakes, Greek yogurt, nut butter, cheese).  \n   * Add a liquid meal replacement (Ensure, Boost) to your routine.  \n   * If appetite is low, discuss appetite stimulants (e.g., megestrol acetate) with your team.\n\n3. **Pain & comfort** – Gentle abdominal massage, warm compresses, and a supportive pillow can ease tightness. If pain persists, review your pain plan with the oncology nurse.\n\n4. **Family support** – Invite your daughter to help prepare a simple meal or snack together. Even a small plate at the table can restore normalcy. Let her know you’re okay with her helping.\n\n5. **Emotional care** – A brief talk with a counselor or a cancer‑support group (many teachers find peer support helpful) can ease the shame you’re feeling. Body‑image counseling can also be useful.\n\n6. **Professional help** – A dietitian experienced in oncology can tailor a meal plan that fits your comfort level and treatment schedule.\n\nStart with one or two of these, and let your care team know how you’re doing. You deserve support and comfort, both physically and emotionally.",
          "order": 1,
          "qid": "S4-Q01"
        },
        {
          "q": "I’m scared my daughter is googling worst-case stories alone. How do we talk so she feels included but not crushed?",
          "gt": "**Start a calm, age‑appropriate conversation.**  \n- **Invite her to ask questions**: “What do you want to know about my treatment?”  \n- **Use simple, honest language**: “I’m getting surgery and chemo, and it’s a tough road, but doctors are doing everything they can.”  \n- **Reassure her**: “I’m still the same teacher, and I’ll keep teaching you.”  \n- **Set boundaries on online searching**: “If you want to look up information, let’s pick reliable sites together (e.g., Cancer.org, Mayo Clinic).”  \n- **Involve her in care decisions**: “When we talk to the oncologist, you can be there and ask what you want to know.”  \n- **Offer support resources**: a child‑life specialist or school counselor can help her process feelings.  \n- **Keep the dialogue ongoing**: schedule a short family check‑in each week to share how you’re feeling and what’s happening.  \n\nBy giving her a safe space to ask, answering honestly, and guiding her to trustworthy information, you keep her included without overwhelming her with fear.",
          "order": 2,
          "qid": "S4-Q02"
        },
        {
          "q": "If my hair falls out and my students stare, how do I walk back into my classroom with dignity?",
          "gt": "Hair loss is a common side‑effect of carboplatin/paclitaxel, and most students will notice it only if you let them.  \n1. **Choose a cover that feels like you** – a lightweight wig, a stylish scarf, a headband, or a simple hat can be both functional and fashionable.  \n2. **Practice your “look”** – try different styles in front of a mirror or a friend; pick one that boosts your confidence.  \n3. **Communicate subtly** – a brief note to the school or a quick chat with a trusted colleague can let them know you’re fine and that you’ll be back in class soon.  \n4. **Use your voice** – when you return, greet the class with a warm smile and a short statement (“I’m back, ready to teach!”).  \n5. **Seek support** – talk to a counselor or join a cancer‑support group; sharing feelings can ease the anxiety of being stared at.  \nRemember, your expertise and dedication are what matter most; the rest is just a temporary change.",
          "order": 3,
          "qid": "S4-Q03"
        },
        {
          "q": "Do I pass this to my daughter—did I cause this?",
          "gt": "Your cancer isn’t something you “caused” your daughter. High‑grade serous ovarian cancer often has a hereditary component—most commonly BRCA1 or BRCA2 mutations. If you carry one of these mutations, the risk to a daughter is about 50 % for developing the same type of cancer later in life. It’s not a matter of blame; it’s a genetic inheritance pattern.\n\nThe next step is to have a genetic test (preferably a BRCA panel) and a counseling session. If you test positive, your daughter can be offered surveillance (e.g., transvaginal ultrasound, CA‑125) and, if she chooses, risk‑reducing options such as prophylactic oophorectomy. If you’re negative, her risk is similar to the general population. In either case, you’re not responsible for the cancer—just a carrier of a genetic risk that can be managed proactively.",
          "order": 4,
          "qid": "S4-Q04"
        },
        {
          "q": "How will you prove the chemo is worth what it takes from me?",
          "gt": "I understand the weight of this decision. In high‑grade serous ovarian cancer, the standard carboplatin‑paclitaxel regimen after optimal cytoreduction improves median overall survival by about 6–8 months compared with surgery alone, and it extends progression‑free survival by 4–6 months. These numbers come from large, randomized trials (e.g., GOG‑0213, ICON7) and are the benchmark for “worth.”  \n\nBeyond statistics, we look at your specific situation: the amount of residual disease after surgery, your performance status, and any BRCA or HR‑DNA status that could make PARP‑maintenance therapy add another 6–12 months of survival.  \n\nWe also track your quality of life: pain relief, ability to teach, and time with your daughter. If the side‑effect burden outweighs these gains, we can adjust the plan.  \n\nSo, the proof comes from both the evidence‑based survival benefit and the measurable improvement in your day‑to‑day life.",
          "order": 5,
          "qid": "S4-Q05"
        },
        {
          "q": "I’m terrified of neuropathy making me drop dishes at school lunches. Can we prevent or manage it?",
          "gt": "I’m really sorry you’re feeling so anxious—neuropathy is a common concern with paclitaxel, but there are practical steps to reduce its risk and keep you safe at school.\n\n**Pre‑emptive measures**  \n- **Dose‑adjusted schedule**: Your oncologist can use a lower paclitaxel dose or a weekly regimen, which often lowers neuropathy while still treating the cancer.  \n- **Growth factor support**: G‑CSF can help keep white‑cell counts stable, allowing you to stay on schedule without dose reductions.  \n- **Lifestyle tweaks**: Avoid alcohol, keep blood sugar stable, and maintain a balanced diet rich in B‑vitamins and omega‑3s—these may help nerve health.  \n\n**Early detection & management**  \n- **Regular checks**: Every visit, ask for a quick neuropathy screen (pin‑prick, vibration).  \n- **Medications**: If symptoms appear, duloxetine (often the first line) or gabapentin can relieve pain and numbness.  \n- **Supportive care**: Physical therapy, hand‑strengthening exercises, and occupational therapy can improve grip and coordination.  \n\n**Practical school tips**  \n- Use a sturdy dish holder or a tray with a non‑slip base.  \n- Keep a small, weighted bag for dishes so you can hold them with one hand if needed.  \n- If you feel numbness, pause and rest your hand before handling dishes.\n\nSpeak with your oncology team about dose‑adjusted schedules and early neuropathy monitoring. With these steps, you can stay safer and keep your teaching routine as smooth as possible.",
          "order": 6,
          "qid": "S4-Q06"
        },
        {
          "q": "If surgery can’t remove everything, does that mean we failed?",
          "gt": "No, it isn’t a failure.  \nThe goal of cytoreductive surgery is to remove as much visible tumor as safely possible.  In high‑grade serous ovarian cancer, microscopic disease often remains, and that is expected.  What matters most is how the remaining cancer responds to chemotherapy and maintenance therapy, and how long you stay free of progression.  Even with residual disease, many patients achieve long periods of remission and maintain a good quality of life.  Think of surgery as the first, most aggressive step; the subsequent chemo, targeted agents, and genetic testing help control what’s left.  Your treatment team will adjust the plan to maximize your chances of a meaningful, hopeful outcome.",
          "order": 7,
          "qid": "S4-Q07"
        },
        {
          "q": "What will maintenance therapy look like if I respond?",
          "gt": "After surgery and 6 cycles of carboplatin/paclitaxel, a “good” response usually leads to a maintenance phase that keeps the cancer in check while you try to preserve quality of life.\n\n**PARP inhibitor**  \n– If your tumor is BRCA‑mutated or shows homologous‑repair deficiency (HRD‑positive), you’ll likely receive a PARP inhibitor (olaparib, niraparib, or rucaparib) for about 2 years.  \n– Daily oral dosing, with routine blood counts and liver‑function checks; common side effects are fatigue, nausea, and low blood counts.\n\n**Bevacizumab**  \n– If the disease is high‑risk or you’re HRD‑negative, bevacizumab (an anti‑VEGF antibody) may be given every 3 weeks for ~18 months.  \n– Monitor blood pressure, proteinuria, and watch for bleeding or wound‑healing issues.\n\n**Clinical trials**  \n– You’ll be screened for trials that combine PARP inhibitors with other agents or novel drugs.\n\nYour oncologist will tailor the exact schedule and monitor you closely, aiming to keep the cancer dormant while minimizing side‑effects.",
          "order": 8,
          "qid": "S4-Q08"
        },
        {
          "q": "I want to plan one normal family trip between cycles. Is that realistic?",
          "gt": "It’s absolutely possible to plan a short family trip between cycles, but timing and logistics matter. After each 3‑week cycle, you’ll have a “rest” week (days 1–7) when your blood counts are recovering and you’re usually less fatigued. Schedule the trip during that window, and keep it brief (1–3 days) to avoid over‑exertion. Choose a low‑stress destination—ideally a place you can stay in a single location, with easy access to medical care if needed. Pack a small medical kit (antibiotics, pain meds, hydration supplies) and carry your chemo‑plan and contact info for your oncology team. Discuss the itinerary with your oncologist; they can advise on any travel restrictions (e.g., avoiding crowded places if your white‑cell count is low). With careful planning, a short family getaway can be a welcome break and a chance to reconnect without compromising your treatment.",
          "order": 9,
          "qid": "S4-Q09"
        },
        {
          "q": "What should my daughter say if someone at school asks if I’m dying?",
          "gt": "If a teacher or classmate asks, your daughter can keep it short, honest, and respectful.  \n“Mom’s dealing with a serious health issue—she’s in treatment and we’re hopeful. She’s not dying right now.”  \n\nIf she feels uncomfortable sharing details, she can say, “I don’t want to talk about it, but thank you for asking.”  \n\nThis lets the person know the situation is serious but not terminal, respects privacy, and keeps the conversation brief and supportive.",
          "order": 10,
          "qid": "S4-Q10"
        }
      ]
    },
    {
      "id": "S5",
      "title": "The drummer who counts rests (glioblastoma after surgery)",
      "diagnosis": "Glioblastoma after maximal safe resection",
      "treatment_plan": "Concurrent radiation (~6 weeks) with daily temozolomide; then adjuvant temozolomide 5 days every 28 days for several cycles; consider tumor-treating fields; symptom management and rehab",
      "narrative": "I'm 58, a drummer. They removed what they could and now it's radiation with daily chemo. I keep practicing rudiments to feel normal, but the rests feel longer than the notes.",
      "qa": [
        {
          "q": "If my thinking slows or words jam, how do I stay myself in front of a band that's never seen me drop a beat?",
          "gt": "I’m sorry you’re dealing with this. Temozolomide and radiation can slow thinking, but you can still keep your groove.  \n\n1. **Rehearse the “slow‑down”** – practice the set at a reduced tempo and add a visual cue (a hand signal or a light) that tells you to pause or reset.  \n2. **Use a metronome or click‑track** – it anchors your timing even when your mind lags.  \n3. **Keep a quick‑reference sheet** – write key phrases or chord changes on a small card you can glance at if you feel a “jam.”  \n4. **Communicate with the band** – let them know you may need a brief pause; most musicians will respect that.  \n5. **Mindful breathing** – a 4‑2‑4 inhale‑hold‑exhale pattern steadies focus and reduces anxiety.  \n6. **Ask for neuro‑cognitive support** – discuss with your oncologist about medications or cognitive‑rehab strategies that may help.  \n\nRemember, the band’s rhythm is a partnership; a brief pause is part of the music, not a flaw.",
          "order": 1,
          "qid": "S5-Q01"
        },
        {
          "q": "I’m afraid of seizing on stage. Do I have to quit performing altogether?",
          "gt": "It’s understandable to worry about a seizure while playing. Most people with glioblastoma who are on antiepileptic drugs (AEDs) and have no recent seizures can continue performing safely, but it requires careful planning.\n\n1. **Medication & Monitoring** – Keep your AED level in the therapeutic range and have regular neurologic checks. If you’ve had a seizure, your doctor may adjust the dose or add a second AED.\n2. **Trigger Awareness** – Avoid extreme fatigue, dehydration, and sudden changes in lighting or sound that can precipitate seizures. Practice in a controlled environment first.\n3. **Safety Plan** – Have a trusted bandmate or stage crew ready to help if you feel a seizure coming. Consider a protective head‑gear or a “seizure‑aware” stage setup.\n4. **Gradual Return** – Start with short rehearsal sessions, gradually increasing duration as you feel comfortable and your doctor approves.\n\nIf your neurologist and oncologist feel your seizure risk is low, you don’t have to quit entirely. Work closely with them, stay on medication, and use a safety plan to keep performing safely.",
          "order": 2,
          "qid": "S5-Q02"
        },
        {
          "q": "How do we tell real tumor growth from treatment swelling so I don't live scan to scan in panic?",
          "gt": "I’m sorry you’re feeling so anxious.  In the first 6–8 weeks after surgery and during concurrent chemoradiation, MRI changes are usually **post‑operative edema and radiation‑induced inflammation**—they can look like a growing mass but tend to improve with steroids and time.  Recurrence typically appears later (often 3–6 months) and usually shows **increased contrast enhancement, new necrosis, or a “ring” pattern** that does not respond to steroids.  \n\n**What to watch for:**  \n- New or worsening focal neurological deficits (e.g., weakness, speech changes)  \n- Rapidly enlarging lesion on MRI that does not shrink with steroids  \n- Persistent or increasing edema despite optimal steroid dosing  \n\n**When to call:** If you develop new deficits, severe headaches, or the MRI shows a lesion that grows or fails to respond to steroids, contact your neuro‑oncology team immediately.  \n\nYour imaging schedule (typically every 2–3 months after completion of chemoradiation) is designed to catch true progression early while avoiding unnecessary scans. Trust the team’s plan, and keep a symptom diary—this helps differentiate treatment effects from real growth.",
          "order": 3,
          "qid": "S5-Q03"
        },
        {
          "q": "Steroids make me feel wired and unlike myself. Can we limit them?",
          "gt": "Steroids (usually dexamethasone) are kept on the lowest dose that controls swelling and keeps you comfortable.  They can indeed make you feel “wired,” cause mood swings, insomnia, or high blood sugar.  Here’s what you can discuss with your neuro‑oncologist:\n\n1. **Taper schedule** – Gradually reduce the dose (e.g., 4 mg → 3 mg → 2 mg → 1 mg every 3–5 days) rather than stopping abruptly.  \n2. **Lowest effective dose** – If 2 mg/day keeps your symptoms in check, that’s usually the target.  \n3. **Steroid‑sparing options** – For refractory edema, bevacizumab or a short course of a different steroid (e.g., methylprednisolone) can be tried.  \n4. **Monitoring** – Keep an eye on blood sugar, blood pressure, mood, and seizure activity; report any changes promptly.  \n5. **Adjunct measures** – Adequate sleep, hydration, and a balanced diet can help offset steroid side‑effects.\n\nWork closely with your team to find the minimal dose that keeps you safe and lets you keep drumming.",
          "order": 4,
          "qid": "S5-Q04"
        },
        {
          "q": "Does wearing tumor-treating fields make me look 'sick' all the time? Is it worth it?",
          "gt": "Tumor‑treating fields (TTF) are worn on the scalp with a small, lightweight device that delivers low‑intensity electrical fields. The electrodes look like a thin cap or a set of adhesive pads, so you’re not “sick” in the way a hospital gown might make you feel. Many patients report that the device is discreet enough to wear under a hat or even a baseball cap, and most people who see you don’t notice anything unusual.\n\nThe evidence shows that adding TTF to standard temozolomide after surgery can extend overall survival by about 6–7 months in average‑age patients, and it’s generally well tolerated. The main trade‑offs are skin irritation at the electrode sites and a small increase in fatigue. If you value the modest survival benefit and can manage the skin care, TTF is usually worth it. Discuss with your neuro‑oncology team about the best placement and skin‑care routine to keep it as inconspicuous as possible.",
          "order": 5,
          "qid": "S5-Q05"
        },
        {
          "q": "What does MGMT or IDH status actually change for me?",
          "gt": "MGMT promoter methylation and IDH mutation are *prognostic* and *predictive* markers, not surgical or radiation decisions.  \n\n**MGMT (O‑6‑methylguanine‑DNA methyltransferase)**  \n- If the promoter is **methylated**, the tumor’s DNA repair is impaired, so it tends to respond better to temozolomide.  \n- You’ll likely see a modest survival advantage (≈2–3 months) and may tolerate the daily chemo more comfortably.  \n- If unmethylated, the benefit of temozolomide is less clear; clinicians may consider alternative regimens or clinical trials.\n\n**IDH (isocitrate dehydrogenase) mutation**  \n- An IDH‑mutated glioblastoma is rare but carries a *much better overall prognosis* (median survival >2 years vs ~15 months for IDH‑wildtype).  \n- It may broaden eligibility for certain clinical trials and can influence long‑term expectations.\n\nIn short, these tests help you and your team gauge how aggressively the tumor may respond to standard therapy and what your overall outlook might be, but they don’t change the surgery or radiation plan you’re already following.",
          "order": 6,
          "qid": "S5-Q06"
        },
        {
          "q": "I want to leave my family something more than fear. What can we set up now?",
          "gt": "I’m glad you’re thinking ahead. Here are a few practical steps that can give your family a lasting, positive legacy:\n\n1. **Legacy Letter/Video** – Record a short message or write a letter to your loved ones. Share your hopes, memories, and what matters most to you. Store it in a safe place (cloud, USB, or a physical safe).\n\n2. **Music Time Capsule** – Curate a playlist of your favorite drum tracks, record a few short drum lessons or a “family drum circle” video, and include a note about how music has shaped your life. Add photos or a small instrument (e.g., a drumstick) to a memory box.\n\n3. **Future‑Date Letter** – Write a letter to be opened on a specific future date (e.g., your 70th birthday or a family reunion). It can be a source of comfort and continuity.\n\n4. **Legal & Financial Planning** – Review or create a living will, durable power of attorney, and a simple will. Even a basic “letter of intent” can clarify your wishes and reduce uncertainty for your family.\n\n5. **Charitable Tribute** – Consider setting up a small donation or scholarship in your name (e.g., to a music program or glioblastoma research). It extends your impact beyond your immediate circle.\n\n6. **Daily Rituals** – Keep a brief daily journal or a “thank‑you” note to your family. Even a few lines can become a treasured record of your resilience.\n\nThese actions turn your experience into a tangible, hopeful gift for those you love.",
          "order": 7,
          "qid": "S5-Q07"
        },
        {
          "q": "If the tumor returns, what are the realistic next steps?",
          "gt": "If imaging shows a recurrence, the next steps are guided by the tumor’s location, prior treatment, and your overall health.  \n1. **Multidisciplinary review** – neurosurgery, neuro‑oncology, radiation oncology, and palliative care meet to decide feasibility of a second resection.  \n2. **Re‑irradiation** – stereotactic radiosurgery or hypofractionated external beam can be considered if the dose to normal brain is acceptable.  \n3. **Systemic therapy** – options include bevacizumab (anti‑VEGF), lomustine, or a clinical‑trial agent; choice depends on MGMT methylation, IDH status, and prior temozolomide exposure.  \n4. **Tumor‑treating fields (TTF)** – can be added if not already used.  \n5. **Supportive care** – symptom control, rehabilitation, and psychosocial support remain essential.  \n\nDiscuss each option with your team to align treatment with your goals and quality‑of‑life priorities.",
          "order": 8,
          "qid": "S5-Q08"
        },
        {
          "q": "How do I protect my energy so I’m not sleeping through the parts of life I want to be awake for?",
          "gt": "I’m glad you’re staying active—music can be a powerful anchor. Here are a few practical steps to conserve energy while you’re on radiation/temozolomide:\n\n1. **Prioritize sleep hygiene** – aim for 7–8 h nightly, keep a consistent bedtime, and use a cool, dark room. If you’re feeling drowsy during the day, short 20‑minute naps can reset your alertness without disrupting nighttime sleep.\n\n2. **Pace your practice** – break sessions into 15‑20 min blocks with 5‑min rest in between. Use a metronome or drum pad to keep a steady rhythm; the “rests” can become intentional breathing breaks.\n\n3. **Nutrition & hydration** – a balanced diet with protein, complex carbs, and plenty of fluids fuels both brain and body. Small, frequent meals keep blood sugar steady.\n\n4. **Medication side‑effects** – discuss with your oncologist any fatigue‑relieving options (e.g., low‑dose stimulants, dexamethasone for edema, anti‑emetics). Adjusting temozolomide dose or schedule may help if fatigue is severe.\n\n5. **Supportive care** – a neuro‑oncology nurse or palliative‑care team can monitor mood, pain, and fatigue, and refer you to physical or occupational therapy for energy‑conservation strategies.\n\n6. **Mind‑body tools** – gentle stretching, short meditation, or listening to calming music between drumming can recharge you without exhausting you.\n\nRemember, it’s okay to let some parts of a practice sit for a day or two. Your brain needs rest to heal, and protecting that energy will let you keep playing the parts that matter most.",
          "order": 9,
          "qid": "S5-Q09"
        },
        {
          "q": "How do I ask for help without feeling like a burden?",
          "gt": "It’s normal to feel hesitant, but asking for help is a form of self‑care, not a burden.  \n1. **Clarify what you need** – Is it help with medication reminders, transportation, meal prep, or emotional support?  \n2. **Use “I” statements** – “I’m finding it hard to keep up with my chemo schedule; could you help me set up a reminder system?”  \n3. **Pick the right person** – A close friend, family member, or a caregiver who already cares about you; they’ll feel honored to help.  \n4. **Offer a specific ask** – “Could you drive me to the clinic next week?” or “Would you mind checking in on me after my radiation session?”  \n5. **Reassure them** – “Your support means a lot to me; it’s not a burden, it’s part of my recovery.”  \n6. **Leverage resources** – Ask your oncology team about home‑health aides, patient‑navigator services, or local support groups.  \n\nRemember, you’re not a burden—you’re a patient who deserves help and support.",
          "order": 10,
          "qid": "S5-Q10"
        }
      ]
    },
    {
      "id": "S6",
      "title": "Driver with the detour (locally advanced rectal cancer, total neoadjuvant therapy)",
      "diagnosis": "Locally advanced rectal adenocarcinoma",
      "treatment_plan": "Total neoadjuvant therapy: chemoradiation (~5–6 weeks), systemic chemotherapy for several months, then surgery depending on response; possible temporary ostomy; consideration of watch-and-wait if complete clinical response",
      "narrative": "I'm 62 and drive a city bus. Treatment will be chemoradiation, then systemic chemo, then maybe surgery. I keep picturing an ostomy and panicking about the smell on a crowded route.",
      "qa": [
        {
          "q": "I can’t stop imagining a bag leaking while I’m on shift. What’s real versus fear, and who teaches me to manage it if I need one?",
          "gt": "It’s normal to worry, but most patients who need a temporary ostomy after rectal cancer treatment learn to manage it safely on the job.  \n**Real risk** – About 20‑30 % of patients with locally advanced rectal cancer receive a diverting ileostomy or colostomy. The chance of a “leak” that would interrupt a bus shift is very low once the bag is fitted and the skin is protected.  \n**What to do** –  \n1. **Ask your surgeon** if a temporary ostomy is likely and whether a “watch‑and‑wait” approach could avoid it.  \n2. **Stoma‑nurse education**: they’ll teach you how to change the bag, use skin‑barrier products, and check for leaks.  \n3. **Occupational‑therapy or bus‑company support** can help you adapt your route and schedule breaks for care.  \n4. **Practice**: try a mock change at home; confidence reduces anxiety.  \n\nWith proper training and support, most drivers return to work with no interruption.",
          "order": 1,
          "qid": "S6-Q01"
        },
        {
          "q": "Is watch-and-wait a real option if the tumor melts away, or just internet rumor?",
          "gt": "Yes—watch‑and‑wait is a real, evidence‑based option for a carefully selected group of patients whose rectal cancer shows a **complete clinical response (cCR)** after total neoadjuvant therapy (TNT). In such cases, the tumor is no longer visible on MRI, endoscopy, and digital rectal exam, and the patient has no residual symptoms. Instead of immediate surgery, the patient is monitored with frequent imaging, endoscopy, and clinical exams (often every 3–6 months for the first 2 years, then less often). If the cancer recurs, prompt surgery is performed.  \n\nWatch‑and‑wait is **not** for everyone; it requires a multidisciplinary team, strict surveillance, and patient commitment. It can spare many people from an ostomy or major surgery, but it is not a “rumor”—it is an established, carefully studied strategy in high‑volume centers. If you’re concerned about an ostomy’s impact on your bus route, discuss watch‑and‑wait with your oncologist; it may be a realistic, safe alternative for you.",
          "order": 2,
          "qid": "S6-Q02"
        },
        {
          "q": "I’m scared of incontinence after treatment. Can we do anything to protect function?",
          "gt": "I understand how worrying this is, especially with your job. The goal of total neoadjuvant therapy is to shrink the tumor before surgery, which often allows a sphincter‑sparing operation (low anterior resection or intersphincteric resection) instead of a permanent colostomy.  \n\n**What can help preserve function**\n\n| Step | Practical tip |\n|------|---------------|\n| **Pre‑treatment** | • Pelvic‑floor physiotherapy to strengthen the anal sphincter.<br>• Dietitian guidance to avoid constipation or diarrhea that can strain the sphincter. |\n| **During chemoradiation** | • Intensity‑modulated RT (IMRT) or volumetric‑modulated arc therapy (VMAT) limits dose to the anal sphincter. |\n| **Surgery** | • Surgeons use intra‑operative nerve‑sparing techniques and may perform a “watch‑and‑wait” if you achieve a complete clinical response, avoiding surgery altogether. |\n| **Post‑op** | • Early pelvic‑floor rehab, biofeedback, and medications (e.g., antidiarrheals, stool softeners) can reduce urgency and leakage. |\n| **If a temporary ostomy is needed** | • Stoma care education and support can make it manageable; many patients close the stoma after a few months. |\n\nDiscuss these options with your multidisciplinary team. Most patients who receive total neoadjuvant therapy and a sphincter‑sparing approach maintain good bowel control, and early rehabilitation makes a big difference.",
          "order": 3,
          "qid": "S6-Q03"
        },
        {
          "q": "How do we schedule treatment so I’m not nodding off at the wheel?",
          "gt": "I’m sorry you’re feeling so anxious—your safety and the safety of your passengers are top priorities. Here’s a practical plan you can discuss with your oncology team:\n\n1. **Schedule treatments on non‑workdays or early in the week** (e.g., Monday–Wednesday) so you have a full day to recover before driving again.  \n2. **Avoid driving during the first 24–48 h after a chemotherapy infusion** or a radiation session, when fatigue, nausea, or dizziness can peak.  \n3. **Use “buffer” days**: if you feel unwell, arrange a ride‑share, bus‑driver colleague, or a short‑term temporary leave.  \n4. **Ask about supportive medications** (anti‑emetics, sleep aids) that can be timed to minimize daytime drowsiness.  \n5. **Monitor side‑effect peaks**: keep a simple log of energy levels and share it with your team; they can adjust doses or add breaks if needed.  \n6. **Consider a temporary shift change** or a short break from driving during the most intense part of therapy, then return once you’re stable.  \n\nBy coordinating timing, using support, and keeping open communication with your employer and medical team, you can maintain safe driving while completing your treatment.",
          "order": 4,
          "qid": "S6-Q04"
        },
        {
          "q": "Will intimacy be possible after all this, or are we pretending?",
          "gt": "It’s very common to worry about sex after rectal cancer treatment, but most people do resume intimacy. After chemoradiation and systemic chemo you’ll likely have some fatigue and temporary bowel changes; a temporary ostomy can be managed with a pouch that’s discreet and odor‑controlled. Once the pouch is in place, many patients find that sexual activity is still possible—often with a few adjustments.  \n\n**What to expect:**  \n- **Pelvic floor**: Radiation can weaken muscles; pelvic‑floor exercises or a physiotherapist can help.  \n- **Sexual function**: Men may experience erectile dysfunction; medications (PDE‑5 inhibitors) or vacuum devices can help. Women may have vaginal dryness; lubricants or estrogen creams can ease intercourse.  \n- **Timing**: Wait until you feel physically ready—usually a few weeks after completing chemo and any surgery.  \n- **Support**: Discuss concerns with your surgeon, stoma nurse, and a sexual‑health counselor; they can give tailored advice and resources.  \n\nSo, intimacy is very much possible—just give yourself time, use the tools available, and keep the conversation open with your care team.",
          "order": 5,
          "qid": "S6-Q05"
        },
        {
          "q": "If chemo knocks me down, do we push through or change course?",
          "gt": "If the chemotherapy makes you feel “knocked down,” the first step is to talk to your oncology team right away. Most regimens have built‑in dose‑reduction or short‑break options that let you keep the overall plan while giving your body time to recover. You’ll get supportive medications (anti‑nausea, growth factors, hydration) and close monitoring of blood counts and organ function.  \n\nOnly if you develop a grade 3–4 toxicity (severe neutropenia, uncontrolled vomiting, or organ damage) would the team consider changing the drug or stopping it altogether.  \n\nIn the meantime, discuss your driving schedule with your employer and the oncologist. If you need a temporary break from the bus route, that can usually be arranged without jeopardizing the treatment plan. The goal is to keep you safe, healthy, and on track for the best possible outcome.",
          "order": 6,
          "qid": "S6-Q06"
        },
        {
          "q": "What should I eat when everything upsets my stomach on radiation days?",
          "gt": "When radiation makes your stomach feel like a storm, keep meals **bland, low‑fiber, and easy to digest**.  \n- **Small, frequent portions** (4–6 times a day) rather than large meals.  \n- **Low‑fat, low‑spice foods**: plain toast, rice, oatmeal, boiled or steamed potatoes, plain pasta, and well‑cooked vegetables (carrots, zucchini).  \n- **Protein sources** that are gentle: scrambled eggs, plain Greek yogurt, cottage cheese, or a small scoop of protein powder in a smoothie.  \n- **Hydration**: water, clear broths, electrolyte drinks, or diluted fruit juice. Avoid carbonated drinks, caffeine, and alcohol.  \n- **Avoid**: fried or greasy foods, high‑fiber items (raw broccoli, beans, whole grains), spicy sauces, and very hot or very cold foods.  \nIf nausea persists, try a bland smoothie (banana, plain yogurt, a splash of oat milk) or a small bowl of applesauce. Keep a food diary and discuss any persistent issues with your oncology dietitian.",
          "order": 7,
          "qid": "S6-Q07"
        },
        {
          "q": "How will you decide if surgery can spare my sphincter?",
          "gt": "I’ll use a step‑by‑step, team‑based approach:\n\n1. **Baseline mapping** – A high‑resolution pelvic MRI and flexible sigmoidoscopy give the exact distance of the tumor from the anal verge and its size, nodal status, and involvement of the sphincter complex.\n\n2. **Response assessment** – After chemoradiation (and any additional systemic chemo), we repeat MRI and endoscopy. A clinical complete response (no palpable mass, normal mucosa, no residual tumor on imaging) is the key sign that the tumor has shrunk enough to consider sphincter preservation.\n\n3. **Surgical planning** – If the tumor is still ≥1–2 cm from the anal verge and the sphincter appears intact on imaging, a low anterior resection or trans‑anal local excision can be planned. If the tumor is very close or involves the sphincter, we may need a proctectomy with a permanent colostomy.\n\n4. **Multidisciplinary review** – The surgical oncologist, radiation oncologist, medical oncologist, and a colorectal surgeon discuss the imaging, your functional status, and your preferences (e.g., willingness to accept a temporary ostomy).\n\n5. **Shared decision** – We’ll explain the risks, benefits, and alternatives (including a watch‑and‑wait if you achieve a complete clinical response). Your comfort and safety on the bus route will guide the final plan.",
          "order": 8,
          "qid": "S6-Q08"
        },
        {
          "q": "If I choose a temporary ostomy, how long might I have it?",
          "gt": "A temporary ostomy after rectal surgery is usually a short‑term measure. Most patients have the stoma reversed within **4–6 weeks** once the surgical site has healed and any post‑radiation inflammation has subsided. In some cases—if there’s delayed healing, infection, or additional radiation‑related tissue changes—the reversal may be postponed to **8–12 weeks**. The exact timing is decided by your surgeon based on how quickly your bowel and skin recover. If you’re doing a watch‑and‑wait approach, no ostomy is needed at all. Remember, the temporary stoma is a protective step that lets you return to normal life (including driving) once it’s removed.",
          "order": 9,
          "qid": "S6-Q09"
        },
        {
          "q": "What’s the long-term follow-up so I’m not blindsided later?",
          "gt": "**Long‑term follow‑up (≈10–15 min)**  \n\n1. **Surveillance schedule**  \n   * **CEA & physical exam** every 3 months for 2 years, then every 6 months to year 5, then yearly.  \n   * **CT chest/abdomen/pelvis** every 6 months first 2 years, then yearly to year 5.  \n   * **Colonoscopy** 1 year after treatment, then every 3 years.  \n   * **Pelvic MRI** if you had a high‑risk tumor or residual disease.  \n\n2. **Late‑effect monitoring**  \n   * **Bowel function**: stool diary, stool‑softening diet, pelvic floor PT.  \n   * **Urinary/sexual health**: discuss with urology/gynecology if symptoms arise.  \n   * **Ostomy care**: regular stoma checks, pouch‑change schedule, contact stoma nurse for issues.  \n\n3. **Lifestyle & support**  \n   * Maintain a healthy weight, exercise, and avoid smoking.  \n   * Screen for depression/anxiety; consider counseling or support groups.  \n\n4. **Work‑related**  \n   * Discuss temporary leave or modified duties with your employer; you may need a brief break while you recover from chemoradiation.  \n\n5. **Emergency plan**  \n   * Keep your oncologist’s contact and a “next‑step” list (e.g., “if you notice bleeding, pain, or fever, call immediately”).  \n\nStaying on this schedule keeps you ahead of recurrence and late‑effects, so you can focus on driving safely and living well.",
          "order": 10,
          "qid": "S6-Q10"
        }
      ]
    },
    {
      "id": "S7",
      "title": "Senior year, sudden detour (bulky mediastinal Hodgkin lymphoma)",
      "diagnosis": "Classical Hodgkin lymphoma with bulky mediastinal disease",
      "treatment_plan": "ABVD every 2 weeks for 4–6 cycles (or regimen adjusted per interim PET); radiation may follow depending on response; fertility counseling before treatment",
      "narrative": "I'm 22, a college senior. I’m supposed to take graduation photos and go on a cross-country trip. Now it’s ABVD and maybe radiation.",
      "qa": [
        {
          "q": "How do I tell my friends without becoming the 'project' everyone hovers over?",
          "gt": "It’s perfectly fine to let your friends know what’s happening, but you can keep it brief and set clear boundaries.  \n1. **Pick a moment**—a quick chat or a short message works.  \n2. **Use “I” language**: “I’ve been diagnosed with Hodgkin lymphoma and will start ABVD. I’m focusing on treatment and recovery.”  \n3. **State what you need**: “I’d appreciate your support and understanding, but I don’t want to be a case study.”  \n4. **Offer updates on your own terms**: “I’ll share progress when I feel ready.”  \n5. **Invite specific help** (e.g., “Could you help me with grocery runs?”) rather than open-ended requests.  \n\nBy being honest yet concise, you give them the information they need without turning your journey into a project. Remember, you’re in control of how much you share and when.",
          "order": 1,
          "qid": "S7-Q01"
        },
        {
          "q": "Can we bank sperm without delaying chemo dangerously?",
          "gt": "Absolutely—sperm banking can be done quickly and won’t meaningfully delay your ABVD.  \n1. **Schedule a fertility consult ASAP** (often a same‑day or next‑day appointment).  \n2. **Provide a semen sample** (usually 1–2 days after the appointment).  \n3. The sample is frozen and stored; you can start chemo within 1–2 weeks of the first cycle, which is the typical window for ABVD.  \n\nIf you’re already in the middle of a cycle, a “quick‑bank” (a single sample) can still be done without postponing treatment. Talk to your oncologist and a reproductive specialist right away—most centers coordinate this in a single visit. This way you preserve fertility while staying on schedule for your lymphoma therapy.",
          "order": 2,
          "qid": "S7-Q02"
        },
        {
          "q": "What can I realistically expect from hair loss and timing so I can plan photos I won’t hate?",
          "gt": "ABVD is the mildest of the standard regimens for Hodgkin lymphoma.  You’ll usually see only **minimal thinning or a “scruffy” look**—not a full bald patch.  Hair loss, if it occurs, tends to appear **within 2–3 weeks after each 2‑week cycle** and is often reversible.  After the last cycle, most people notice regrowth within **3–6 months**; the first few weeks after treatment can be a bit patchy, but it improves quickly.  \n\nIf you’re worried about the graduation photos, plan to take them **after the first cycle** (when any thinning is mild) or **once the hair has started to come back**.  A lightweight hat, scarf, or a discreet wig can keep you comfortable and confident.  Radiation to the chest can add a little more scalp sensitivity, but it usually doesn’t cause significant hair loss.  Talk with your team about any specific concerns—they’ll tailor the plan to keep you looking and feeling your best.",
          "order": 3,
          "qid": "S7-Q03"
        },
        {
          "q": "If my PET after two cycles isn’t perfect, does that mean I failed?",
          "gt": "A “not‑perfect” interim PET (i.e., a residual uptake that isn’t completely resolved) doesn’t mean you’ve failed. In Hodgkin lymphoma, the PET after 2–4 cycles is used to gauge how well the disease is responding and to tailor the rest of the plan. If the scan shows a partial response, the oncologist may add more ABVD cycles, switch to a different regimen, or give involved‑field radiation—each option is designed to improve your outcome. If the scan is negative, you’ll likely finish the planned cycles. So, a less-than‑ideal PET is a signal to adjust, not a verdict of failure. Stay in close contact with your team; they’ll guide you through the next steps.",
          "order": 4,
          "qid": "S7-Q04"
        },
        {
          "q": "Will my lungs be okay for hiking later if I get bleomycin or chest radiation?",
          "gt": "I’m really sorry you’re facing this sudden change. Bleomycin and chest radiation can affect lung tissue, but the risk depends on dose, your age, and baseline lung health. In a 22‑year‑old who hasn’t smoked, the cumulative bleomycin dose for 4–6 ABVD cycles is usually below the threshold that causes significant fibrosis, and most patients recover normal lung function. Chest radiation for bulky mediastinum is often limited to 20–30 Gy; at that dose the long‑term risk of restrictive lung disease is low, especially if the field is carefully shaped.  \n\nYour team will do baseline pulmonary function tests and monitor you during treatment. If you’re concerned, discuss a PET‑adapted approach that may spare bleomycin or reduce radiation dose. With proper monitoring, most people return to normal activity—including hiking—after therapy. Stay in touch with your oncologist about any breathing changes, and avoid smoking or high‑altitude exposure until your lungs are fully evaluated.",
          "order": 5,
          "qid": "S7-Q05"
        },
        {
          "q": "Can I keep a piece of senior year—clubs, trip, something—without risking my health?",
          "gt": "It’s understandable you want to hold onto those senior‑year memories.  \n**Short, low‑risk activities are usually safe**—you can take a brief campus photo session or a short weekend trip before you start ABVD, as long as you’re not feeling fatigued or febrile.  \n**Longer or cross‑country travel is best postponed** until after the first 2–3 cycles, when your blood counts are usually stable and you’ve had a chance to recover from the initial chemotherapy.  \nIf you do travel, keep the itinerary simple: stay in a single city, avoid strenuous activities, and have a plan for medical care if you feel unwell.  \nDiscuss any travel plans with your oncology team; they can advise on timing, vaccination needs, and how to manage side‑effects on the road.  \nAbove all, prioritize your treatment schedule—your health and future graduation will be worth the brief delay.",
          "order": 6,
          "qid": "S7-Q06"
        },
        {
          "q": "What should I do about vaccines and infections with roommates coming and going?",
          "gt": "**Vaccines & Infection Prevention for Your ABVD Course**\n\n1. **Get pre‑treatment shots** (before the first cycle):  \n   • Influenza (annual)  \n   • Pneumococcal (PCV20 or PCV15 + PPSV23)  \n   • Varicella titer (or vaccine if non‑immune)  \n   • Hepatitis B (if not immune)  \n   • COVID‑19 booster (if not up‑to‑date)  \n\n   *Live vaccines are contraindicated during ABVD; schedule them only after therapy.*\n\n2. **Household hygiene**  \n   • Ask roommates to stay current on flu, COVID, and pneumococcal shots.  \n   • Encourage frequent hand‑washing, mask‑wearing in shared spaces, and avoiding close contact with anyone who is sick.  \n\n3. **During treatment**  \n   • Limit large gatherings and travel until after your last cycle.  \n   • Keep a clean, well‑ventilated living area; use disinfectants on high‑touch surfaces.  \n\n4. **If you feel feverish or have a sore throat**  \n   • Notify your oncology team immediately; they’ll guide you on antibiotics or further evaluation.  \n\nBy staying vaccinated and practicing good hygiene, you’ll reduce infection risk for both you and your roommates while you focus on treatment.",
          "order": 7,
          "qid": "S7-Q07"
        },
        {
          "q": "How do I handle dating and the 'big C' conversation without scaring someone off?",
          "gt": "It’s normal to feel nervous, but honesty is the safest route. Pick a calm moment—maybe after a treatment session or a casual hang‑out—and say something like, “I want to share something important about my health. I’ve been diagnosed with Hodgkin lymphoma and I’m on ABVD. I’m actively treating it and my doctors are optimistic.” Keep it brief, focus on the facts, and let the conversation flow naturally.  \n\nShow what you’re doing to stay healthy: mention your treatment plan, the support you have, and how you’re coping. If your date asks about side effects or future plans, answer honestly but also reassure them that you’re still the same person you were before the diagnosis.  \n\nIf you’re unsure, practice what you’ll say or write it down. You can also ask a close friend or counselor to help you frame the conversation. Remember, a supportive partner will appreciate your openness and the courage it takes to share.",
          "order": 8,
          "qid": "S7-Q08"
        },
        {
          "q": "Is alcohol totally off-limits during treatment?",
          "gt": "Alcohol isn’t recommended while you’re on ABVD (or any chemotherapy). Even moderate drinking can interfere with how your body metabolizes the drugs, increase liver toxicity, and worsen side‑effects such as nausea, fatigue, and mouth sores. It can also dampen your immune system, which is already compromised by treatment, and may impair wound healing if you receive radiation. Most oncologists advise complete abstinence during the entire chemotherapy course and for a few weeks afterward. If you’re struggling with the idea of giving up alcohol, talk to your oncology team—they can offer coping strategies, support groups, or a plan to gradually reduce intake. Your health and recovery are the priority, and staying alcohol‑free helps you stay on track with treatment and minimize complications.",
          "order": 9,
          "qid": "S7-Q09"
        },
        {
          "q": "What does life look like if treatment works—am I always looking over my shoulder?",
          "gt": "If ABVD (and any needed radiation) puts you into a complete remission, most people return to a normal, active life. You’ll still have routine follow‑ups—physical exams, blood tests, and sometimes imaging every 3–6 months for the first 2–3 years, then yearly for 5–10 years—to catch a relapse early. The chance of relapse after a good response is low (≈10–15 % in early‑stage bulky disease), and most relapses are still curable.  \n\nLong‑term concerns are mainly late effects: heart toxicity from ABVD, a small risk of secondary leukemia, and, if you had radiation, a slight increase in secondary cancers. Healthy habits (exercise, balanced diet, no smoking, sun protection) and regular cardiac monitoring help mitigate these risks.  \n\nSo, while you’ll keep an eye on your health, you won’t need to live in constant fear—many survivors resume normal careers, relationships, and adventures.",
          "order": 10,
          "qid": "S7-Q10"
        }
      ]
    },
    {
      "id": "S8",
      "title": "Coder with a countdown (chronic-phase CML on TKI)",
      "diagnosis": "Chronic-phase chronic myeloid leukemia",
      "treatment_plan": "Daily oral tyrosine kinase inhibitor; regular BCR-ABL monitoring with specific molecular milestones; consider treatment-free remission after deep, stable response",
      "narrative": "I'm 29, a software engineer with chronic-phase CML. I look fine, but the word 'leukemia' keeps crashing my thoughts. They’re starting me on a daily TKI pill.",
      "qa": [
        {
          "q": "How do I keep working sprints when my brain pings 'I have leukemia' every 10 minutes?",
          "gt": "I’m sorry you’re feeling this way—leukemia can feel like a constant reminder, but it doesn’t have to derail your work.  \n1. **Set a “leukemia‑pause.”** Every 10–15 min, take a 1‑minute break: breathe, stretch, or jot the thought in a notebook.  \n2. **Use a “task‑focus” cue.** Keep a sticky note or a short‑term task list on your monitor. When the thought pops up, glance at the list and shift back to the next item.  \n3. **Schedule “mind‑reset” moments.** During your sprint planning, allocate a 5‑minute slot for a quick meditation or a short walk—this trains your brain to switch gears.  \n4. **Talk to your team.** A brief disclosure (“I’m managing CML; I’ll need short breaks”) can foster understanding and reduce anxiety.  \n5. **Seek support.** A therapist or CML support group can help you reframe the constant reminder into a manageable part of your routine.  \n\nRemember, TKIs often lead to deep, stable responses, so your leukemia is not a permanent obstacle—just a temporary challenge you can navigate with these tools.",
          "order": 1,
          "qid": "S8-Q01"
        },
        {
          "q": "What side effects actually show up day to day, not the terrifying list online?",
          "gt": "**Day‑to‑day “real” side effects (most people see them early on)**  \n\n| Symptom | Typical timing | What to do | Notes |\n|---------|----------------|------------|-------|\n| **Fatigue / low energy** | Often within the first week | Rest, short walks, caffeine if tolerated | Usually improves after 2–4 weeks as the disease burden drops. |\n| **Muscle cramps / aches** | 1–2 weeks | Gentle stretching, warm shower, magnesium supplement | Mild, not the severe “muscle‑pain” that some headlines warn about. |\n| **Mild diarrhea / loose stools** | 1–3 days | Stay hydrated, bland diet, over‑the‑counter anti‑diarrheal (e.g., loperamide) | Most resolve with a few days of supportive care. |\n| **Nausea / mild upset stomach** | 1–2 days | Take pill with food, ginger tea | Rarely severe; anti‑emetics are rarely needed. |\n| **Skin rash / itching** | 1–2 weeks | Topical hydrocortisone, antihistamine | Usually mild; severe rash is uncommon. |\n| **Edema (puffy hands/feet)** | 1–3 weeks | Elevate legs, low‑salt diet, compression socks | Often transient; adjust dose if persistent. |\n| **Mouth sores / dry mouth** | 1–2 weeks | Good oral hygiene, sugar‑free lozenges | Rarely painful enough to stop the drug. |\n| **Weight gain (≈1–2 lb)** | 2–4 weeks | Monitor diet, light exercise | Usually modest and reversible. |\n\n**What to keep in mind**\n\n* Most side effects are **mild, short‑lived, and manageable**.  \n* If anything feels worse than “just a bit annoying,” note it in a diary and bring it up at your next appointment.  \n* Serious toxicities (e.g., severe liver injury, pulmonary hypertension, or heart problems) are **rare** but are monitored with routine labs and imaging.  \n* Your oncologist can adjust the dose or switch to a different TKI if side effects persist.\n\n**Bottom line:** The daily pill may make you feel a little tired or give you a mild stomach upset, but most people find these side effects are easily handled and improve as the disease responds. Keep a simple symptom log and stay in touch with your care team—most of the scary headlines are about rare, severe events that are not the norm.",
          "order": 2,
          "qid": "S8-Q02"
        },
        {
          "q": "Do I have to give up my morning PPI and supplements?",
          "gt": "**Short answer:**  \nYou don’t have to stop your PPI or supplements entirely, but you’ll need to adjust timing (and sometimes the type) to avoid reducing the TKI’s absorption.\n\n**What to do**\n\n| Medication | Interaction | Practical tip |\n|------------|-------------|---------------|\n| **Imatinib, nilotinib, bosutinib, ponatinib** | PPIs lower stomach acidity → ↓ absorption | Take the TKI 1 h before breakfast or 2 h after the PPI. If you need daily acid suppression, consider an H₂ blocker (ranitidine) or a “low‑dose” PPI taken at night. |\n| **Dasatinib** | Less affected by PPIs, but still best to separate doses | Take dasatinib 1 h before breakfast or 2 h after the PPI. |\n| **Calcium, magnesium, iron, zinc, high‑dose vitamin D** | Bind to the TKI → ↓ absorption | Take these supplements 4–6 h after the TKI dose. |\n| **Herbal supplements (e.g., St. John’s wort, ginseng)** | Can induce CYP3A4 → ↓ TKI levels | Avoid or discuss with your pharmacist. |\n\n**Bottom line:**  \nAdjust the timing of your PPI and supplements, or switch to an H₂ blocker if you need continuous acid suppression. Always check with your oncologist or pharmacist before making changes.",
          "order": 3,
          "qid": "S8-Q03"
        },
        {
          "q": "How do you know this pill is truly working and not just wishful thinking?",
          "gt": "I understand the anxiety that “leukemia” brings, even when you feel fine. The pill’s effect is measured, not imagined. Every 3–6 weeks you’ll have a blood draw for a quantitative PCR that reports the BCR‑ABL transcript level as a percentage of a standardized baseline. In chronic‑phase CML the goal is a 3.0 log reduction (≤0.1 % IS) by 12 months, then a deeper “MR4” (≤0.01 %) by 18–24 months. These milestones are validated in clinical trials and predict long‑term survival. Your doctor will also monitor complete blood counts, liver enzymes, and any side‑effects to confirm the drug is working and tolerable. If the numbers stay stable or improve, the pill is truly doing its job—your body’s response, not wishful thinking.",
          "order": 4,
          "qid": "S8-Q04"
        },
        {
          "q": "Could I ever stop treatment, or is this forever?",
          "gt": "I know it can feel overwhelming, but many patients find peace",
          "order": 5,
          "qid": "S8-Q05"
        },
        {
          "q": "I want kids in a couple years—how do we plan around pregnancy and this medication?",
          "gt": "You’re in a good spot to plan for pregnancy, but the daily TKI is a key factor. All first‑line TKIs (imatinib, dasatinib, nilotinib, ponatinib) are teratogenic, so they must be stopped before conception.  \n\n**Steps to take now:**\n\n1. **Talk to your hematologist** about your pregnancy plans.  \n2. **Aim for a deep, stable molecular remission** (BCR‑ABL ≤ 0.01 % for ≥12 months). If you’re already in treatment‑free remission (TFR), you can try to conceive while off drug.  \n3. **Stop the TKI 3 months before trying to conceive** and monitor BCR‑ABL every 4–6 weeks. If the disease flares, restart the TKI immediately.  \n4. **Fertility preservation**: consider oocyte or embryo freezing now, and sperm banking for your partner if you’re concerned about future fertility.  \n5. **Pregnancy monitoring**: once pregnant, you’ll need close coordination between obstetrics and oncology; most TKIs are avoided, but if relapse occurs, restarting after delivery is common.\n\nWith careful timing and monitoring, many patients successfully conceive and carry healthy pregnancies while keeping CML under control.",
          "order": 6,
          "qid": "S8-Q06"
        },
        {
          "q": "Travel matters to me—can I fly internationally and keep labs on schedule?",
          "gt": "Yes—international travel is usually safe for someone on a daily TKI, but a few practical steps help keep your monitoring on track.\n\n1. **Medication**: TKI is oral and can be taken during the flight. Pack at least 30 days’ worth, keep it in your carry‑on, and bring a copy of your prescription or a letter from your oncologist.  \n2. **Lab timing**: BCR‑ABL testing is done every 3–6 months in the first year, then every 6–12 months. Arrange a local lab or hospital in your destination to draw blood on the same day you would normally do it. Many countries have accredited labs that accept international samples.  \n3. **Documentation**: Carry a brief medical summary and your latest test results. Some airlines or immigration authorities may ask for a health clearance if you have a chronic condition.  \n4. **Coordination**: Notify your local oncologist (or a trusted GP) of your travel dates so they can review results and adjust dosing if needed.  \n5. **Side‑effect monitoring**: Keep a symptom diary; if you notice new or worsening side effects, seek care promptly.\n\nWith these steps, you can fly internationally while maintaining the rigorous monitoring your CML treatment requires.",
          "order": 7,
          "qid": "S8-Q07"
        },
        {
          "q": "What if I miss doses during crunch time at work?",
          "gt": "Missing a dose of your TKI during a busy workday is understandable, but consistency is key to keeping the BCR‑ABL transcript at a safe level.  \n**If you forget a dose:**  \n1. Take it as soon as you remember, unless it’s almost time for the next scheduled dose.  \n2. If it’s within 2–4 hours of the next dose, skip the missed one and resume your regular schedule—don’t double‑take.  \n3. If you’re unsure, call your oncology team; they can advise on the safest approach.  \n\n**Prevent future gaps:**  \n- Keep a pillbox or use a phone alarm set for the same time each day.  \n- Store the medication in a visible spot at work or bring a small, discreet container.  \n- If you’re traveling or on a shift change, set a reminder on your phone or use a smartwatch.  \n\nStaying on schedule keeps your response durable and reduces the risk of resistance. If you’re consistently missing doses, discuss alternative dosing schedules or support tools with your provider.",
          "order": 8,
          "qid": "S8-Q08"
        },
        {
          "q": "What’s my plan if side effects hit hard at 2 a.m.?",
          "gt": "**If a TKI side‑effect hits hard at 2 a.m., follow this quick plan:**\n\n1. **Assess severity**  \n   • Mild (nausea, fatigue, mild rash): take the pill with a full glass of water and a light snack, and consider an over‑the‑counter anti‑nausea (e.g., dimenhydrinate) if you’ve been cleared to use it.  \n   • Severe (vomiting, chest pain, severe dizziness, or any symptom that feels life‑threatening): call your oncology nurse line or go to the nearest emergency department immediately.\n\n2. **Document the episode**  \n   • Write down what you ate, the exact time, the intensity of symptoms, and any medications you took. This will help your team adjust your plan.\n\n3. **Adjust timing if needed**  \n   • If nighttime symptoms are common, ask your doctor if taking the TKI earlier in the day or splitting the dose (if the drug allows) helps.\n\n4. **Consider a dose tweak**  \n   • If you’re consistently having trouble, your hematologist may reduce the dose or switch to a different TKI (e.g., from imatinib to dasatinib or nilotinib) that your body tolerates better.\n\n5. **Supportive measures**  \n   • Stay hydrated, keep a small snack handy, and use a cool compress for headaches or muscle aches.  \n   • If nausea is frequent, a prescription anti‑emetic (e.g., ondansetron) can be added.\n\n**Bottom line:** Mild symptoms → food, water, and an anti‑nausea; severe symptoms → call your team right away. Keep a symptom log, and work with your oncologist to tweak timing or the drug if nighttime flare‑ups persist.",
          "order": 9,
          "qid": "S8-Q09"
        },
        {
          "q": "How do I tell my parents I’m okay when the word 'leukemia' makes them panic?",
          "gt": "**Start with the facts, then add reassurance.**  \n1. **Explain the diagnosis simply** – “I have chronic‑phase CML, a blood cancer that’s now a chronic condition.”  \n2. **Describe",
          "order": 10,
          "qid": "S8-Q10"
        }
      ]
    },
    {
      "id": "S9",
      "title": "Meeting my granddaughter (EGFR-mutated metastatic NSCLC)",
      "diagnosis": "EGFR-mutated metastatic non-small cell lung cancer",
      "treatment_plan": "Osimertinib oral therapy once daily; routine monitoring for rash, diarrhea, heart rhythm, and rare lung inflammation; imaging every 2–3 months",
      "narrative": "I'm 68, a soon-to-be grandfather with an EGFR mutation. I feel guilty about old smoking years and I'm terrified I won't be there to hold my granddaughter next month.",
      "qa": [
        {
          "q": "How quickly might my breathing ease so I can fly to meet her without gasping in the aisle?",
          "gt": "I’m sorry you’re feeling so anxious. Osimertinib often begins to relieve cough, wheeze, and shortness of breath within a few weeks, but the full radiologic response can take 3–6 months. If you notice a modest improvement in your breathing after 2–4 weeks, many patients feel comfortable traveling, especially if you have a routine of bronchodilators or low‑dose steroids that help during flights. However, if you still feel significant exertional dyspnea, or if you develop new cough or chest pain, you should contact your oncologist before booking a flight. They may recommend a short‑course of steroids, supplemental oxygen, or a brief pause in travel until your symptoms are better. In short, expect some relief in a few weeks, but plan the trip only after your doctor confirms it’s safe for you.",
          "order": 1,
          "qid": "S9-Q01"
        },
        {
          "q": "I read about dangerous lung inflammation from this pill. What would that feel like and what would we do?",
          "gt": "I’m sorry you’re worried—pneumonitis from osimertinib is rare but can be serious.  \n**What it feels like:**  \n- New or worsening cough (often dry)  \n- Shortness of breath or a feeling of tightness in the chest  \n- Low‑grade fever, chills, or fatigue  \n- Sometimes chest pain or a “tight” sensation that worsens with breathing  \n\n**What to do if it happens:**  \n1. **Stop the drug** immediately.  \n2. **Call your oncologist or go to urgent care**—they’ll arrange a chest X‑ray or CT scan and blood tests.  \n3. If imaging shows inflammation, the usual treatment is a tapering course of oral steroids (prednisone).  \n4. Your team will monitor oxygen levels, repeat imaging, and decide whether to restart osimertinib once the inflammation resolves.  \n\nEarly reporting of new breathing symptoms gives the best chance for a quick, effective response. Stay in close contact with your care team; they’ll keep you informed and supported.",
          "order": 2,
          "qid": "S9-Q02"
        },
        {
          "q": "Do I need to hide from crowds like airports and skip the baby to avoid infection?",
          "gt": "Osimertinib does **not** make you immunocompromised, so the risk of catching a serious infection is low. You don’t need to stay away from airports or avoid meeting your granddaughter entirely.  \n**Practical steps**:  \n- Wear a mask and practice hand‑washing or use alcohol gel, especially in crowded places.  \n- If you’re traveling, choose flights with fewer passengers, travel during off‑peak times, and keep a safe distance from others.  \n- Meet the baby outdoors or in a well‑ventilated space, keep a few feet apart, and consider a mask if you’re uncomfortable.  \n- Stay up to date on routine vaccines (influenza, COVID‑19, pneumococcal).  \n- If you develop fever, cough, or other infection signs, contact your oncologist promptly.  \n\nEnjoy the visit—your treatment plan keeps you healthy enough to be there.",
          "order": 3,
          "qid": "S9-Q03"
        },
        {
          "q": "Will I lose my hair or look 'sick' in photos?",
          "gt": "Osimertinib is a targeted EGFR inhibitor, not a chemotherapy drug, so it rarely causes the dramatic hair loss that people associate with “cancer treatment.” Most patients keep their hair and only notice mild fatigue, a light rash, or occasional diarrhea. If you do develop a rash, it’s usually mild and can be managed with topical creams or a short course of oral steroids. You’re unlikely to look noticeably “sick” in photos—just a little tired or with a mild skin flare. If anything, the side‑effect profile is mild enough that you can still enjoy the moment with your granddaughter. Keep your doctor informed of any rash or other symptoms, and they’ll help you stay comfortable.",
          "order": 4,
          "qid": "S9-Q04"
        },
        {
          "q": "I’m ashamed about past smoking. Does that change my prognosis or how you treat me?",
          "gt": "I’m sorry you’re carrying that guilt—many people feel the same, and it doesn’t change how we treat your cancer.  \nFor EGFR‑mutated NSCLC, the key factors that influence prognosis are the extent of disease, how well the tumor responds to osimertinib, and any comorbidities that might affect your overall health. Smoking history is a major risk factor for developing lung cancer, but once the cancer is diagnosed, it doesn’t alter the effectiveness of EGFR‑targeted therapy or the monitoring plan.  \n\nYour treatment—daily osimertinib with routine checks for rash, diarrhea, heart rhythm, and imaging every 2–3 months—remains the same. Focus on the present: keep up with appointments, report side‑effects early, and maintain a healthy lifestyle. You deserve the best care and the chance to be there for your granddaughter.",
          "order": 5,
          "qid": "S9-Q05"
        },
        {
          "q": "How will we know it’s working beyond me wanting it to be?",
          "gt": "You’ll know osimertinib is working by objective, measurable changes, not just how you feel.  \n\n1. **Imaging** – CT scans every 2–3 months will show tumor shrinkage or stable disease (no new lesions).  \n2. **Tumor markers** – If you have a measurable marker (e.g., CEA), a drop or plateau suggests response.  \n3. **Symptoms & performance** – Reduced cough, weight loss, fatigue, and improved ability to walk or do daily tasks are tangible signs.  \n4. **Physical exam** – Less lymphadenopathy or pleural effusion on exam.  \n5. **Lab tests** – Normalization of liver enzymes, blood counts, and absence of new organ dysfunction.  \n\nYour doctor will compare these data points to baseline; a consistent trend of improvement or stability confirms the drug is working.",
          "order": 6,
          "qid": "S9-Q06"
        },
        {
          "q": "What happens if or when the pill stops working?",
          "gt": "When osimertinib no longer controls the cancer, the disease will start to grow again.  On routine scans you’ll see new or enlarging lesions, or the existing ones will increase in size.  Symptoms may appear or worsen—shortness of breath, cough, weight loss, pain, or fatigue.  \n\nOnce progression is confirmed, the next step is to re‑biopsy or obtain a liquid biopsy to look for resistance mutations (e.g., EGFR T790M loss, C797S, MET amplification).  Depending on the findings, options include:\n\n* **Switch to another EGFR‑TKI** (e.g., a first‑generation drug if T790M is lost).  \n* **Add a MET inhibitor** or a HER2‑targeted agent if amplification is present.  \n* **Standard platinum‑based chemotherapy** with or without bevacizumab.  \n* **Clinical trials** (e.g., newer TKIs, combination therapies).  \n* **Palliative care** to manage symptoms and maintain quality of life.\n\nEarly discussion with your oncologist will help plan the best next step and keep you and your family prepared.",
          "order": 7,
          "qid": "S9-Q07"
        },
        {
          "q": "Can I stay active with my walking group, or should I rest more?",
          "gt": "It’s generally safe—and even beneficial—to keep up a light walking routine while on osimertinib, as long as you listen to your body.  \n- **Start small**: 10–15 min at a comfortable pace, gradually adding a few minutes each week.  \n- **Watch for symptoms**: Fatigue, shortness of breath, chest discomfort, or a sudden drop in energy should prompt you to pause and rest.  \n- **Monitor heart rhythm**: If you notice palpitations or irregularity, stop walking and notify your oncologist.  \n- **Stay hydrated and avoid overheating**—osimertinib can cause mild rash or diarrhea that may worsen with heat.  \n- **Keep a log**: Note how you feel after each walk; this helps your care team adjust activity levels.  \n\nIf you ever feel unusually tired or notice new symptoms, rest and discuss them with your oncologist. Walking can support both physical and emotional well‑being, so aim for a balanced approach—active enough to feel good, but not so hard that it compromises your health.",
          "order": 8,
          "qid": "S9-Q08"
        },
        {
          "q": "Are there heart checks I need to worry about?",
          "gt": "Osimertinib can lengthen the QT interval, which may increase the risk of arrhythmias.  \n**What to do:**  \n1. **Baseline ECG** before starting therapy (and a repeat after 2–4 weeks).  \n2. **Periodic ECGs** every 3–6 months, or sooner if you develop symptoms (palpitations, dizziness, fainting).  \n3. **Check electrolytes** (potassium, magnesium) at each visit, as low levels can worsen QT prolongation.  \n4. **Avoid other QT‑prolonging drugs** (certain antibiotics, antipsychotics, etc.) unless absolutely necessary.  \n5. **Watch for heart‑failure signs**—shortness of breath, swelling, or rapid weight gain—and report them promptly.  \n\nIf your ECG shows a prolonged QT, your oncologist may adjust the dose or add a cardiac‑protective strategy. Regular monitoring keeps the risk low and lets you focus on enjoying time with your granddaughter.",
          "order": 9,
          "qid": "S9-Q09"
        },
        {
          "q": "What’s my plan if diarrhea hits mid-flight?",
          "gt": "**Quick mid‑flight plan for osimertinib‑related diarrhea**\n\n1. **Hydrate immediately** – sip small amounts of water or an oral rehydration solution (e.g., Pedialyte) every 5–10 min.  \n2. **Use loperamide** – 2 mg after the first loose stool, then 1 mg after each subsequent stool. Do **not** exceed 8 mg/day.  \n3. **Eat light, bland foods** – toast, bananas, rice, applesauce; avoid dairy, caffeine, spicy or greasy foods.  \n4. **Monitor severity** – if you have >3 stools in 24 h, vomiting, fever, or blood, stop osimertinib and call your oncologist or the flight medical team.  \n5. **Carry essentials** – a small bag with water, electrolytes, loperamide, a note for flight attendants, and your oncologist’s contact.  \n6. **If dehydration signs appear** (dry mouth, dizziness, dark urine), seek urgent care immediately.  \n\nThis keeps you stable until you can resume normal care and reach your loved one.",
          "order": 10,
          "qid": "S9-Q10"
        }
      ]
    },
    {
      "id": "S10",
      "title": "Sunday dinners matter (metastatic pancreatic cancer)",
      "diagnosis": "Metastatic pancreatic adenocarcinoma with weight loss and pain",
      "treatment_plan": "Gemcitabine + nab-paclitaxel weekly for 3 weeks, then 1 week off (28-day cycles); symptom control; nutrition and enzyme support; reassessment each cycle",
      "narrative": "I'm 72, a retired teacher. Pain steals my sleep and I’m losing weight. My family’s Sunday dinner and church choir are my anchors. The plan is gemcitabine with nab-paclitaxel.",
      "qa": [
        {
          "q": "Can you get my pain under control now so I can sit through dinner without faking a smile?",
          "gt": "I’m sorry you’re in so much pain. The first step is to let your oncology team know how bad it is—pain scores and timing help them adjust therapy. In most cases, a short‑acting opioid (e.g., oxycodone or hydromorphone) taken 30–60 min before dinner can give you a few hours of relief. If the pain is more constant, a long‑acting opioid (like oxycodone‑extended release) plus a rescue dose for breakthrough pain is common.  \n\nAdd adjuvants that are inexpensive and low‑risk: acetaminophen, NSAIDs (if kidney function allows), or a low‑dose antidepressant (duloxetine) for neuropathic pain. If opioids alone don’t help, ask about a nerve block or a palliative‑care consult—these can dramatically reduce pain and improve quality of life.  \n\nKeep a simple pain diary (time, intensity, meds) and bring it to your next appointment; it gives the team the data they need to fine‑tune your plan. You deserve to enjoy Sunday dinner, not just survive it.",
          "order": 1,
          "qid": "S10-Q01"
        },
        {
          "q": "I can’t keep weight on and everything tastes wrong. What can actually help this week?",
          "gt": "I’m sorry you’re feeling so drained. Here are a few practical steps you can try this week:\n\n1. **Small, frequent meals** – 5–6 mini‑meals or snacks instead of 3 large ones. Aim for 300–500 kcal each (protein‑rich shakes, peanut butter, Greek yogurt, cheese, nuts).  \n2. **High‑calorie, high‑protein supplements** – a ready‑to‑drink formula (e.g., Ensure, Boost) or homemade smoothies with protein powder, avocado, nut butter, and a splash of milk.  \n3. **Flavor tricks** – use salt, lemon, vinegar, or a splash of soy sauce to enhance taste; try cold foods (ice cream, chilled soups) which often taste better.  \n4. **Pancreatic enzyme replacement** – take the prescribed pancrelipase with every meal to improve digestion and nutrient absorption.  \n5. **Pain control** – keep your pain meds on schedule; if pain spikes, call your oncologist or palliative team.  \n6. **Hydration** – sip water, broth, or electrolyte drinks throughout the day.  \n7. **Consider an appetite stimulant** – discuss megestrol acetate or dronabinol with your oncologist if appetite remains low.  \n\nIf weight loss continues or you feel overwhelmed, reach out to your oncology team or a palliative care specialist—they can tailor nutrition and symptom plans to your needs.",
          "order": 2,
          "qid": "S10-Q02"
        },
        {
          "q": "Will this treatment take all my 'good days,' or can we plan around choir and grandkids?",
          "gt": "I’m sorry you’re dealing with so much pain and weight loss. Gemcitabine + nab‑paclitaxel is given Monday‑Thursday, with a rest day Friday and a week off, so you can plan family time around the cycle. Most patients feel the heaviest fatigue after the first few days of chemo, but many still attend short choir rehearsals or sit with grandkids on the weekend.  \n\n**Practical tips**  \n- **Schedule**: Do chemo Monday‑Thursday, rest Friday, then Sunday dinner and church on Saturday or Sunday after the week‑off.  \n- **Energy**: Keep the choir session brief (15–20 min) and sit if you’re tired.  \n- **Support**: Use anti‑emetics, pain meds, and a high‑calorie, enzyme‑supplemented diet to keep strength.  \n- **Talk to your oncologist** about dose adjustments or a “chemo‑on‑demand” approach if fatigue becomes overwhelming.  \n\nWith careful planning, you can still enjoy those anchors while receiving treatment.",
          "order": 3,
          "qid": "S10-Q03"
        },
        {
          "q": "How do you know it’s working without waiting months?",
          "gt": "I’m sorry you’re feeling so uncertain. In practice we look for early clues that the regimen is having an effect, even before a full‑cycle scan:\n\n1. **CA‑19‑9 trend** – A drop of 20‑30 % after the first 2–3 infusions often signals a response, though it’s not definitive.  \n2. **Symptom relief** – Noticeable easing of pain, better sleep, or less need for opioids can be a practical sign that the tumor’s pressure is decreasing.  \n3. **Weight & appetite** – Gaining even a few pounds or eating more comfortably suggests the disease is less aggressive.  \n4. **Early imaging** – A CT or MRI after 2 cycles (≈6 weeks) can show size reduction or less metabolic activity on PET.  \n\nIf any of these improve, it’s a good reason to keep going; if not, we discuss alternatives sooner rather than later. Your family’s Sunday dinners and choir are precious—let’s use these early signals to keep them as long as possible.",
          "order": 4,
          "qid": "S10-Q04"
        },
        {
          "q": "What if the side effects feel worse than the disease—do I have permission to ask for less?",
          "gt": "It’s absolutely okay to ask for a gentler approach when the treatment feels heavier than the cancer itself. Talk openly with your oncologist about your pain, fatigue, and weight loss—these are the real measures of how you’re doing. Most regimens, including gemcitabine + nab‑paclitaxel, have built‑in dose‑reduction and schedule‑modification options (e.g., fewer cycles, lower doses, or a switch to a single‑agent or oral therapy). You can also add or intensify supportive measures—anti‑nausea drugs, neuropathy‑pain meds, nutritional supplements, enzyme replacement, and palliative care services. If the side‑effect burden outweighs the benefit, the team can safely pause or stop therapy and focus on comfort and quality of life. Your voice matters; it guides the balance between treatment and living well.",
          "order": 5,
          "qid": "S10-Q05"
        },
        {
          "q": "I don’t want to die in a hospital. When do we talk about those wishes without giving up?",
          "gt": "It’s best to bring up goals of care early—ideally after your first cycle or whenever you feel ready. Ask your oncologist to schedule a dedicated “goals‑of‑care” visit. Bring family and a trusted friend or chaplain if that helps. In that conversation you can:\n\n* Clarify that you want to avoid hospital death and prefer home or hospice care if needed.  \n* Discuss advance directives, a DNR order, and a living will.  \n* Explore palliative‑care options that keep you comfortable while you continue treatment.  \n* Review symptom‑control plans (pain meds, nutrition, enzyme support) so you can stay as independent as possible.  \n\nTreating the cancer doesn’t mean giving up comfort. By planning now, you keep your treatment goals and your wish to stay at home aligned.",
          "order": 6,
          "qid": "S10-Q06"
        },
        {
          "q": "Will I lose my hair, and if I do, how do I handle people’s reactions at church?",
          "gt": "Gemcitabine + nab‑paclitaxel can cause hair changes, but most people experience only mild thinning or a “soft” loss rather than the dramatic baldness seen with some other regimens. If you notice hair loss, it usually improves after a few weeks of treatment and often returns to normal once therapy is paused.\n\n**Handling reactions at church**\n\n1. **Plan ahead** – bring a comfortable hat, scarf, or headwrap that fits your style and lets you feel confident.  \n2. **Communicate** – a quick note to the choir director or a trusted friend can let them know you’re dealing with hair changes, so they can offer support or adjust seating if needed.  \n3. **Focus on the music** – let the joy of singing and the community’s warmth remind you that your worth isn’t tied to appearance.  \n4. **Self‑compassion** – if someone comments, a gentle, “I’m still here, just a bit different” can defuse awkwardness and keep the focus on the shared experience.\n\nYou’re not alone, and most people will respect and support you.",
          "order": 7,
          "qid": "S10-Q07"
        },
        {
          "q": "Can I keep taking my walks without risking a fall when I’m weak?",
          "gt": "It’s usually safe—and even helpful—to keep walking, but you should do it with precautions that match your current strength and balance.  \n- **Start slow**: 5–10 min at a time, gradually increasing as you feel stronger.  \n- **Choose safe surfaces**: even sidewalks, indoor halls, or a treadmill with handrails.  \n- **Wear supportive shoes** and consider a cane or walker if you feel unsteady.  \n- **Watch for neuropathy** (common with nab‑paclitaxel) – numbness or tingling can increase fall risk.  \n- **Take breaks** and stay hydrated; fatigue can worsen weakness.  \n- **Check bone health**: if you have osteoporosis, discuss calcium/vitamin D or bisphosphonates.  \n- **Get a quick assessment** from a physical therapist or your oncology team if you notice worsening balance or pain.  \n\nWith these steps, you can usually maintain your Sunday walks while minimizing fall risk.",
          "order": 8,
          "qid": "S10-Q08"
        },
        {
          "q": "My family is afraid to eat with me, like food will 'hurt' the cancer. What should we tell them?",
          "gt": "It’s a common myth that eating “feeds” cancer, but it’s not true. Tumor cells grow regardless of what you eat, and good nutrition actually helps your body tolerate chemotherapy, maintain strength, and keep pain under control.  \n\n**What to say to your family:**  \n- “I need the calories, protein, and vitamins from our meals to stay strong and to recover from treatment.”  \n- “Eating together gives me emotional support, which is just as important as the food itself.”  \n- “If certain foods feel heavy, we can have smaller, more frequent meals or a dietitian can suggest easier‑to‑digest options.”  \n\nEncourage them to join you at the table; the shared experience is a powerful part of your care plan.",
          "order": 9,
          "qid": "S10-Q09"
        },
        {
          "q": "If this stops working, what’s next so we aren’t scrambling?",
          "gt": "I’m sorry you’re facing this. If gemcitabine‑nab‑paclitaxel no longer controls the disease, the next steps are usually:\n\n1. **Re‑evaluate** your performance status, organ function, and tumor genetics (if not already done).  \n2. **Second‑line chemotherapy**:  \n   * **FOLFIRINOX** (5‑FU, leucovorin, irinotecan, oxaliplatin) – more active but also more toxic; suitable if you’re still fit.  \n   * **Nanoliposomal irinotecan + 5‑FU/leucovorin** (Nal‑IRI) – approved for metastatic disease after gemcitabine‑based therapy.  \n3. **Targeted or immune therapy** if a driver mutation is found:  \n   * **PARP inhibitors** (olaparib) for BRCA or PALB2 mutations.  \n   * **Pembrolizumab** for MSI‑H/dMMR or high tumor mutational burden.  \n4. **Clinical trials** – many are enrolling patients with metastatic pancreatic cancer; they can offer newer agents or combinations.  \n5. **Palliative care**: focus on pain control, nutrition, and quality of life, which can be integrated alongside any of the above.\n\nDiscuss these options with your oncologist; they’ll tailor the choice to your health status, preferences, and the most recent evidence.",
          "order": 10,
          "qid": "S10-Q10"
        }
      ]
    },
    {
      "id": "S11",
      "title": "My hands play, my bones ache (transplant-eligible multiple myeloma)",
      "diagnosis": "Multiple myeloma with lytic bone disease, transplant-eligible",
      "treatment_plan": "Induction (bortezomib/lenalidomide/dexamethasone), stem-cell collection and autologous transplant when appropriate, then maintenance (often lenalidomide)",
      "narrative": "I'm 58, a guitarist. My fingers are my identity, but my back aches from bone lesions. They're talking about transplant after several months of treatment.",
      "qa": [
        {
          "q": "Will treatment numb my fingers and steal my music?",
          "gt": "I’m really glad you’re asking this—your hands are central to who you are. The main drugs in the induction (bortezomib, lenalidomide, dexamethasone) can cause peripheral neuropathy, most often a mild, reversible tingling or numbness that usually improves if the dose is reduced or the drug is switched. Bortezomib‑induced neuropathy is dose‑related, so your team will monitor symptoms closely and adjust therapy early. Lenalidomide and steroids rarely cause neuropathy. After transplant, many patients report a significant reduction in bone pain and a return of strength. In short, while there is a risk of temporary numbness, it is usually manageable, and most patients regain full use of their fingers and can continue playing. Keep the conversation open with your oncologist—early reporting of symptoms is key to preserving your music.",
          "order": 1,
          "qid": "S11-Q01"
        },
        {
          "q": "What does a 'transplant' actually mean for me day to day—am I isolated for months?",
          "gt": "A transplant for you is a short‑term “reset” of the bone‑marrow system, not a months‑long isolation.  \n**Induction** (bortezomib/lenalidomide/dexamethasone) is usually 4–6 cycles over 3–4 months.  \n**Stem‑cell collection** happens while you’re still on induction—usually a few days of apheresis after a short “mobilization” course.  \n**Autologous transplant** is a single day of high‑dose melphalan followed by reinfusion of your own stem cells. You’ll stay in the hospital for 2–3 days, then spend about 2–3 weeks in a protected environment (single room, limited visitors) while your white‑cell count recovers.  \nAfterward you return home, resume a maintenance regimen (often lenalidomide), and continue routine follow‑ups. So, the only isolation is a brief, 2–3‑week period; the rest of your treatment is outpatient and can be scheduled around your guitar practice.",
          "order": 2,
          "qid": "S11-Q02"
        },
        {
          "q": "Can you stabilize my spine so I’m not afraid to pick up my guitar?",
          "gt": "I’m sorry you’re dealing with this pain. In myeloma, spinal stability is usually addressed in three ways:\n\n1. **Imaging & risk assessment** – A CT/MRI of the spine tells us if a vertebra is at risk of fracture.  \n2. **Medical therapy** – Bisphosphonates (e.g., zoledronic acid) or denosumab, plus short‑course steroids, reduce bone resorption and help prevent new fractures.  \n3. **Local intervention** – If a vertebra is already fractured or imminently unstable, a spine surgeon may perform a **vertebroplasty/kyphoplasty** (cement injection) or, in severe cases, a **surgical fixation** to restore alignment and relieve pain.\n\nThese measures are done before, during, or after induction and transplant. Discuss with your oncologist and a spine specialist; they’ll tailor the plan to keep you safe while you keep playing.",
          "order": 3,
          "qid": "S11-Q03"
        },
        {
          "q": "Steroids make me wired and edgy. How do I sleep and not snap at my partner?",
          "gt": "I’m sorry you’re dealing with this. Steroids can definitely throw your sleep cycle off and make you irritable. Here are a few practical steps that often help:\n\n1. **Timing** – Take your dexamethasone as early in the day as possible (ideally before noon). If your doctor agrees, a lower evening dose or a short‑acting formulation can reduce nighttime arousal.  \n2. **Sleep hygiene** – Keep a consistent bedtime routine: dim lights, cool room, no screens 1 h before sleep, and a brief wind‑down (reading, gentle stretching, or a warm shower).  \n3. **Relaxation** – Try progressive muscle relaxation or guided imagery for 5–10 min before bed. A small dose of melatonin (0.5–1 mg) can be helpful, but discuss it with your oncologist.  \n4. **Manage irritability** – If you feel a surge of agitation, pause, take a few deep breaths, and excuse yourself for a short walk or a glass of water.  \n5. **Communicate** – Let your partner know you’re experiencing “steroid‑wakefulness” and that you’re working on it. A simple “I’m feeling wired; I’ll try to calm down before we talk” can reduce tension.  \n6. **Ask for help** – If the symptoms persist, talk to your oncology team; they may adjust the steroid dose or add a short‑acting sleep aid or anxiolytic.\n\nSmall changes can make a big difference in both your rest and your relationship.",
          "order": 4,
          "qid": "S11-Q04"
        },
        {
          "q": "I heard about jaw problems with bone drugs. Do I need a dentist first?",
          "gt": "**Short answer:**  \nYes—if you’re going to receive a bisphosphonate (e.g., zoledronic acid) or denosumab for bone protection, a dental check‑up before you start is strongly recommended.  \n\n**Why it matters:**  \nBoth drugs can cause osteonecrosis of the jaw (ONJ), especially after invasive dental work. A dentist can:  \n\n1. **Treat any existing cavities, gum disease, or infections** that could become a risk.  \n2. **Plan or postpone extractions or surgeries** until after you’ve finished the drug or until you’re on a maintenance dose.  \n3. **Give you a personalized oral‑hygiene plan** (brushing, flossing, mouthwash) to keep the jaw healthy.  \n\n**What to do next:**  \n- Ask your oncology team to refer you to a dentist experienced with oncology patients.  \n- Bring your medication list and any recent imaging.  \n- Keep regular dental visits during and after treatment.  \n\nThis proactive step helps protect your jaw while you focus on fighting myeloma and keeping your fingers in tune.",
          "order": 5,
          "qid": "S11-Q05"
        },
        {
          "q": "What’s the plan if my numbers drop again after transplant?",
          "gt": "After an autologous transplant, a “drop” in your M‑protein or rising free light chains usually means the disease has relapsed. The next step is a **salvage regimen** that’s different from what you used before, to avoid cross‑resistance. Common options include:\n\n| Regimen | Typical use | Why it’s chosen |\n|---------|-------------|-----------------|\n| **Daratumumab + lenalidomide + dex** | First‑line salvage | Targets CD38, works even after lenalidomide exposure |\n| **Carfilzomib + lenalidomide + dex** | For patients who tolerated bortezomib | Potent proteasome inhibition |\n| **Pomalidomide + dex** | If lenalidomide resistance | Strong immunomodulatory effect |\n| **Bortezomib + daratumumab + dex** | If you’re still sensitive to bortezomib | Dual mechanism |\n| **Allogeneic transplant** | In select, fit patients | Potential cure, but higher risk |\n\nYou’ll also get a **bone‑health work‑up** (DEXA, bisphosphonate/denosumab) and **minimal residual disease (MRD)** testing to guide intensity. If you’re eligible for a clinical trial, that’s often the best next step. Discuss these options with your hematologist; they’ll tailor the plan to your prior therapy, side‑effect profile, and overall health.",
          "order": 6,
          "qid": "S11-Q06"
        },
        {
          "q": "Can I keep teaching lessons between cycles without risking infections?",
          "gt": "You can usually keep teaching, but timing and precautions are key.  \n- **Check your blood counts** before each cycle. If your neutrophil count is > 1.5 × 10⁹/L and you’re not on high‑dose steroids, the risk of infection is lower.  \n- **Avoid crowded or high‑traffic venues** during the first 7–10 days after a dose of bortezomib/lenalidomide/dexamethasone, when neutropenia peaks.  \n- **Use hand‑washing, masks, and keep your instruments clean**.  \n- **Consider virtual lessons** or short, one‑on‑one sessions when you’re feeling weak or have low counts.  \n- **Stay alert for fever, sore throat, or cough**—seek care immediately if these occur.  \n\nSpeak with your oncologist about a personalized schedule; most patients resume normal activities once counts recover and the transplant period is over.",
          "order": 7,
          "qid": "S11-Q07"
        },
        {
          "q": "How do you decide when to collect my stem cells?",
          "gt": "**When to collect your stem cells?**  \nYour transplant team will usually schedule collection after 4–6 cycles of induction (bortezomib‑lenalidomide‑dexamethasone). The goal is to harvest a good yield while the disease is under control and you’re still fit for high‑dose melphalan.  \n\nKey checkpoints:  \n\n1. **Response** – at least partial remission (or better) and low disease burden.  \n2. **Counts** – neutrophils ≥1 × 10⁹/L, platelets ≥100 × 10⁹/L, no active infection.  \n3. **Organ function** – adequate kidney, liver, and cardiac status.  \n4. **Timing** – before the transplant, so you can proceed to high‑dose therapy without delay.  \n\nIf you’re not responding well, the team may postpone collection until additional cycles improve counts and disease control. The decision is a collaborative one, balancing your health, response, and the transplant center’s protocol.",
          "order": 8,
          "qid": "S11-Q08"
        },
        {
          "q": "What does 'MRD negative' mean and should I chase it?",
          "gt": "**MRD = Minimal Residual Disease** – a laboratory test that looks for any remaining myeloma cells after treatment, using highly sensitive methods (flow cytometry or next‑generation sequencing).  \n**MRD‑negative** means no disease is detected at the level the test can see (often 1 myeloma cell in 10⁵–10⁶ normal cells).  \n\n**Should you chase it?**  \n- **Pros**: MRD negativity is linked to longer progression‑free and overall survival, especially after transplant.  \n- **Cons**: Achieving it may require more intensive therapy, with added side‑effects and cost.  \n- **Practical step**: Discuss with your hematologist whether the potential benefit outweighs the risks for you, considering your quality of life (e.g., keeping your fingers healthy for guitar).  \nIn short, MRD negativity is a useful goal, but the decision to pursue it should be individualized and made together with your care team.",
          "order": 9,
          "qid": "S11-Q09"
        },
        {
          "q": "Will I ever feel strong enough to perform a full set again?",
          "gt": "I’m glad you’re asking this—it’s a real concern for many musicians. After a transplant, most patients regain a good amount of strength and mobility, but the timeline varies. Your bone lesions can cause lingering pain, especially in the back and hands, so managing that pain (with steroids, bisphosphonates, and a pain‑management plan) and protecting your spine are key. A physical‑therapy program focused on core stability and gentle finger‑strength exercises can help you rebuild endurance. Many people return to playing, sometimes with a slightly modified technique or shorter sets at first. With consistent pain control, bone‑health support, and gradual re‑introduction to the guitar, you can often perform a full set again—though it may take several months of recovery and adaptation. Stay in close touch with your oncology team and a pain specialist to tailor the plan to your needs.",
          "order": 10,
          "qid": "S11-Q10"
        }
      ]
    },
    {
      "id": "S12",
      "title": "Voice on the line (HPV-positive base-of-tongue cancer)",
      "diagnosis": "HPV-positive oropharyngeal squamous cell carcinoma",
      "treatment_plan": "Definitive chemoradiation with speech/swallow therapy; consider feeding tube support if needed",
      "narrative": "I'm 49, a choir singer and call-center lead. The tumor is at the base of my tongue. The plan is chemoradiation. My voice is my livelihood and my joy.",
      "qa": [
        {
          "q": "Will I still sound like me after treatment, or is that voice gone?",
          "gt": "Chemoradiation for a base‑of‑tongue tumor can alter the voice, but it isn’t automatically “gone.” Radiation can cause temporary hoarseness, breathiness, or a slightly lower pitch, and the tongue’s flexibility may be reduced. Most patients notice improvement as the mucosa heals, especially with early, intensive speech‑and‑swallow therapy. Some subtle, permanent changes (e.g., a slightly raspier tone or reduced range) can remain, but many singers return to a voice that is recognizably theirs. Working closely with a speech‑pathologist, practicing vocal exercises, and protecting your voice during recovery will maximize the chance of regaining the quality and strength you need for singing and speaking.",
          "order": 1,
          "qid": "S12-Q01"
        },
        {
          "q": "Everyone keeps mentioning a feeding tube. How will I know if I really need one?",
          "gt": "A feeding tube is usually considered when you can’t keep enough calories and fluids in the first 2–4 weeks of chemoradiation. The main red‑flags are:\n\n| Red‑flag | What it means |\n|----------|----------------|\n| **Weight loss >5 % of baseline** (or >10 % if you’re already lean) | Indicates inadequate intake. |\n| **Persistent dysphagia or choking** | Suggests the tumor or swelling is blocking the airway/food passage. |\n| **Frequent aspiration or pneumonia** | Shows you’re inhaling food/secretions. |\n| **Inability to meet 70–80 % of caloric needs** after a dietitian’s plan | Even with a high‑calorie diet, you’re still malnourished. |\n| **Significant fatigue or weakness** | Often a sign of protein‑energy depletion. |\n\nYour speech‑language pathologist will do a swallow study early in treatment and again if symptoms worsen. If any of the above are present, a percutaneous endoscopic gastrostomy (PEG) or nasogastric tube is usually recommended to keep you safe and maintain strength for voice recovery. If you’re stable, we’ll monitor closely and try to keep you on a high‑calorie oral diet first.",
          "order": 2,
          "qid": "S12-Q02"
        },
        {
          "q": "Is HPV something I 'gave' my spouse—do we need to stop kissing forever?",
          "gt": "It’s understandable to worry, but the short answer is **no, you don’t have to stop kissing forever**.  \nHuman papillomavirus (HPV) is extremely common—most adults have been exposed at some point. The strain that causes oropharyngeal cancer (often HPV‑16) is usually acquired through oral–oral or oral–genital contact, not through casual kissing. Most people clear the virus naturally, and the risk of transmitting it to a partner who is already infected is low.  \n\nIf you and your spouse are both HPV‑positive, the main concerns are monitoring for recurrence and protecting each other from new strains. Discuss vaccination (the 9‑vaccine protects against many high‑risk types) and consider routine dental/ENT check‑ups. Maintaining good oral hygiene and avoiding high‑risk behaviors (e.g., unprotected oral sex) are practical steps.  \n\nSo, you can continue kissing and singing—just keep the usual precautions and stay in touch with your oncology team.",
          "order": 3,
          "qid": "S12-Q03"
        },
        {
          "q": "Will my mouth feel like sand forever?",
          "gt": "I’m sorry you’re facing this. During chemoradiation the tongue, palate, and salivary glands often become inflamed and dry, so the “sand‑like” gritty feeling is common. Most people’s mucosa heals within 6–12 weeks after treatment, and saliva production usually improves, though some dryness can linger for months. Persistent taste changes or a gritty sensation beyond a year is uncommon but can happen, especially if the radiation dose was high or if you have pre‑existing dry‑mouth conditions.  \n\nKey steps to help recovery:  \n- **Hydration & saliva substitutes** (xylitol gum, artificial saliva).  \n- **Regular mouth care** (salt‑water rinses, gentle brushing).  \n- **Speech/swallow therapy** to retrain tongue movement and voice.  \n- **Dietary adjustments** (soft, moist foods, avoid very hot or spicy items).  \n\nIf the gritty feeling persists, let your oncology team know—it may be managed with medications or further therapy. With diligent care, many patients return to normal mouth sensation and can resume singing, though it may take several months to feel fully “normal.”",
          "order": 4,
          "qid": "S12-Q04"
        },
        {
          "q": "Can I keep working phones with a sore throat and fatigue?",
          "gt": "I’m sorry you’re dealing with this. During chemoradiation the mucosa is inflamed, the voice is often hoarse, and fatigue can be profound. Working a call‑center shift—especially with a sore throat—can worsen voice strain, increase the risk of aspiration, and delay recovery. It’s usually safer to limit voice use: consider a short‑term leave, a reduced‑hours schedule, or a “voice‑rest” period with a headset that allows you to speak minimally. If you must work, take frequent breaks, stay hydrated, use a humidifier, and avoid shouting or speaking for long stretches. Discuss a flexible work plan with your employer and your oncology team; they can help you balance job duties with healing.",
          "order": 5,
          "qid": "S12-Q05"
        },
        {
          "q": "How do I eat when everything burns?",
          "gt": "I’m sorry you’re dealing with that burning—chemoradiation can make eating feel like a battle. Here are some practical steps that often help:\n\n1. **Soft, high‑calorie foods** – think smoothies, mashed potatoes, yogurt, oatmeal, scrambled eggs, and protein‑rich shakes.  \n2. **Small, frequent meals** – 5–6 tiny bites a day keep calories in without overloading the mouth.  \n3. **Temperature control** – keep foods and drinks cool or at room temperature; avoid hot, spicy, acidic, or rough‑textured foods that sting.  \n4. **Hydration** – sip water, electrolyte drinks, or ice chips between bites to soothe the mucosa.  \n5. **Oral care** – rinse gently with salt water or a prescribed mouthwash after meals; use a soft toothbrush.  \n6. **Pain management** – use prescribed topical anesthetics (e.g., lidocaine gel) or oral pain meds as directed.  \n7. **Consider a feeding tube** – if you can’t meet 70–80 % of your calorie needs orally, a PEG tube can keep you nourished while you recover.\n\nSpeak with your radiation oncologist or dietitian about a tailored plan; they can adjust the diet and medications to keep you comfortable and nourished.",
          "order": 6,
          "qid": "S12-Q06"
        },
        {
          "q": "Will I ever sing a solo again?",
          "gt": "I’m sorry you’re facing this uncertainty. Chemoradiation for base‑of‑tongue cancer can cause temporary swelling, hoarseness, and changes in resonance, but most patients regain a usable voice within 6–12 months, especially with early, intensive speech‑language therapy. Some may experience a slightly breathier or less powerful tone, and a small fraction develop chronic dysphonia or aspiration that limits singing. Your choir background and vocal training give you a strong foundation for recovery. Work closely with a speech‑pathologist, follow voice‑rest guidelines, and consider a voice‑rest period after each treatment cycle. With diligent therapy and realistic expectations, many patients return to solo performances—though the voice may sound a bit different. Stay hopeful and keep your vocal coach involved in the rehabilitation process.",
          "order": 7,
          "qid": "S12-Q07"
        },
        {
          "q": "What happens to my teeth with all this radiation?",
          "gt": "Radiation to the base‑of‑tongue field often spills over into the oral cavity, so your teeth can receive a significant dose. The main effects are:\n\n* **Xerostomia (dry mouth)** – salivary glands are hit, reducing saliva that protects teeth.  \n* **Enamel erosion & increased caries** – less saliva means more acid attack and bacterial growth.  \n* **Periodontal changes** – inflammation and gum recession can occur.  \n* **Bone changes** – high doses can weaken jaw bone, raising the risk of osteoradionecrosis if a tooth is lost.\n\n**What you can do:**  \n1. Get a full dental exam before starting treatment.  \n2. Use high‑strength fluoride varnish or mouth rinses, and consider sealants.  \n3. Maintain meticulous oral hygiene—brushing twice, flossing, and using a soft‑bristle brush.  \n4. Avoid sugary drinks, use sugar‑free gum, and stay hydrated.  \n5. Schedule regular dental check‑ups during and after therapy.  \n\nWith proactive dental care, most patients keep their teeth healthy and avoid serious complications.",
          "order": 8,
          "qid": "S12-Q08"
        },
        {
          "q": "If I choke on water one day, is that the new normal?",
          "gt": "Choking on a sip of water can be a common side‑effect of chemoradiation for base‑of‑tongue cancer, especially early in treatment when swelling, numbness, or muscle weakness affect the swallowing mechanism. It isn’t “new normal” for everyone, but it’s a signal that your swallow needs extra support.  \n\n**What to do:**  \n- **Speak with your speech‑language pathologist (SLP).** They can assess aspiration risk, teach compensatory strategies, and prescribe exercises.  \n- **Use thickened liquids or sip‑sip‑spoon techniques** if advised, to reduce aspiration.  \n- **Monitor for red flags:** coughing, wheezing, or shortness of breath after swallowing, or recurrent choking episodes. If any of these occur, seek prompt medical evaluation.  \n\nWith early intervention, most patients regain safe swallowing and can return to singing with proper voice‑care strategies.",
          "order": 9,
          "qid": "S12-Q09"
        },
        {
          "q": "How will you check if the cancer is gone without another surgery?",
          "gt": "After chemoradiation you’ll be monitored with a **non‑invasive “watch‑and‑wait” protocol** that combines clinical exam, imaging, and functional tests:\n\n1. **Clinical exam** – every 3–4 weeks for the first 6 months, then every 3 months for 2 years. A trained ENT or head‑and‑neck specialist will look for residual lesions, swelling, or ulceration.  \n2. **Endoscopic evaluation** – flexible laryngoscopy (or fiber‑optic nasopharyngoscopy) to inspect the base of the tongue and pharynx directly.  \n3. **Imaging** – a **PET‑CT** (or PET‑MRI) at 12–16 weeks post‑therapy is the gold standard for detecting metabolic activity; if suspicious, a repeat scan at 6 months.  \n4. **Biopsy** – only if imaging or endoscopy shows a suspicious area; otherwise, no repeat surgery is needed.  \n5. **Functional assessment** – voice‑quality tests, swallowing studies, and quality‑of‑life questionnaires to confirm that the tumor’s absence correlates with preserved function.\n\nThis schedule balances thorough surveillance with avoidance of unnecessary surgery, allowing you to focus on your voice and career.",
          "order": 10,
          "qid": "S12-Q10"
        }
      ]
    },
    {
      "id": "S13",
      "title": "Choice overload (early ER+/PR+ HER2- breast cancer)",
      "diagnosis": "Early-stage hormone receptor–positive, HER2-negative breast cancer",
      "treatment_plan": "Breast-conserving surgery plus radiation or mastectomy; adjuvant endocrine therapy; chemotherapy guided by genomic risk when indicated",
      "narrative": "I'm 41, engaged, and deciding between lumpectomy with radiation or mastectomy. I want to live, look like myself in photos, and still feel like me.",
      "qa": [
        {
          "q": "Is survival the same with lumpectomy plus radiation versus mastectomy, or am I gambling?",
          "gt": "For most early‑stage, hormone‑receptor positive, HER2‑negative breast cancers, overall survival is essentially the same whether you choose breast‑conserving surgery (lumpectomy + radiation) or a mastectomy, as long as the tumor is completely removed and all other treatment steps (endocrine therapy, possible chemo) are followed.  \nThe trade‑off is a slightly higher chance of a local recurrence after lumpectomy, but this does not translate into a survival difference in large, randomized trials.  \nYour decision can therefore focus on what feels right for you—body image, comfort with radiation, personal risk factors, and any genetic findings—rather than a survival gamble. If you’re unsure, a second opinion or a multidisciplinary tumor board can help clarify how your specific tumor characteristics fit into these data.",
          "order": 1,
          "qid": "S13-Q01"
        },
        {
          "q": "Do I need chemo, or can a test spare me? Waiting for results is torture.",
          "gt": "I understand how stressful the waiting is. For early‑stage, ER⁺/PR⁺, HER2‑negative breast cancer, the decision to add chemotherapy is largely guided by a genomic assay (e.g., Oncotype DX, MammaPrint, Prosigna).  \n• **Low‑risk score** → endocrine therapy alone is usually sufficient; chemo can be safely avoided.  \n• **Intermediate‑risk score** → the benefit of chemo is modest; discuss your preferences and comorbidities with your oncologist.  \n• **High‑risk score** → chemotherapy is recommended because it significantly lowers recurrence risk.  \n\nThe test results typically arrive in 2–4 weeks. In the meantime, you can schedule your surgery (lumpectomy + radiation or mastectomy) as planned; the choice of surgery doesn’t depend on the chemo decision. Talk to your medical team about any interim concerns—you’re not alone, and they’ll help you weigh the benefits and side‑effects to make the best choice for you.",
          "order": 2,
          "qid": "S13-Q02"
        },
        {
          "q": "Will endocrine therapy make me feel old overnight?",
          "gt": "Endocrine therapy (tamoxifen or an aromatase inhibitor) is usually taken for 5–10 years and its side‑effects develop gradually, not overnight. The most common symptoms are hot flashes, night sweats, fatigue, mood swings, and joint aches. Most people find these manageable with lifestyle tweaks, medications, or supportive care. You won’t suddenly feel “old” the first day you start; the changes are usually mild to moderate and can be monitored and treated. If you’re concerned about specific side‑effects, talk with your oncologist—they can adjust the drug, dose, or add supportive therapies to keep you feeling as vibrant as possible.",
          "order": 3,
          "qid": "S13-Q03"
        },
        {
          "q": "Can I preserve fertility before treatment without losing precious time?",
          "gt": "Yes—fertility preservation can be done without delaying your cancer treatment.  \n**Oocyte or embryo cryopreservation** is the most common option. It requires 2–3 weeks of ovarian stimulation, egg retrieval, and freezing, and can be scheduled right after your diagnosis and before surgery. Because breast‑conserving surgery or mastectomy does not involve the ovaries, the procedure does not interfere with the operation or radiation fields.  \n\nIf you need chemotherapy, you can also add a **GnRH‑agonist** (e.g., goserelin) during treatment to help protect ovarian function.  \n\nAt 41, acting sooner is wise because ovarian reserve declines with age, but the fertility work‑up can be completed in the same window you’re already planning for surgery and endocrine therapy. Discuss the plan with your oncologist and a reproductive specialist to coordinate timing and minimize any delay.",
          "order": 4,
          "qid": "S13-Q04"
        },
        {
          "q": "I’m terrified of recurrence—how will follow-up actually catch something early?",
          "gt": "I’m really sorry you’re feeling so anxious. The follow‑up plan is designed to catch any recurrence as early as possible, when it’s most treatable.\n\n**What you’ll get:**\n- **Physical exams** every 6–12 months for the first 5 years, then annually.  \n- **Mammography** of the treated breast (or both breasts if you had a mastectomy) every 6–12 months for 5 years, then annually.  \n- **Breast‑MRI** is usually reserved for high‑risk patients; it’s not routine for early ER⁺/PR⁺ disease.  \n- **Self‑exam** and symptom awareness: any new lump, skin change, or nipple discharge should prompt immediate imaging.  \n\n**Why it works:** Most recurrences appear within the first 3–5 years, and early detection (often before symptoms) allows surgery, radiation, or systemic therapy to be started before the disease spreads. Your risk is low, and the surveillance schedule is evidence‑based to catch problems early. If you’re still uneasy, we can discuss a more intensive imaging plan or a second opinion.",
          "order": 5,
          "qid": "S13-Q05"
        },
        {
          "q": "What about reconstruction if I choose mastectomy—will it feel like me?",
          "gt": "Choosing mastectomy with reconstruction can give you a breast shape that looks similar to your pre‑surgery appearance, but the feel and sensation will usually differ from a natural breast.  \n\n**Reconstruction options**  \n- **Implant‑based** (silicone or saline) – quick, often done immediately, but may feel firmer and can change over time.  \n- **Autologous tissue** (DIEP, TRAM, latissimus‑dorsi flaps) – uses your own skin and fat, giving a more natural feel and contour, but requires a longer operation and a donor‑site scar.  \n- **Delayed reconstruction** – allows you to finish radiation and recovery first, then rebuild when you’re ready.\n\n**What to expect**  \n- **Sensation**: Most patients lose some nipple‑areolar sensation after mastectomy; reconstruction can restore some touch, but it rarely matches the original feel.  \n- **Shape & symmetry**: A skilled plastic surgeon can match your remaining breast and body contour closely.  \n- **Complications**: Infection, capsular contracture (implants), or flap loss are rare but possible; discuss risks with your surgeon.\n\n**Next steps**  \n- Schedule a consultation with a board‑certified plastic surgeon early in your treatment plan.  \n- Bring photos of your pre‑surgery breasts and any concerns about shape or feel.  \n- Ask about timing (immediate vs. delayed), expected recovery, and realistic outcomes.\n\nMany patients report feeling “like themselves” after reconstruction, especially when expectations are set early. Your body image and sense of self can be preserved, even if the tactile experience changes.",
          "order": 6,
          "qid": "S13-Q06"
        },
        {
          "q": "Can I keep wedding plans, or should we postpone?",
          "gt": "It’s understandable you want to keep the wedding date, but the timing of surgery and recovery matters.  \n\n**Lumpectomy + radiation**: surgery is quick, but you’ll need 5–6 weeks of daily radiation, plus a few weeks to heal—about 2–3 months total.  \n**Mastectomy** (no nodes or low‑risk nodes): recovery is 2–4 weeks; radiation is usually not needed, so you could be back in 1–2 months.\n\nIf the wedding is within a month, most people either postpone it by 4–6 weeks or schedule a small ceremony after surgery. If you can wait a month or two, you’ll have time to heal, feel comfortable in photos, and still celebrate on the day you choose. Discuss the exact timeline with your surgeon—many couples successfully marry after treatment, but a brief delay often gives you peace of mind and a better appearance.",
          "order": 7,
          "qid": "S13-Q07"
        },
        {
          "q": "Will exercise help, or am I supposed to rest?",
          "gt": "After surgery, the goal is to balance gentle movement with adequate rest so the incision can heal while you keep your energy and mood up.  \n**What the guidelines say**  \n- **Early post‑op** (first 1–2 weeks): rest the arm on the side of the surgery, avoid heavy lifting or strenuous activity, and follow your surgeon’s instructions about dressing changes and wound care.  \n- **After the first week**: start light walking or gentle range‑of‑motion exercises as tolerated. Most patients can resume normal daily activities within 2–4 weeks, but avoid heavy lifting or high‑impact sports until your doctor clears you.  \n- **During radiation**: moderate exercise (e.g., walking, gentle cycling) is usually fine; just stay away from the radiation field and keep the arm elevated if advised.  \n\n**Why it matters**  \n- Light activity reduces fatigue, improves circulation, and supports mental well‑being.  \n- Rest is still essential for wound healing, but complete inactivity can lead to stiffness and deconditioning.  \n\nSo, aim for a gradual return to movement—start with short walks and gentle stretches, and let your surgeon guide any restrictions. This balanced approach helps you recover faster while keeping you feeling like yourself.",
          "order": 8,
          "qid": "S13-Q08"
        },
        {
          "q": "Do I have to take pills for 5 years no matter what?",
          "gt": "**Short answer:**  \nMost early‑stage ER⁺/PR⁺ breast cancers are treated with **5 years of endocrine therapy** (tamoxifen for pre‑menopausal women, an aromatase inhibitor for post‑menopausal). That 5‑year course is recommended regardless of whether you choose lumpectomy + radiation or mastectomy, because it reduces the risk of recurrence and second cancers.\n\n**What can change it?**  \n- **Risk assessment** (tumor size, grade, genomic tests) may allow a shorter course (3 years) if your risk is very low.  \n- **Side‑effect profile** or personal preference can lead to a discussion about a shorter or extended (up to 10 years) regimen.  \n- **Premenopausal status**: tamoxifen is the usual choice; aromatase inhibitors are for post‑menopausal patients.\n\nTalk with your medical oncologist about your specific risk factors and how they weigh against the benefits and side‑effects of a 5‑year course.",
          "order": 9,
          "qid": "S13-Q09"
        },
        {
          "q": "How do I explain all this to future in-laws without becoming 'the sick bride'?",
          "gt": "**Short, clear, and confident.**  \n1. **Start with the facts:** “I’ve had a lumpectomy (or mastectomy) and radiation, plus a 5‑year course of endocrine therapy. The cancer is hormone‑positive, HER2‑negative, and the surgery was chosen to keep the breast (or remove it) while giving the best chance of cure.”  \n2. **Emphasize normalcy:** “I’m healthy, active, and looking forward to the same life I had before. The treatment is routine for early‑stage breast cancer and doesn’t change who I am.”  \n3. **Invite support, not pity:** “I’d appreciate your encouragement and understanding, but I’m not a patient in the house. I’m a woman who’s taken care of herself and will continue to do so.”  \n4. **Keep it brief:** “In short, I’m on a proven plan that keeps me safe and lets me stay the same person.”  \n\nThis approach keeps the conversation factual, positive, and avoids turning you into a “sick bride.”",
          "order": 10,
          "qid": "S13-Q10"
        }
      ]
    },
    {
      "id": "S14",
      "title": "Miles to go (metastatic left-sided RAS wild-type colon cancer)",
      "diagnosis": "Metastatic colorectal cancer, left-sided, RAS wild-type",
      "treatment_plan": "Backbone chemo (e.g., FOLFOX or FOLFIRI) with targeted therapy (anti-EGFR or bevacizumab) based on goals and side-effect profile; consider liver-directed options if response",
      "narrative": "I'm 52, a sales rep living on the road. I need a plan that controls cancer without wrecking my ability to drive and meet clients.",
      "qa": [
        {
          "q": "How do we pick between regimens when every option sounds like a trade-off?",
          "gt": "**Choosing a regimen that lets you keep driving and meeting clients**\n\n1. **Efficacy vs. side‑effect profile** – For left‑sided, RAS‑wild‑type disease, anti‑EGFR (cetuximab or panitumumab) + FOLFIRI is highly effective, but it can cause diarrhea and a skin rash that may need frequent clinic visits.  \n2. **Neuro‑toxicity** – FOLFOX + bevacizumab has less cumulative neuropathy, which is important for safe driving.  \n3. **Treatment schedule** – FOLFOX is usually every 2 weeks, while FOLFIRI is every 2 weeks as well; both require IV infusions. Oral capecitabine + bevacizumab can reduce clinic time but adds hand‑foot syndrome.  \n4. **Practicality** – Pick the regimen that fits your travel schedule: fewer infusion days, minimal monitoring, and side‑effects that you can manage on the road (e.g., keep hydration for diarrhea, use antihistamines for rash).  \n\n**Bottom line:** Discuss with your oncologist the trade‑offs above. A common compromise is **FOLFOX + bevacizumab** for lower neuropathy and manageable side‑effects, or **FOLFIRI + cetuximab** if you’re comfortable handling diarrhea and rash. The goal is to keep the cancer controlled while preserving your ability to drive and work.",
          "order": 1,
          "qid": "S14-Q01"
        },
        {
          "q": "If I get the anti-EGFR drug and my face breaks out, am I stuck hiding at home?",
          "gt": "A facial rash (acne‑like “acral” dermatitis) is the most common side effect of anti‑EGFR therapy, but it’s usually manageable and doesn’t mean you must stay home. Start early with a topical steroid‑antibiotic (e.g., clindamycin 1 % with a mild steroid) and keep the skin moisturized. If it’s moderate to severe, oral doxycycline or minocycline can help, and your oncologist may temporarily reduce the dose or pause the drug until it clears. Most patients keep driving and meeting clients once the rash is under control. If you’re worried about appearance, a discreet makeup or a simple face mask can be used during travel, but the rash itself won’t impair your ability to work.",
          "order": 2,
          "qid": "S14-Q02"
        },
        {
          "q": "Will neuropathy make it unsafe to drive?",
          "gt": "Neuropathy from oxaliplatin or other agents can affect driving safety, but it depends on severity. Mild numbness or tingling in the feet or hands usually doesn’t impair driving, though it can cause fatigue or discomfort. Moderate to severe neuropathy—especially if it causes loss of sensation, impaired reflexes, balance problems, or significant pain—can reduce reaction time, coordination, and the ability to brake or steer safely.  \n\n**What to do:**  \n1. **Assess symptoms** with a neurologist or occupational therapist.  \n2. **Get a functional driving evaluation** (many states require medical clearance for drivers with neurological deficits).  \n3. **Adjust treatment** if neuropathy worsens (dose reduction, switch to a non‑neurotoxic regimen, or add neuroprotective agents).  \n4. **Use supportive measures** (orthotics, pain control, physical therapy) to maintain balance and reflexes.  \n\nIf you experience numbness, dizziness, or difficulty controlling the vehicle, stop driving and seek medical clearance before resuming.",
          "order": 3,
          "qid": "S14-Q03"
        },
        {
          "q": "Can the liver spots ever be removed, or is that false hope?",
          "gt": "I’m sorry you’re facing this uncertainty. Whether the liver lesions can be “removed” depends on several factors: how many spots there are, their size and location, how well they respond to systemic therapy, and your overall health. In many cases, a combination of chemotherapy (e.g., FOLFOX/FOLFIRI with an anti‑EGFR or bevacizumab) can shrink the metastases enough to make surgical resection, radio‑frequency ablation, or stereotactic body radiation feasible. If the lesions remain unresectable, we focus on systemic control and liver‑directed palliative options (e.g., transarterial chemoembolization or Y‑90 radioembolization) to keep them stable and minimize symptoms. So removal isn’t always impossible, but it’s not guaranteed; it’s a decision made after evaluating response and surgical candidacy.",
          "order": 4,
          "qid": "S14-Q04"
        },
        {
          "q": "Cold drinks triggering pain—does that mean I’m stuck sipping lukewarm forever?",
          "gt": "Cold‑induced pain is a common neuropathic side‑effect of many chemotherapies. It doesn’t mean you’re doomed to sip only lukewarm drinks forever. First, try simple avoidance: keep beverages at room temperature or slightly warm, and use a straw to reduce direct contact with the tongue. If the pain persists, talk to your oncologist about neuropathic agents—gabapentin, duloxetine, or low‑dose lidocaine patches can blunt the sensation. Topical capsaicin or menthol creams applied to the mouth can also help. In some cases, a brief “cold‑tolerance” exercise (gradually sipping chilled drinks) under medical guidance can reduce sensitivity. So, you still have options to enjoy your favorite drinks while keeping the pain manageable.",
          "order": 5,
          "qid": "S14-Q05"
        },
        {
          "q": "How often will I be tethered to an infusion pump?",
          "gt": "**Infusion schedule for a typical FOLFOX + targeted‑therapy regimen**\n\n| Treatment | How often | What you’ll experience |\n|-----------|-----------|------------------------|\n| **FOLFOX (chemo)** | 2–3 weeks per cycle | Day 1: oxaliplatin IV + 5‑FU bolus, then a 46‑hour 5‑FU infusion (usually 1–2 days in the clinic). |\n| **Targeted therapy** | Every 2 weeks | • **Bevacizumab** – 5‑min IV infusion. <br>• **Anti‑EGFR (cetuximab)** – 30‑min IV infusion. |\n\n**Practical take‑away**\n\n- You’ll be in the infusion center **2–3 times a month**.  \n- Each chemo session lasts **1–2 days** (the 5‑FU infusion is continuous).  \n- Targeted‑therapy infusions are quick (≈30 min) and can be scheduled on the same day or a separate visit.  \n- If you need more flexibility, oral capecitabine or subcutaneous bevacizumab can replace some IV visits, reducing clinic time.  \n\nSo, expect to spend a few days in the clinic every 2–3 weeks, with brief 30‑minute infusions for the targeted drug.",
          "order": 6,
          "qid": "S14-Q06"
        },
        {
          "q": "What if my bowels go haywire on a client visit?",
          "gt": "If you’re on a regimen that can trigger diarrhea (e.g., anti‑EGFR or FOLFOX), plan ahead:\n\n1. **Timing** – Schedule chemo on a day you’re at a stable location (office or hotel) rather than on a road trip.  \n2. **Medications** – Keep loperamide (Imodium) and a short‑acting anti‑diarrheal (e.g., diphenoxylate‑atropine) in your travel kit. If you’re on bevacizumab, be alert for abdominal pain or perforation—seek care immediately.  \n3. **Hydration & diet** – Carry bottled water, avoid high‑fiber or spicy foods, and use a low‑residue diet while traveling.  \n4. **Emergency plan** – Know the nearest urgent‑care or ER (use a travel app or ask your hotel). Keep a list of your oncologist’s on‑call number.  \n5. **Documentation** – Log bowel patterns; if you notice a sudden increase in frequency, pain, or blood, call your oncology team right away.  \n\nWith these steps, you can keep your bowel under control and stay on schedule with clients.",
          "order": 7,
          "qid": "S14-Q07"
        },
        {
          "q": "Do second opinions slow me down or strengthen my plan?",
          "gt": "A second opinion can actually **strengthen** your treatment plan, even if it adds a short delay. It gives a fresh, independent review of your pathology, imaging, and molecular profile—confirming the RAS‑wild‑type status and ensuring no missed mutations. It can also surface alternative options: newer anti‑EGFR agents, different chemotherapy backbones, or liver‑directed therapies that might spare you the side‑effects that would impair driving. Many centers now offer rapid tele‑oncology consultations, so you can get the second view without leaving the road. In short, a quick second opinion is worth the brief wait because it can refine the strategy, reduce unnecessary toxicity, and keep you on the road longer.",
          "order": 8,
          "qid": "S14-Q08"
        },
        {
          "q": "How do you know when to switch before the scan says so?",
          "gt": "**When to switch before the next scan?**  \n1. **Tumor‑marker trend** – If CEA rises steadily (≥20 % above baseline) despite therapy, it often precedes radiographic progression.  \n2. **New or worsening symptoms** – New pain, fatigue, or weight loss that interferes with driving or daily work signals disease activity.  \n3. **Side‑effect burden** – If chemo‑related neuropathy, neutropenia, or fatigue limits your ability to travel, consider a less toxic regimen.  \n4. **Performance status** – A decline in ECOG (e.g., from 0 to 1) or a drop in functional capacity suggests early change.  \n5. **Imaging hints** – Small new lesions or growth on interim scans (if available) can prompt a switch even before the scheduled full scan.  \n\nUse these clinical cues, discuss them with your oncologist, and decide on a change that balances cancer control with your need to stay on the road.",
          "order": 9,
          "qid": "S14-Q09"
        },
        {
          "q": "Is it okay to keep small goals, like hitting my sales summit, or is that denial?",
          "gt": "It’s not denial to set realistic, meaningful goals—your work can be a source of purpose and normalcy, which many patients find helpful for mood and motivation. The key is to balance ambition with your treatment plan and side‑effect profile.  \n\n**Practical tips:**  \n- **Prioritize**: Focus on the most critical client meetings or deadlines that can be achieved with minimal travel or fatigue.  \n- **Schedule**: Plan travel during times when you feel strongest (often early in the day) and allow extra recovery time after chemotherapy or targeted therapy.  \n- **Support**: Use tele‑conference options when possible, and let a trusted colleague cover high‑intensity tasks if you’re feeling unwell.  \n- **Monitor**: Keep a simple log of energy, nausea, or neuropathy; if symptoms worsen, adjust the goal or take a short break.  \n\nSetting achievable targets can keep you engaged without compromising your health. If you notice that the pressure to meet a summit consistently leads to fatigue or anxiety, consider scaling back or redefining success in a way that feels sustainable.",
          "order": 10,
          "qid": "S14-Q10"
        }
      ]
    },
    {
      "id": "S15",
      "title": "Sun runner (BRAF V600E metastatic melanoma)",
      "diagnosis": "BRAF V600E positive metastatic melanoma",
      "treatment_plan": "Immunotherapy and/or targeted BRAF/MEK inhibitors depending on goals and disease features",
      "narrative": "I'm 39, a trail runner with metastatic melanoma. I want to keep moving and not lose months to side effects if there’s a path that fits me.",
      "qa": [
        {
          "q": "How do we choose between immunotherapy and targeted pills without gambling my best shot?",
          "gt": "For a 39‑year‑old trail runner with BRAF V600E‑positive metastatic melanoma, the choice hinges on how quickly you need disease control versus long‑term durability.\n\n**Targeted BRAF + MEK inhibitors**  \n• Fast‑acting (median response 2–3 weeks).  \n• Excellent for bulky, symptomatic disease or when you need rapid relief to keep running.  \n• Side‑effects (rash, fatigue, arthralgia, photosensitivity) are usually manageable and often reversible after a few months.  \n\n**Immunotherapy (anti‑PD‑1/PD‑L1 ± CTLA‑4)**  \n• Durable responses in ~40–50 % of patients, but onset is slower (weeks to months).  \n• Risk of immune‑related adverse events (colitis, thyroiditis, dermatitis) that can be severe and may require steroids or treatment breaks.  \n\n**Practical approach**  \n1. **High tumor burden or symptomatic lesions** → start BRAF + MEK inhibitors for rapid control.  \n2. **Low burden, desire for long‑term remission, or prior targeted therapy** → start anti‑PD‑1/PD‑L1 (± CTLA‑4).  \n3. **If you tolerate targeted therapy well and want to preserve activity**, consider a short course (6–12 weeks) followed by immunotherapy for consolidation.  \n\nDiscuss with your oncologist to tailor the plan to your disease pattern, prior treatments, and personal tolerance for side‑effects.",
          "order": 1,
          "qid": "S15-Q01"
        },
        {
          "q": "What side effects stop runs versus ones I can work around?",
          "gt": "**Side‑effects that usually make running impractical**  \n- **Severe fatigue or malaise** (especially if it limits daily activity)  \n- **Intense arthralgia/arthropathy** that hurts joints or causes swelling  \n- **Severe neuropathy** (tingling, numbness, or weakness in legs)  \n- **High‑grade skin rash or blistering** that interferes with footwear or causes pain  \n- **Severe diarrhea or colitis** (needs hospitalization or steroids)  \n- **Pneumonitis or cardiac toxicity** (shortness of breath, chest pain, arrhythmias)  \n- **Ocular toxicity** (severe uveitis or vision loss)  \n\n**Side‑effects you can usually work around**  \n- Mild to moderate fatigue (adjust rest periods, sleep hygiene)  \n- Low‑grade arthralgia (NSAIDs, physiotherapy, lighter shoes)  \n- Mild neuropathy (avoid high‑impact surfaces, use supportive footwear)  \n- Mild rash or photosensitivity (topical steroids, sunscreen, protective clothing)  \n- Mild diarrhea (dietary changes, antidiarrheals)  \n- Low‑grade ocular dryness (artificial tears, eye drops)  \n\nIf any symptom crosses the “severe” threshold, pause running and discuss dose adjustment or supportive therapy with your oncologist. The goal is to keep you moving while keeping side‑effects manageable.",
          "order": 2,
          "qid": "S15-Q02"
        },
        {
          "q": "If I spike fevers on pills, am I done running for good?",
          "gt": "A fever that comes on with a new pill doesn’t mean you have to quit running forever.  \n- **Check the severity**: If your temperature is <38.5 °C (101 °F) and you feel otherwise fine, most people can keep a light to moderate run (e.g., a short trail jog) with extra hydration and rest afterward.  \n- **Watch for red flags**: Persistent fever >38.5 °C, chills, fatigue, shortness of breath, or new pain warrants stopping exercise and contacting your oncology team.  \n- **Coordinate with treatment**: Your oncologist can tell you whether the fever is an immune‑related flare (common with checkpoint inhibitors) or a drug side‑effect (often seen with BRAF/MEK inhibitors). They may adjust the dose or add supportive meds.  \n- **Timing matters**: If you’re on a daily pill, try running a few hours after dosing when peak side‑effects are lower.  \nIn short, a mild, short‑lived fever usually isn’t a permanent roadblock—just pause, monitor, and keep your oncologist in the loop.",
          "order": 3,
          "qid": "S15-Q03"
        },
        {
          "q": "Will immunotherapy make my body attack my thyroid or gut forever?",
          "gt": "Immunotherapy can trigger immune‑related adverse events (irAEs) that affect the thyroid and gut, but the course varies.  \n\n**Thyroid** – About 10–20 % develop hypothyroidism or hyperthyroidism. Most cases respond to levothyroxine or a short course of steroids and can be managed long‑term; only a minority become permanently hypothyroid.  \n\n**Gut** – Colitis occurs in 5–10 % of patients. With prompt steroids (or infliximab if needed) the inflammation usually resolves, and many patients return to normal bowel function. A small fraction may need ongoing treatment, but permanent damage is uncommon.  \n\nEarly monitoring (labs, symptom check‑ins) and rapid treatment keep these side effects reversible for most people. Discuss your activity goals with your oncologist so they can tailor the plan and schedule routine checks while you keep running.",
          "order": 4,
          "qid": "S15-Q04"
        },
        {
          "q": "Can I still race this season if scans look better?",
          "gt": "**Short answer:** Yes—many patients with improving scans can keep racing, but it must be a joint decision with your oncology team and a clear plan for monitoring side‑effects.\n\n**Why it’s possible:**  \n- **Improved disease** means you’re in a window where activity can be safe and even beneficial (exercise can boost immune function).  \n- **Targeted BRAF/MEK therapy** often causes fatigue, rash, or mild neuropathy; these can usually be managed while running, especially if you taper intensity or add rest days.  \n- **Immunotherapy** can trigger immune‑related events (colitis, pneumonitis, thyroiditis). If you’re asymptomatic and your labs are stable, short‑distance or trail runs are generally fine.\n\n**What to do:**  \n1. **Get clearance** from your oncologist or a sports‑medicine specialist.  \n2. **Monitor** vitals, blood counts, and any new symptoms (fatigue, pain, shortness of breath).  \n3. **Adjust** intensity: start with easy runs, add mileage gradually, and avoid high‑impact moves if neuropathy or joint pain appears.  \n4. **Stay hydrated** and watch for skin changes if on BRAF/MEK inhibitors.  \n\nIf any new side‑effect arises, pause training and re‑evaluate. With careful oversight, you can keep racing while staying on track with your treatment.",
          "order": 5,
          "qid": "S15-Q05"
        },
        {
          "q": "Do I need to hide from the sun now?",
          "gt": "Yes—sun protection is essential for anyone with melanoma, even while you’re on therapy. UV light can trigger new lesions and, with BRAF/MEK inhibitors, can increase photosensitivity and rash risk. You can still run, but take these precautions:\n\n- **Wear protective clothing** (long sleeves, pants, a wide‑brimmed hat, UV‑blocking sunglasses).  \n- **Apply broad‑spectrum sunscreen SPF 30+** to all exposed skin, reapplying every 2 hours or after heavy sweating.  \n- **Avoid peak sun hours** (10 am–4 pm) when possible; if you must run then, use extra shielding.  \n- **Check for skin changes** regularly and report new spots or changes to your oncologist.\n\nWith these measures you can keep moving safely while minimizing the risk of new melanoma growth or therapy‑related skin toxicity.",
          "order": 6,
          "qid": "S15-Q06"
        },
        {
          "q": "If brain spots show up later, does that end everything?",
          "gt": "If brain “spots” (metastases) appear later, it doesn’t automatically mean the end of treatment or the end of life. Brain lesions are a serious complication, but many patients with BRAF‑V600E melanoma can still receive effective systemic therapy—BRAF/MEK inhibitors, immunotherapy, or a combination—often while staying active. Treatment options include stereotactic radiosurgery, targeted therapy that penetrates the brain, and sometimes whole‑brain radiation or surgery for symptomatic lesions. The key factors that influence prognosis are the number and size of lesions, how well the rest of the disease is controlled, and your overall performance status. Discuss early with your oncologist; with timely intervention, many people maintain a good quality of life and continue running or other activities.",
          "order": 7,
          "qid": "S15-Q07"
        },
        {
          "q": "Can I keep my job while doing this, or should I plan leave?",
          "gt": "You can often keep working while on treatment, but it depends on how you feel and the specific drugs you’re taking.  \n**Immunotherapy (PD‑1/CTLA‑4 inhibitors)** usually causes mild fatigue, rash, or flu‑like symptoms that can be managed with rest and supportive care. Most patients stay in the office or run a flexible schedule.  \n**BRAF/MEK inhibitors** can produce fatigue, joint pain, rash, and diarrhea—symptoms that may require dose breaks or supportive meds. If these become severe, a short leave or part‑time arrangement is reasonable.  \n\nPlan:  \n1. Discuss your job demands with your oncologist and occupational health.  \n2. Keep a symptom diary and schedule regular check‑ins.  \n3. Have a flexible work plan (remote days, staggered hours) and a backup for intense flare‑ups.  \n\nIf side effects flare, a brief leave is usually the safest choice; otherwise, many trail runners maintain full‑time work with proper support.",
          "order": 8,
          "qid": "S15-Q08"
        },
        {
          "q": "What signals tell me to call you the same day?",
          "gt": "**Call me the same day if you notice any of these urgent signs:**\n\n- **Severe or sudden pain** (especially in the chest, abdomen, or joints) that doesn’t improve with usual measures.  \n- **Shortness of breath, wheezing, or chest tightness**—could signal pulmonary embolism or severe inflammation.  \n- **High fever (>38.5 °C) or chills** that persist or worsen, suggesting infection or cytokine‑release syndrome.  \n- **New or worsening swelling, redness, or warmth** at a drug infusion site or in a limb—possible infection or deep‑vein thrombosis.  \n- **Unexplained fatigue, dizziness, fainting, or palpitations**—could indicate anemia, cardiac arrhythmia, or severe side‑effect.  \n- **Severe nausea, vomiting, or diarrhea** that lasts >24 h or leads to dehydration.  \n- **Skin changes**: sudden rash, blistering, or itching that spreads rapidly.  \n- **Vision changes, headaches, or confusion**—possible neuro‑toxicity or intracranial pressure.  \n\nIf any of these occur, contact me immediately (or your oncologist) for prompt evaluation.",
          "order": 9,
          "qid": "S15-Q09"
        },
        {
          "q": "If I choose wrong first, did I ruin my chance at the other option?",
          "gt": "It’s understandable to worry about “missing out.” In practice, the two approaches are interchangeable and can be sequenced in either order. Most clinicians start with immunotherapy (nivolumab/ipilimumab or pembrolizumab) because it can produce durable responses and its side‑effect profile is often more manageable for an active runner. If you begin with a BRAF/MEK inhibitor (dabrafenib + trametinib, for example) you still retain the option to switch to immunotherapy later—many patients do well on both, though the response rates differ. The key is close monitoring and early discussion of side‑effects with your oncologist. Choosing one first does not “ruin” the other; it just changes the timing and may affect how you tolerate each.",
          "order": 10,
          "qid": "S15-Q10"
        }
      ]
    },
    {
      "id": "S16",
      "title": "Hospital or home (newly diagnosed AML at 67)",
      "diagnosis": "Acute myeloid leukemia in a 67-year-old",
      "treatment_plan": "Either intensive inpatient induction or lower-intensity therapy (hypomethylating agent + venetoclax) with transfusion support; infection prophylaxis; consider trial",
      "narrative": "I'm 67 and blindsided by leukemia. They’re talking about weeks in the hospital or a gentler plan mostly at home. I want time, but I also want myself.",
      "qa": [
        {
          "q": "If I choose the hospital route, how long am I really there and what does a day look like?",
          "gt": "If you opt for the standard “7‑day” induction, you’ll be in the hospital for about **2–3 weeks**.  \n**Day‑to‑day:**  \n\n1. **Morning** – blood tests, CBC, chemistry panel, and a dose of cytarabine (or daunorubicin) given by IV or infusion.  \n2. **Mid‑day** – a short break, then a second drug dose (often a second cytarabine or anthracycline).  \n3. **Afternoon** – routine labs, monitoring for side‑effects (fever, low platelets, neutropenia).  \n4. **Evening** – supportive care: transfusions (red cells/platelets) as needed, antibiotics or antifungals if you’re neutropenic, and pain/fever management.  \n\nYou’ll have frequent nursing checks (every 4–6 hrs) and may need a central line for medications and blood draws. The goal is to achieve remission, so the intensity is high, but the hospital stay is relatively short—most patients are discharged once counts recover and the chemo cycle ends.",
          "order": 1,
          "qid": "S16-Q01"
        },
        {
          "q": "If I choose the at-home regimen, am I less likely to be alive for my granddaughter’s birthday?",
          "gt": "I’m sorry you’re facing this. In a 67‑year‑old with AML, the classic “7 + 3” induction gives the highest chance of a deep remission, but it also carries a higher early‑mortality risk (especially if you have comorbidities). The outpatient hypomethylating‑agent + venetoclax regimen is less intensive, has lower early death rates, and many patients stay well enough to enjoy family time, but overall survival is usually a bit shorter than with full induction—though the difference can be modest and depends on your cytogenetics, performance status, and how well you tolerate transfusions and infections.  \nIn short, choosing the at‑home plan does not automatically mean you’ll miss your granddaughter’s birthday; it simply shifts the balance toward a gentler course with a slightly different survival profile. Discuss your goals, comorbidities, and any clinical‑trial options with your hematologist to decide what feels right for you.",
          "order": 2,
          "qid": "S16-Q02"
        },
        {
          "q": "Will I be transfusion-dependent for months?",
          "gt": "It’s common for AML patients to need transfusions while the bone marrow is suppressed.  \nDuring intensive induction, most people receive packed‑red‑cell and platelet transfusions for 4–6 weeks, sometimes longer if counts stay low. With a lower‑intensity regimen (hypomethylating agent + venetoclax), the marrow often recovers a bit faster, but many still need transfusions for several weeks to a few months until neutrophil and platelet counts rise.  \n\nIf you achieve a durable remission, transfusion needs usually drop off. If the disease remains active or you’re in a prolonged recovery phase, you may stay transfusion‑dependent for several months. Your oncologist will tailor the plan and monitor counts closely, so the exact duration depends on your response and overall health.",
          "order": 3,
          "qid": "S16-Q03"
        },
        {
          "q": "How do we prevent infections when my immune system vanishes?",
          "gt": "I’m sorry you’re facing this. When neutrophils drop, infections are the biggest risk, but there are concrete steps to keep you safer:\n\n1. **Prophylactic meds** – Your team usually gives a fluoro‑insecticidal antibiotic (e.g., levofloxacin) and an antifungal (posaconazole or voriconazole) while neutropenic.  \n2. **Vaccinations** – Get the pneumococcal, influenza, and COVID‑19 shots before therapy starts.  \n3. **Hand hygiene & masks** – Wash hands with soap or alcohol gel before meals, after bathroom use, and when you’re around sick people. Wear a mask in crowded or indoor settings.  \n4. **Diet & environment** – Eat cooked foods, avoid raw produce, and keep your living space clean.  \n5. **Early warning** – Monitor temperature, sore throat, or any new symptom; report it within 24 h.  \n6. **Supportive care** – Transfuse platelets/erythrocytes as needed and consider G‑CSF if your doctor recommends it.  \n\nThese measures, combined with close follow‑up, give you the best chance to stay infection‑free while you fight AML.",
          "order": 4,
          "qid": "S16-Q04"
        },
        {
          "q": "What if the plan isn’t working—do we know early enough to pivot?",
          "gt": "If the chosen regimen isn’t working, you’ll usually know by the first few weeks.  \n**Early monitoring**:  \n- **Day 7–10**: CBC and blast count in the peripheral blood; a drop of >50 % blasts is a good sign.  \n- **Day 14–21**: Repeat bone‑marrow aspirate/biopsy. A complete remission (CR) is defined by <5 % blasts, normal cytopenias, and no circulating blasts.  \n- **Day 28**: If CR is not achieved, the induction is considered “failed.”  \n\nIf the plan stalls, you can pivot promptly:  \n- **Intensive failure** → salvage chemotherapy (e.g., FLAG‑M, CLAG‑M) or enrollment in a clinical trial.  \n- **Low‑intensity failure** → switch to a different hypomethylating agent, add venetoclax, or move to a clinical trial.  \n\nYour oncology team will review these results weekly and discuss options before the next cycle, ensuring you’re not left waiting for a decision.",
          "order": 5,
          "qid": "S16-Q05"
        },
        {
          "q": "Can I appoint my daughter to make decisions if I’m too sick?",
          "gt": "Yes—you can legally appoint your daughter to make medical decisions for you if you become unable to do so. In the U.S., this is done by completing a **Durable Power of Attorney for Health Care** (sometimes called a “healthcare proxy” or “medical power of attorney”). The form names the person (your daughter) and gives them authority to make treatment decisions, including choosing between inpatient induction, outpatient hypomethylating‑agent therapy, or clinical trials.  \n\n**Steps to take now:**\n\n1. **Obtain the form** from your state’s health department, your doctor’s office, or an online legal‑services site.  \n2. **Discuss your wishes** with your daughter and your oncology team so she knows your values and treatment preferences.  \n3. **Sign the form in front of a notary** (or as required by state law).  \n4. **Give copies** to your daughter, your oncologist, and keep one in your medical record.  \n\nHaving this in place ensures your daughter can act promptly if you become too ill to speak, and it gives you peace of mind while you focus on treatment.",
          "order": 6,
          "qid": "S16-Q06"
        },
        {
          "q": "Will chemo steal my mind or only my hair?",
          "gt": "**Short answer:** Most AML induction regimens (cytarabine + anthracycline) mainly cause hair loss, nausea, and myelosuppression. “Chemo‑brain” is uncommon and usually mild—short‑term memory lapses or difficulty concentrating that resolve after treatment. Lower‑intensity therapy (hypomethylating agent + venetoclax) is even less likely to affect cognition.  \n\n**What to expect:**  \n- **Hair loss:** Yes, most patients lose hair during induction.  \n- **Cognitive changes:** Rare, usually transient, and not a major concern for most people.  \n- **Other side effects:** Fatigue, infections, and organ toxicity are more common.  \n\n**Practical tips:**  \n- Keep a simple schedule and use reminders to help with memory.  \n- Discuss any persistent cognitive issues with your team; they can adjust medications or add supportive care.  \n\nOverall, the main physical toll is on your blood cells and hair, not on your mind.",
          "order": 7,
          "qid": "S16-Q07"
        },
        {
          "q": "Do I have to stop my daily walk?",
          "gt": "You don’t have to quit walking entirely, but the type and intensity of activity should be tailored to your treatment phase and how you feel.\n\n**During intensive induction**  \n- You’ll likely become neutropenic (low white‑cell count) and very fatigued.  \n- Light, short walks (5–10 min) in a safe environment are usually fine, but avoid strenuous or high‑impact activity.  \n- If you develop fever, chills, or feel dizzy, stop and seek care.\n\n**With lower‑intensity therapy (hypomethylating agent + venetoclax)**  \n- You can often keep up a regular walk, but monitor for excessive fatigue, bruising, or infections.  \n- Adjust the pace or duration if you feel weak or notice new symptoms.\n\n**General tips**  \n- Wear supportive shoes, stay hydrated, and keep a hand‑rail or support if you’re at risk of falling.  \n- Discuss any new symptoms with your oncology team; they can give a specific “walk‑safe” plan based on your blood counts and overall health.  \n\nSo, keep walking, but listen to your body and follow your doctor’s guidance.",
          "order": 8,
          "qid": "S16-Q08"
        },
        {
          "q": "How do costs and caregiver time differ between options?",
          "gt": "**Intensive inpatient induction**  \n- **Cost:** Hospital stay (often 2–4 weeks) plus chemotherapy, transfusions, antibiotics, and monitoring. The total bill can reach $150–250 k, but most of it is usually covered by insurance; out‑of‑pocket costs are often lower.  \n- **Caregiver time:** You’ll need a caregiver for the first few days (transport, paperwork) but most day‑to‑day care is handled by nurses. After discharge, routine visits are infrequent.\n\n**Lower‑intensity home therapy (hypomethylating agent + venetoclax)**  \n- **Cost:** Drug acquisition is high ($30–40 k per year), but you avoid prolonged inpatient bills. Insurance may cover the meds, yet copays and infusion‑related costs (transfusions, supportive meds) add up.  \n- **Caregiver time:** Much more hands‑on involvement—administering oral meds, arranging transfusions, monitoring for infections, and frequent clinic visits. Expect 10–20 hours per week of caregiver effort, especially in the first 3–6 months.\n\nIn short, inpatient care concentrates cost and medical work in the hospital, sparing you daily caregiving duties, while home therapy spreads costs over time and demands more caregiver involvement.",
          "order": 9,
          "qid": "S16-Q09"
        },
        {
          "q": "If I want to switch paths later, can I?",
          "gt": "It’s absolutely possible to change your treatment plan later, but the timing matters.  \n• **Intensive induction** is usually given in a hospital for 2–3 weeks. If you start that, you’ll need to finish the full course before switching.  \n• **Low‑intensity therapy** (hypomethylating agent + venetoclax) can be started at home and is often continued for several months. If you begin this, you can switch to intensive induction only if the leukemia shows signs of rapid progression or if you’re not responding after a few cycles.  \n• Switching back to intensive therapy is more challenging if you’ve already had a full induction course, but it can be considered in a clinical trial or if your disease is aggressive.  \n\nDiscuss your preferences with your hematologist early—most centers have protocols for “bridge” therapy or trial enrollment that allow a smooth transition if your situation changes.",
          "order": 10,
          "qid": "S16-Q10"
        }
      ]
    },
    {
      "id": "S17",
      "title": "Waiting feels like doing nothing (CLL watch-and-wait)",
      "diagnosis": "Chronic lymphocytic leukemia, asymptomatic",
      "treatment_plan": "Active surveillance with regular labs and exams; start treatment when specific triggers are met",
      "narrative": "I'm 63 and told we aren't treating yet. It feels like ignoring a ticking clock.",
      "qa": [
        {
          "q": "How is 'watch and wait' not just 'wait and worry'?",
          "gt": "**Watch‑and‑wait is a deliberate, evidence‑based strategy, not passive anxiety.**  \n- **Clear criteria**: Treatment starts only when blood counts drop, lymph nodes enlarge, or symptoms appear—so you’re not “ignoring” a ticking clock but following a proven plan that avoids unnecessary chemo and its side‑effects.  \n- **Regular monitoring**: Blood tests every 1–3 months and physical exams keep the disease under close watch. Any change is caught early, often before symptoms develop.  \n- **Quality of life**: You avoid the fatigue, nausea, and immune suppression that many early‑treatment patients experience, preserving your day‑to‑day well‑being.  \n- **Psychological support**: Many patients find that scheduled visits and clear milestones reduce uncertainty; counseling or support groups can help turn “waiting” into a structured, reassuring process.  \n\nSo, watch‑and‑wait is a proactive, data‑driven plan that protects you from overtreatment while keeping the disease in check.",
          "order": 1,
          "qid": "S17-Q01"
        },
        {
          "q": "What exact signs mean it’s time to act so I’m not guessing?",
          "gt": "**When to stop “watch‑and‑wait” in CLL**\n\n| Trigger | Typical threshold | Why it matters |\n|---------|-------------------|----------------|\n| **Absolute lymphocyte count (ALC)** | > 30 × 10⁹/L (30 k/µL) | Rapidly rising ALC indicates active proliferation. |\n| **Progressive lymphadenopathy or splenomegaly** | > 2 cm increase or new nodes > 3 cm | Suggests disease expansion. |\n| **Cytopenias** | Hemoglobin < 10 g/dL, platelets < 100 × 10⁹/L, neutropenia < 1.5 × 10⁹/L | Reflects marrow infiltration. |\n| **B‑symptoms** | Fever, night sweats, unexplained weight loss > 10 % | Sign of systemic disease. |\n| **Rapid disease progression** | > 50 % increase in ALC or lymph node size in < 6 months | Indicates aggressive biology. |\n| **Elevated LDH or β‑2‑microglobulin** | > 2× upper limit | Correlates with tumor burden. |\n| **New organ involvement** | e.g., liver, kidney, CNS | Requires immediate therapy. |\n\nIf **any** of these appear, discuss treatment with your hematologist. Regular labs (CBC, ALC, LDH) every 3–6 months and physical exams every 6 months help catch changes early. This clear checklist removes guesswork and ensures timely intervention.",
          "order": 2,
          "qid": "S17-Q02"
        },
        {
          "q": "Can I still travel without labs every month?",
          "gt": "It’s understandable to want to keep your routine flexible while you’re traveling. In a watch‑and‑wait CLL plan, the key is to keep your disease under close surveillance, not to skip the labs entirely. Most guidelines recommend a CBC with differential every 4–6 weeks while you’re in the “watch” phase. If you’re going on a trip, you can:\n\n1. **Schedule a lab visit before you leave** (or at the start of the trip) and have the results sent to your oncologist.  \n2. **Use a local lab** at your destination—most hospitals or community labs can run the same tests, and you can fax or email the results.  \n3. **Telehealth check‑ins** can help you discuss any new symptoms or lab trends without an in‑person visit.\n\nIf you’re truly stable and your oncologist has approved a longer interval (e.g., every 8 weeks) for a short trip, that’s acceptable, but you should still have a lab done before you depart. In short: you can travel, but keep the labs on schedule—just coordinate them with local facilities or your care team.",
          "order": 3,
          "qid": "S17-Q03"
        },
        {
          "q": "Will my immunity be weak even without treatment?",
          "gt": "I’m sorry you’re feeling uneasy about the “ticking clock.” In early‑stage CLL that’s still under watch‑and‑wait, the disease itself can dampen the immune system, but it usually does so gradually. Many people have normal or only mildly reduced immunity for months or years before treatment is needed. The key is regular monitoring—blood counts, lymphocyte subsets, and infection signs—so that any decline is caught early. While you’re not on chemo, you can help keep your defenses strong by staying up‑to‑date on vaccines (influenza, pneumococcal, COVID‑19), practicing good hand hygiene, eating a balanced diet, and avoiding sick contacts. If you notice fevers, sore throats, or unusual infections, let your oncologist know right away. That way, you’ll stay as healthy as possible while waiting for the right moment to start therapy.",
          "order": 4,
          "qid": "S17-Q04"
        },
        {
          "q": "Should I change my diet or supplements to slow this down?",
          "gt": "I understand how unsettling it can feel to “watch and wait.”  \n**What the evidence says:**  \n- No specific diet or supplement has been proven to slow CLL progression.  \n- Large‑scale studies show that a balanced, nutrient‑dense diet (fruits, vegetables, whole grains, lean protein, healthy fats) supports overall health and immune function.  \n- High‑dose antioxidants (e.g., vitamin E, vitamin C, beta‑carotene) or other supplements can interfere with chemotherapy if treatment starts, and some may even blunt immune responses.  \n\n**Practical steps:**  \n1. **Maintain a healthy weight**—avoid rapid weight loss or gain.  \n2. **Eat a varied diet** rich in colorful produce, lean protein, and healthy fats (olive oil, nuts, fatty fish).  \n3. **Limit alcohol** and avoid smoking.  \n4. **Discuss any supplements** with your hematologist before starting; most are unnecessary and could delay treatment.  \n\nKeep up with your scheduled labs and exams—those are the most reliable way to detect when therapy is needed.",
          "order": 5,
          "qid": "S17-Q05"
        },
        {
          "q": "Will insurance balk when I’m not 'actively' treated?",
          "gt": "I understand how uneasy it can feel to “do nothing” while a disease is ticking in the background. In most U.S. plans, a watch‑and‑wait strategy for asymptomatic CLL is covered because it’s the standard of care. Insurers typically require that you keep the scheduled visits, labs, and imaging that define the surveillance protocol; missing those appointments can be seen as non‑compliance and may trigger a denial.  \n\nTo stay protected, keep a clear record of every visit, test, and the physician’s notes that justify the watchful‑waiting approach. If you ever need to pause appointments, call your insurer’s member services and explain the plan—most will accept the documented surveillance.  \n\nSo, as long as you stay on the agreed schedule and keep documentation, insurance should not balk at the lack of active treatment.",
          "order": 6,
          "qid": "S17-Q06"
        },
        {
          "q": "Is there a benefit to clinical trials now?",
          "gt": "For an asymptomatic 63‑year‑old under watch‑and‑wait, enrolling in a clinical trial can offer two main benefits:  \n\n1. **Early access to novel agents** – some trials target untreated CLL and may provide a drug that could delay or replace standard therapy.  \n2. **Intensive monitoring and data contribution** – you’ll receive close follow‑up and help advance knowledge that may benefit future patients.\n\nHowever, there are caveats. Many trials require measurable disease or specific biomarkers, so you might not qualify. Side‑effects can be significant, and if the trial drug isn’t effective you could lose the window for standard therapy.  \n\nDiscuss with your hematologist whether any ongoing studies fit your disease status and personal goals. If you’re comfortable with the risks and the trial’s design, it can be a worthwhile option.",
          "order": 7,
          "qid": "S17-Q07"
        },
        {
          "q": "How do I tell family I’m okay when the word leukemia scares them?",
          "gt": "It helps to frame the conversation in plain, reassuring language.  \n1. **Use the “watch‑and‑wait” phrase** – say, “I’m in a careful observation phase. My doctors are checking my blood and health every few months, and I’ll start treatment only if certain numbers change.”  \n2. **Explain the plan simply** – “Leukemia is not an immediate danger right now; it’s a slow‑progressing condition. I’m doing the same thing many people do when they’re diagnosed early.”  \n3. **Emphasize normalcy** – “I’m still eating, exercising, and enjoying life. The only difference is that I’ll have regular check‑ups.”  \n4. **Invite updates** – “I’ll keep you posted on any changes, and we’ll all know when it’s time to act.”  \n5. **Reassure them** – “The word ‘leukemia’ can sound scary, but in my case it’s a manageable condition with a clear plan.”  \n\nThis keeps the message factual, calm, and supportive, so your family feels informed and reassured.",
          "order": 8,
          "qid": "S17-Q08"
        },
        {
          "q": "Can stress make this speed up?",
          "gt": "I understand how unsettling it can feel to “watch” a ticking clock. In chronic lymphocytic leukemia (CLL), the disease’s natural history is driven mainly by genetics and the immune system’s balance, not by emotional state. Current research shows no reliable evidence that psychological stress accelerates CLL progression or triggers earlier treatment. Stress can, however, affect your overall well‑being, sleep, and immune function, which may influence how you feel and how you cope with the disease. Managing stress—through mindfulness, gentle exercise, supportive counseling, or talking with a trusted friend—can improve quality of life and may help you feel more in control. Keep regular follow‑ups; if any clinical or laboratory changes occur, your doctor will initiate therapy promptly.",
          "order": 9,
          "qid": "S17-Q09"
        },
        {
          "q": "How often do people never need treatment?",
          "gt": "In early‑stage, asymptomatic CLL, the majority of patients never require therapy. Studies of “watch‑and‑wait” cohorts show that roughly **80–90 % of patients remain treatment‑free for at least 5 years**, and about **50–60 % never need therapy during their lifetime**. The median time to first treatment is around 5–7 years, but many people stay stable for decades. So while it can feel like a ticking clock, the likelihood of never needing treatment is high—especially if your disease remains low‑grade and you stay symptom‑free. Keep regular labs and check‑ups; they’re the best way to catch any change early.",
          "order": 10,
          "qid": "S17-Q10"
        }
      ]
    },
    {
      "id": "S18",
      "title": "Finding my voice again (papillary thyroid cancer)",
      "diagnosis": "Papillary thyroid carcinoma after thyroidectomy",
      "treatment_plan": "Surgery followed by thyroid hormone replacement; consider radioactive iodine based on risk; lifelong surveillance",
      "narrative": "I'm 35, a teacher. Surgery took my thyroid. My voice is hoarse and the scar is new territory. I’m trying to feel normal again.",
      "qa": [
        {
          "q": "Will my voice return to my old classroom strength?",
          "gt": "I’m sorry you’re dealing with this change. After thyroidectomy the recurrent laryngeal nerve can be stretched or injured, which often causes hoarseness that improves over time. Most patients notice gradual recovery within 3–6 months, and many regain near‑normal vocal strength with voice‑therapy exercises, vocal rest, and good hydration. In some cases the nerve does not fully recover, and the voice may remain slightly weaker or breathier. An ENT or speech‑language pathologist can assess nerve function and guide a tailored therapy plan. If you’re still hoarse after a few months, a repeat laryngoscopy can rule out other issues. Keep your voice rested, stay hydrated, and follow up with your surgeon/ENT—most teachers find their classroom voice returns or improves significantly.",
          "order": 1,
          "qid": "S18-Q01"
        },
        {
          "q": "Do I need radioactive iodine, or can we skip it safely?",
          "gt": "I’m sorry you’re dealing with both a new scar and a hoarse voice—both can feel unsettling. Whether you need radioactive iodine (RAI) depends on your **risk stratification** after surgery:\n\n| Risk level | Typical features | RAI usually recommended? |\n|------------|------------------|---------------------------|\n| **Low‑risk** | Tumor ≤4 cm, no extrathyroidal extension, no nodal metastasis | Often **skipped**; surveillance with thyroglobulin and ultrasound is enough. |\n| **Intermediate‑risk** | Tumor >4 cm, microscopic extrathyroidal extension, limited nodal disease | RAI **often** advised to reduce recurrence risk. |\n| **High‑risk** | Gross extrathyroidal extension, distant metastasis, aggressive histology | RAI **recommended** (sometimes multiple courses). |\n\nYour voice changes are likely due to nerve injury from surgery, not RAI. Discuss your exact pathology with your surgeon/medical‑oncologist; they’ll weigh the benefits of RAI against potential side‑effects (dry mouth, altered taste, radiation exposure). If your case falls into the low‑risk category, you can safely skip RAI and focus on follow‑up. If intermediate or high risk, RAI usually offers a meaningful survival benefit.",
          "order": 2,
          "qid": "S18-Q02"
        },
        {
          "q": "How do we set my hormone dose so I’m not anxious and sleepless?",
          "gt": "I’m sorry you’re feeling unsettled after the surgery. The key to easing anxiety and sleep problems is a **stable, individualized thyroid‑hormone dose** that keeps your TSH in the target range for your risk group (usually 0.5–2.5 mIU/L for low‑risk papillary cancer).  \n\n1. **Start with a calculated dose**: T4 (levothyroxine) ≈ 1.6 µg/kg/day (≈ 1.6 mg for a 70‑kg adult).  \n2. **Recheck TSH in 6–8 weeks**.  \n3. **Adjust by 12.5–25 µg** up or down, then re‑check after another 6–8 weeks.  \n4. **Aim for the lower half of the target** (0.5–1.5 mIU/L) if you’re anxious or have insomnia—this reduces sympathetic overdrive.  \n5. **Keep a consistent daily routine**: same bedtime, avoid caffeine after 2 pm, and practice relaxation (deep breathing, gentle stretching).  \n\nIf anxiety or sleep issues persist, discuss a short course of low‑dose benzodiazepine or a CBT‑based sleep program with your endocrinologist. Regular follow‑ups and a clear dose‑adjustment plan will give you the stability you need.",
          "order": 3,
          "qid": "S18-Q03"
        },
        {
          "q": "Will this scar always shout 'cancer' at people?",
          "gt": "Your scar is a reminder of the surgery, not of the cancer itself. Once the thyroid is removed, the risk of recurrence is very low, especially if you’re receiving appropriate hormone replacement and follow‑up scans. The scar will fade over time, and many people grow to see it as a normal part of their body—just like a surgical scar from any operation. If you’re concerned about how it looks, a dermatologist or plastic surgeon can discuss subtle scar‑reduction options (e.g., silicone sheets, laser therapy). In short, the scar won’t “shout” cancer to others; it’s simply a healed surgical mark that can become less noticeable with time and care.",
          "order": 4,
          "qid": "S18-Q04"
        },
        {
          "q": "Can I get pregnant safely on these medicines?",
          "gt": "I’m really sorry you’re dealing with so many changes right now. Here’s what the evidence says about pregnancy after thyroidectomy and thyroid‑hormone therapy:\n\n- **Levothyroxine (thyroid‑hormone replacement)** is safe in pregnancy. In fact, you’ll need a slightly higher dose once you’re pregnant to keep your levels normal. Your endocrinologist will adjust the dose and monitor TSH every 4–6 weeks during the first trimester and then every 6–8 weeks thereafter.\n\n- **Radioactive iodine (RAI)** is **contraindicated** during pregnancy and breastfeeding. If you’ve had RAI, the standard recommendation is to wait at least 6–12 months before trying to conceive to allow the iodine to clear from your body. Your doctor can confirm the exact interval based on your last dose.\n\n- **Voice changes** from nerve injury are usually permanent; they don’t affect fertility or pregnancy safety, but you might want to discuss voice therapy or a speech‑language pathologist if the hoarseness bothers you.\n\nIn short, you can safely plan a pregnancy while on levothyroxine, but you should avoid RAI during pregnancy and wait the recommended period after any RAI treatment. Talk with your endocrinologist and obstetrician to set up a monitoring plan that keeps you and your baby healthy.",
          "order": 5,
          "qid": "S18-Q05"
        },
        {
          "q": "What follow-up keeps me safe without over-testing?",
          "gt": "I’m glad you’re looking for a clear, balanced plan. For a low‑risk papillary thyroid cancer after total thyroidectomy, the American Thyroid Association recommends:\n\n| What | Frequency | Why |\n|------|-----------|-----|\n| **TSH level** (with free T4) | Every 6 months for the first 2 years, then annually | Keeps TSH low enough to suppress any residual cancer cells. |\n| **Serum thyroglobulin (Tg)** | Every 6–12 months (same schedule as TSH) | Tg is the most sensitive marker for recurrence; a rising trend flags a problem. |\n| **Neck ultrasound** | Annually for 5 years, then every 2–3 years if Tg stays low | Detects new nodules or lymph node changes early. |\n| **Laryngoscopy** | Only if hoarseness persists or worsens | Voice changes can signal recurrent nerve injury or recurrence. |\n| **Clinical exam** | At each visit | Physical exam can pick up subtle signs that labs miss. |\n\nIf your Tg remains undetectable and your ultrasound is clear, you can safely skip routine imaging (CT, PET, or repeat ultrasounds) and avoid unnecessary tests. This schedule protects you while keeping the number of visits and scans reasonable. If any of the markers rise or you notice new symptoms, we’ll adjust the plan promptly.",
          "order": 6,
          "qid": "S18-Q06"
        },
        {
          "q": "Is my calcium low forever after surgery?",
          "gt": "After a total thyroidectomy the most common reason for low calcium is temporary injury or removal of the parathyroid glands. In the majority of patients (≈80‑90 %) calcium levels normalize within a few weeks to a few months as the remaining parathyroids recover. Only about 5–10 % develop permanent hypocalcemia, usually when both glands are removed or severely damaged. Your doctor will monitor serum calcium and PTH for at least 6–12 months. If calcium stays low after that period, you’ll likely need lifelong calcium and vitamin D supplementation. Watch for tingling, muscle cramps, or a tingling “pins‑and‑needles” sensation—these are early signs of low calcium. Discuss any persistent symptoms with your endocrinologist; most people regain normal calcium levels with time and treatment.",
          "order": 7,
          "qid": "S18-Q07"
        },
        {
          "q": "Can I sing in choir again?",
          "gt": "I’m sorry you’re dealing with this extra challenge. After a thyroidectomy the most common issue that can affect singing is injury to the recurrent laryngeal nerve, which can cause hoarseness or a breathy voice. Most patients’ voices improve as the nerves heal over 3–6 months, and many return to normal singing once the scar has settled and the voice is rested.\n\n**What to do next**\n\n1. **Get a voice assessment** – an ENT or speech‑language pathologist can check vocal cord mobility and give you a tailored plan.  \n2. **Start gentle vocal warm‑ups** – short, low‑intensity exercises, avoiding strain or shouting.  \n3. **Hydrate and rest** – keep your vocal folds moist and give yourself a day or two of quiet after intense use.  \n4. **Gradual return** – begin with a few minutes of singing in a quiet room, then slowly increase duration and volume.  \n5. **If hoarseness persists** after 6 months, further imaging or a laryngoscopy may be needed.\n\nWith careful monitoring and gradual re‑introduction, many people successfully re‑join choir singing. Keep your doctor in the loop, and trust the healing process.",
          "order": 8,
          "qid": "S18-Q08"
        },
        {
          "q": "Do I need to avoid certain foods because of iodine?",
          "gt": "I don’t need to cut out iodine‑rich foods unless your doctor tells you to for a radioactive‑iodine (RAI) treatment.  \n- **After thyroidectomy** you’ll take synthetic levothyroxine, so the body gets the hormone it needs regardless of dietary iodine.  \n- **If RAI is planned**, you’ll be asked to limit iodine (e.g., avoid iodinated contrast, high‑iodine supplements, and very iodine‑rich foods like seaweed, kelp, and iodized salt) about 2–4 weeks before the scan and for a short period after.  \n- **If no RAI** is scheduled, a normal, balanced diet—including foods with iodine—is fine and even healthy.  \n\nSo, unless your treatment plan specifically calls for an iodine‑restricted diet, you can keep eating normally. Your hoarseness is likely nerve irritation from surgery, not iodine.",
          "order": 9,
          "qid": "S18-Q09"
        },
        {
          "q": "How do I keep from defining myself by this scar?",
          "gt": "I’m sorry you’re feeling weighed by the scar. Remember that a scar is a visible reminder of survival, not a label.  \n**Practical steps**  \n1. **Scar care** – keep it moisturized, use silicone sheets or gels, and protect it from sun. If it bothers you, ask your surgeon about laser or filler options.  \n2. **Voice support** – a speech‑language pathologist can help you regain strength and confidence in your voice, which often feels more “you” than the scar.  \n3. **Reframe identity** – write a list of qualities and achievements that define you (teacher, mentor, friend). Share this list with a trusted friend or counselor.  \n4. **Support network** – join a thyroid‑cancer or cancer‑survivor group; hearing others’ stories can normalize the experience and shift focus from the scar to resilience.  \n5. **Mindful acceptance** – brief daily meditation or journaling about gratitude can help you see the scar as part of a larger, thriving life.  \n\nYou’re more than a mark on your skin; you’re a survivor, a teacher, and a person with many facets.",
          "order": 10,
          "qid": "S18-Q10"
        }
      ]
    },
    {
      "id": "S19",
      "title": "Runner with a new scar (high-grade thigh sarcoma)",
      "diagnosis": "High-grade soft tissue sarcoma of the thigh",
      "treatment_plan": "Limb-sparing surgery with radiation (pre- or post-operative) and rehabilitation",
      "narrative": "I'm 46, a half-marathoner. A deep thigh mass turned out to be sarcoma. I want to keep my leg strong and my life moving.",
      "qa": [
        {
          "q": "Will surgery steal my stride, or can I run again?",
          "gt": "I’m glad you’re asking—many people who undergo limb‑sparing surgery for a thigh sarcoma do return to running, but it usually takes a structured plan and time. The key factors that influence your stride are the size and depth of the tumor, whether nerves or major vessels were involved, and the amount of tissue removed. Pre‑operative radiation can help preserve muscle and nerve function, and post‑operative radiation may cause some fibrosis that can limit flexibility, but this is often mild.\n\nA dedicated physiotherapist will guide you through progressive strength, balance, and gait training. Start with low‑impact activities (cycling, elliptical), then add short strides, gradually increasing distance and speed. Most patients resume half‑marathons within 6–12 months, though some may need to adjust stride length or pace. Stay patient, follow your rehab plan, and keep your doctor updated on any changes.",
          "order": 1,
          "qid": "S19-Q01"
        },
        {
          "q": "Pre-op or post-op radiation—what protects my leg best?",
          "gt": "For a high‑grade thigh sarcoma, the choice between pre‑operative and post‑operative radiation depends on how the treatment will affect your leg’s strength and function.\n\n**Pre‑operative radiation (≈50 Gy in 25 fractions)**  \n*Pros:*  \n- Shrinks the tumor, often making the limb‑sparing surgery easier and preserving more muscle.  \n- Lower overall dose to the surrounding tissues, which can reduce long‑term fibrosis and stiffness.  \n*Cons:*  \n- The irradiated tissue is more fragile, so wound healing can be slower and there is a higher chance of surgical wound complications.  \n\n**Post‑operative radiation (≈60 Gy in 30 fractions)**  \n*Pros:*  \n- Delivered after the tumor is removed, so the wound is already closed and healing is less likely to be impaired.  \n- Allows a higher dose to the tumor bed if margins are close or positive.  \n*Cons:*  \n- The dose to the surrounding muscle and skin is higher, increasing the risk of late fibrosis, reduced range of motion, and possible loss of strength.  \n\n**What protects your leg best?**  \nIf your surgeon can achieve clear margins and you’re concerned about long‑term function, pre‑operative RT is usually preferred because it tends to spare muscle and reduce late fibrosis. However, if wound healing is a major concern (e.g., you have diabetes or poor vascularity), post‑operative RT may be safer. Discuss with your radiation oncologist and surgeon to weigh the risks of wound complications versus long‑term functional loss, and consider a multidisciplinary plan that includes a physiotherapist to optimize rehabilitation.",
          "order": 2,
          "qid": "S19-Q02"
        },
        {
          "q": "How do I avoid lymphedema or swelling that ends training?",
          "gt": "**Practical steps to keep swelling in check**\n\n1. **Early detection** – Check the leg daily for puffiness, heaviness, or skin changes. Report any new swelling to your oncologist or physio right away.  \n2. **Compression** – Wear a well‑fitted compression stocking (20–30 mm Hg) as prescribed, especially after surgery or radiation.  \n3. **Exercise** – Keep moving with low‑impact activities (walking, cycling, swimming). Your physio can tailor a program that protects the surgical site while strengthening the leg.  \n4. **Elevation & hydration** – Elevate the leg for 15–20 min after activity and stay hydrated to help fluid balance.  \n5. **Manual lymphatic drainage** – Gentle massage by a trained therapist can stimulate lymph flow; avoid vigorous massage over the scar.  \n6. **Avoid trauma & tight clothing** – Protect the leg from bumps and wear loose, breathable fabrics.  \n7. **Maintain a healthy weight & diet** – Excess weight strains lymphatics; a balanced diet supports healing.  \n8. **Regular follow‑up** – Keep scheduled visits for imaging and physical‑therapy reassessment.  \n\nEarly, consistent care keeps lymphedema at bay and lets you keep training.",
          "order": 3,
          "qid": "S19-Q03"
        },
        {
          "q": "If margins are close, does that mean I’ll lose the leg?",
          "gt": "Close surgical margins mean the tumor was near the edge of the tissue removed. It does **not** automatically mean you’ll lose your leg. In most cases, the surgeon will try to re‑excise the area to get wider margins, or the radiation oncologist will boost the dose to cover the close margin. If the tumor is very close or the anatomy makes further re‑excision impossible, the team may consider amputation, but this is a last resort. The decision is made by a multidisciplinary team (surgeon, radiation oncologist, pathologist, and sometimes a medical oncologist) weighing the risk of recurrence against limb function. So, a close margin raises the need for additional treatment, but it doesn’t guarantee loss of the leg.",
          "order": 4,
          "qid": "S19-Q04"
        },
        {
          "q": "Can I work remotely during recovery?",
          "gt": "Yes—remote work is usually possible during the recovery period, but it depends on how your surgery and radiation feel. After limb‑sparing surgery you’ll likely need rest, pain control, and limited weight‑bearing for a few weeks. Radiation can add fatigue and skin irritation, so you may need to pace yourself.  \n\n**Practical tips**  \n- **Check with your oncologist/physiotherapist** about any activity restrictions and the best schedule for work.  \n- **Set up an ergonomic home office** (adjustable chair, monitor height, foot support) to avoid strain on the operated leg.  \n- **Plan short, frequent breaks** to move the leg gently and prevent stiffness.  \n- **Use pain‑management strategies** (medication, heat/cold, compression) before starting a long workday.  \n\nIf you feel strong enough, start with part‑time remote hours and gradually increase as you heal. Keep your team informed and stay flexible—your recovery is the priority.",
          "order": 5,
          "qid": "S19-Q05"
        },
        {
          "q": "What about nerve damage—will my foot drop?",
          "gt": "I’m sorry you’re facing this uncertainty. In limb‑sparing surgery for a thigh sarcoma, the main nerves at risk are the sciatic and its branches (peroneal, tibial). Whether you’ll develop foot drop depends on several factors:\n\n* **Tumor location & size** – If the mass is close to the sciatic or peroneal nerve, the surgeon may need to sacrifice or protect that nerve.  \n* **Surgical approach** – A meticulous dissection can spare the nerve, but sometimes a small sacrifice is unavoidable.  \n* **Radiation** – Post‑operative radiation can cause delayed fibrosis that may compress nerves, but this is less common than direct surgical injury.  \n\nMost patients who preserve the nerve have no foot drop. If the nerve is partially injured, early physiotherapy, ankle‑foot orthoses, and strengthening can prevent or reduce drop. Your surgical team will evaluate the nerve intra‑operatively and discuss any risk; close follow‑up will catch any early weakness so we can intervene promptly.",
          "order": 6,
          "qid": "S19-Q06"
        },
        {
          "q": "Are scans forever, and how often?",
          "gt": "**Surveillance after limb‑sparing surgery for a high‑grade thigh sarcoma**\n\n- **Local imaging (MRI of the thigh)**  \n  - Every **3–6 months** for the first **2–3 years**.  \n  - Then **annually** up to **5 years**.  \n  - After 5 years, if no recurrence, scans can be spaced to **2–3 years** or discontinued, because the risk drops sharply.\n\n- **Chest imaging (CT or chest X‑ray)**  \n  - Every **6 months** for the first **2–3 years**, then **annually** to 5 years.  \n  - Beyond 5 years, chest imaging is usually only done if symptoms arise.\n\n- **Other sites** – only if clinically indicated (e.g., symptoms, new lesions).\n\nSo, scans are **not forever**; they taper off after about 5 years unless new concerns appear. This schedule balances early detection with minimizing unnecessary radiation and cost, while keeping you on track to stay strong and active.",
          "order": 7,
          "qid": "S19-Q07"
        },
        {
          "q": "Is chemo part of this?",
          "gt": "For most high‑grade soft‑tissue sarcomas of the thigh, the standard approach is limb‑sparing surgery plus radiation (pre‑ or post‑op). Chemotherapy is **not automatically required**; it’s added when the tumor is large, deep, or of a subtype that responds well to systemic therapy (e.g., synovial, alveolar rhabdomyosarcoma). The multidisciplinary team will weigh the benefits—lower distant‑metastasis risk—against the side‑effects (fatigue, nausea, neuropathy). If chemo is recommended, it’s usually given before surgery (neoadjuvant) or after (adjuvant) to shrink the tumor or eradicate microscopic disease. Discuss your goals (maintaining strength, running) with your oncologist; they’ll tailor the plan to your specific tumor biology and overall health.",
          "order": 8,
          "qid": "S19-Q08"
        },
        {
          "q": "How do I fuel healing without gaining weight when I can’t run?",
          "gt": "I’m glad you’re thinking ahead—nutrition is a cornerstone of recovery and can keep your weight steady even when running isn’t an option.  \n\n**1. Prioritize protein and calories for healing.** Aim for 1.2–1.5 g/kg of body weight daily (≈ 90–110 g for a 75‑kg man). Use lean sources—chicken, fish, tofu, Greek yogurt, cottage cheese, and protein‑rich legumes. Pair protein with a small portion of complex carbs (brown rice, sweet potato, quinoa) and healthy fats (avocado, nuts, olive oil) to hit your calorie target without excess.\n\n**2. Control portions, not the food.** Use a smaller plate, fill half with veggies, a quarter with protein, a quarter with carbs. Add a ½‑cup of fruit or a handful of nuts for extra calories if needed.\n\n**3. Eat frequent, balanced meals.** Three meals plus two snacks keep energy steady and prevent overeating. A protein shake (whey or plant‑based) after resistance training can boost muscle repair.\n\n**4. Strength training & low‑impact cardio.** Work the unaffected leg, core, and upper body with resistance bands or light weights. A stationary bike, elliptical, or brisk walking (if cleared) keeps circulation active without high impact.\n\n**5. Monitor weight and adjust.** Weigh weekly; if you’re gaining >0.5 kg (1 lb) per week, trim 100–200 kcal/day. If losing >0.5 kg, add a small snack.\n\n**6. Sleep, hydration, and stress.** Aim 7–9 h sleep, drink 2–3 L water, and practice relaxation (deep breathing, meditation) to support healing.\n\nFinally, schedule a visit with a registered dietitian who can tailor a plan to your surgery, radiation, and rehab schedule. This balanced, mindful approach will help you heal strong while keeping your weight in check.",
          "order": 9,
          "qid": "S19-Q09"
        },
        {
          "q": "What if I trip on fear every time I lace up?",
          "gt": "It’s normal to feel a knot of fear when you think about putting the same weight on a limb that’s just been altered. Treat that fear like a muscle that needs training: start small, build confidence, and let the rest of your body follow.  \n\n1. **Rehabilitation first** – work with a PT who knows post‑sarcoma recovery. They’ll guide you through graded strength, balance, and gait exercises that mimic running.  \n2. **Progressive exposure** – lace up for short walks, then jog, then half‑marathon training. Celebrate each milestone.  \n3. **Mind‑body tools** – use visualization, deep‑breathing, or guided imagery before each session to calm the nervous system.  \n4. **Support network** – talk to a counselor or join a sarcoma survivor group; sharing stories reduces isolation.  \n5. **Equipment check** – ensure shoes fit well, consider orthotics or a gait‑analysis clinic if instability persists.  \n\nRemember, the goal isn’t perfection but steady, safe progress. Your body can regain strength, and with patience, the fear will fade.",
          "order": 10,
          "qid": "S19-Q10"
        }
      ]
    },
    {
      "id": "S20",
      "title": "Left the field mid-game (stage II testicular cancer)",
      "diagnosis": "Stage II testicular cancer (seminoma or nonseminoma)",
      "treatment_plan": "Orchiectomy followed by surveillance, chemotherapy, or radiation depending on type and spread; fertility preservation recommended",
      "narrative": "I'm 28, play in a weekend soccer league, and just lost a testicle to cancer. I’m scared about fertility, masculinity, and telling my team.",
      "qa": [
        {
          "q": "Is banking sperm urgent, or can I wait until after the next scan?",
          "gt": "I’m really sorry you’re going through this. Sperm banking is safest **before** any treatment that could damage fertility—chemotherapy, radiation, or even some high‑dose hormone therapy. If your oncologist has already decided you’ll need chemo or radiation, the bank should happen as soon as possible, ideally within a week of the orchiectomy.  \n\nIf the plan is *surveillance* and you’re not scheduled for immediate therapy, you can wait until after the next scan, but it’s still wise to bank within the next few months. Future treatment could be delayed, and fertility can decline with age or additional therapy. Talk to your urologist or reproductive specialist right away; they can arrange a quick, painless collection and storage.",
          "order": 1,
          "qid": "S20-Q01"
        },
        {
          "q": "Will chemo wreck my lungs or stamina permanently?",
          "gt": "**Short answer:**  \nStandard testicular‑cancer chemotherapy (BEP = bleomycin, etoposide, cisplatin) can cause short‑term lung irritation and fatigue, but permanent lung damage is uncommon when doses are kept within recommended limits and patients are closely monitored. Most men recover full lung function and stamina after treatment, though it may take a few weeks to months for energy levels to return to baseline.  \n\n**What to watch for:**  \n- **Pulmonary:** Bleomycin can cause a mild, reversible pneumonitis; your oncologist will check lung function (spirometry) before, during, and after therapy.  \n- **Fatigue & stamina:** Chemotherapy often leads to temporary tiredness and reduced exercise tolerance. A gradual return to soccer, with rest and a supportive fitness plan, usually restores normal performance.  \n\n**Bottom line:** With modern dosing, vigilant monitoring, and a gradual re‑introduction to activity, the risk of lasting lung or stamina loss is low. Discuss any symptoms promptly with your oncology team.",
          "order": 2,
          "qid": "S20-Q02"
        },
        {
          "q": "Do I need a prosthesis to feel 'normal'?",
          "gt": "A testicular prosthesis is **not medically required**—it’s purely cosmetic. Many men feel fine without one, especially if the remaining testicle is healthy and you’re not concerned about appearance. If you notice a noticeable gap, feel self‑conscious, or want a more symmetrical look, a prosthesis can help you feel “normal” and boost confidence. They’re usually inserted during or after surgery, are made of silicone, and have a low complication rate. Discuss timing and type with your urologist; you can also wait until you’re comfortable with the recovery and any other treatments. Ultimately, the decision is personal—opt for a prosthesis only if it improves your self‑image and comfort.",
          "order": 3,
          "qid": "S20-Q03"
        },
        {
          "q": "Is radiation still used, and will it affect fertility?",
          "gt": "**Radiation today?**  \nFor stage II seminoma, external‑beam radiation is still an option for selected patients (especially those with limited retroperitoneal nodes), but many clinicians now favor surveillance or a single‑cycle carboplatin. For non‑seminoma, radiation is rarely used; standard care is 2–3 cycles of cisplatin‑based chemotherapy or surveillance.\n\n**Fertility impact**  \nRadiation can damage the remaining testis if the field includes it. Even low doses (≈2 Gy) can reduce sperm counts, and higher doses (≥10 Gy) can cause permanent azoospermia. If the radiation field is strictly retroperitoneal and the testis is shielded, the risk is lower, but it’s not eliminated. Chemotherapy (cisplatin) also carries a 30–50 % chance of long‑term infertility.\n\n**What to do**  \n- **Sperm banking** before any treatment is the safest step.  \n- Discuss shielding and dose limits with your radiation oncologist.  \n- If you’re concerned about masculinity or team dynamics, remember that many athletes successfully return to play after treatment; focus on recovery and support from teammates.  \n\nYour oncologist can tailor the plan to balance cure, fertility, and quality of life.",
          "order": 4,
          "qid": "S20-Q04"
        },
        {
          "q": "What if tumor markers bounce—am I relapsing?",
          "gt": "A “marker bounce” is a temporary rise in AFP, hCG, or LDH that often occurs in the first 4–6 weeks after orchiectomy and usually resolves without treatment. It’s not automatically a relapse.  \n\n**What to do:**  \n1. **Repeat the test** in 1–2 weeks.  \n2. **Check imaging** (CT chest/abdomen/pelvis) if the rise persists or exceeds the upper limit of normal.  \n3. **Consult your oncologist**—they’ll decide whether to continue surveillance, add a short‑course of chemotherapy, or perform a biopsy.  \n\nIf the marker stays normal or falls back, you’re likely fine. Persistent elevation or a new mass on imaging would indicate relapse and prompt therapy. Stay in close contact with your team; they’ll support you through the process.",
          "order": 5,
          "qid": "S20-Q05"
        },
        {
          "q": "Can I be intimate during treatment?",
          "gt": "After an orchiectomy you can usually resume sexual activity once the incision has healed (about 2–4 weeks) and you feel comfortable.  \nDuring chemotherapy or radiation the main concerns are side‑effects—fatigue, nausea, low blood counts, or a sore wound—that may make intercourse uncomfortable or increase infection risk. If you have a bleeding or infected wound, wait until it’s resolved.  \n\nChemotherapy can lower sperm counts, but it does not make you contagious, so you can be intimate with a partner who is healthy. If you’re worried about fertility, sperm banking before treatment is recommended.  \n\nAlways discuss any specific concerns with your oncologist or nurse; they can tailor advice to your treatment plan and recovery status.",
          "order": 6,
          "qid": "S20-Q06"
        },
        {
          "q": "How do I tell my teammates without jokes swallowing the room?",
          "gt": "**Short, honest, and supportive**  \n1. **Pick a calm moment** – after a game or during a break, not in the middle of a match.  \n2. **Be straightforward** – “I had an orchiectomy for testicular cancer. I’m on treatment and will be back soon.”  \n3. **Share what matters to you** – “I’m concerned about fertility and how this feels for me, but I’m still the same teammate.”  \n4. **Invite questions, but set limits** – “I’m happy to answer what you want to know, but I’d appreciate keeping it respectful.”  \n5. **Lean on a friend** – have a teammate you trust present if you feel nervous.  \n6. **Reassure them** – “I’m still here, still playing, and I value our team.”  \n\nThis keeps the conversation clear, respectful, and avoids turning it into a joke‑filled room.",
          "order": 7,
          "qid": "S20-Q07"
        },
        {
          "q": "Will insurance question a prosthesis?",
          "gt": "Most insurers will cover a testicular prosthesis if it’s documented as medically necessary—often as part of the reconstructive phase after orchiectomy. However, coverage can vary: some plans treat it as cosmetic and may require prior authorization or a letter from your oncologist/urogynecologist stating the need for psychological and physical well‑being. It’s a good idea to:\n\n1. **Ask your insurer** directly about their policy on prosthetic testicles.  \n2. **Get a written recommendation** from your surgeon or oncologist.  \n3. **Submit the paperwork early** (often within 30–60 days of surgery) to avoid delays.  \n\nIf your plan initially denies coverage, you can appeal with the supporting medical documentation. Fertility preservation (sperm banking) is usually covered separately and should be arranged before surgery.",
          "order": 8,
          "qid": "S20-Q08"
        },
        {
          "q": "Does losing a testicle change my hormones forever?",
          "gt": "After a unilateral orchiectomy, most men keep normal testosterone levels. The remaining testicle usually enlarges and ramps up hormone production so that serum testosterone stays within the normal range. Only a small percentage of patients experience a mild drop that can be managed with routine monitoring and, if needed, a short course of testosterone replacement.  \n\nFertility can be affected because sperm production comes from the removed testis, but sperm can be banked before surgery and the remaining testis often produces enough sperm for natural conception.  \n\nSo, losing one testicle does **not** permanently alter your hormones for most people. Regular follow‑up with your oncologist and an endocrinologist will keep you on track, and you can discuss any concerns about masculinity or team dynamics with a trusted friend or counselor.",
          "order": 9,
          "qid": "S20-Q09"
        },
        {
          "q": "If I relapse, is cure still on the table?",
          "gt": "If you relapse, the cancer is still highly curable—especially for a 28‑year‑old with stage II disease.  Most relapses are treated with a platinum‑based chemotherapy regimen (e.g., BEP: bleomycin, etoposide, cisplatin) that has cure rates above 80 % in this setting.  In some cases, additional surgery or radiation may be added, but the overall prognosis remains excellent when relapse is caught early and treated promptly.  Discuss with your oncologist about surveillance schedules, fertility‑preservation options (sperm banking before chemo), and any supportive care you might need.  Staying vigilant and following the follow‑up plan gives you the best chance of a full cure.",
          "order": 10,
          "qid": "S20-Q10"
        }
      ]
    },
    {
      "id": "S21",
      "title": "Keys and the road (brain metastases, stereotactic radiosurgery)",
      "diagnosis": "Limited brain metastases from solid tumor",
      "treatment_plan": "Stereotactic radiosurgery (SRS) to brain lesions; systemic therapy continues or adjusts; seizure precautions and neuro follow-up",
      "narrative": "I'm 56, I drive for work and play piano at church. Small brain spots showed up on my scan. They recommend focused radiation.",
      "qa": [
        {
          "q": "Can I still legally drive after SRS?",
          "gt": "After stereotactic radiosurgery (SRS) you can usually resume driving, but the exact timing depends on how you’re feeling and your local regulations. In most places a physician’s clearance is required, and you’ll need to be seizure‑free, have stable vision, and no significant cognitive or balance problems. Many clinicians recommend waiting 2–4 weeks after SRS before driving, but if you develop headaches, nausea, or new neurological symptoms you should postpone. Check your state or country’s motor‑vehicle department for specific rules—some require a medical statement or a driving test. Talk with your oncologist and neurologist about your symptoms; they can give you a written clearance once you’re symptom‑free and your imaging shows no acute complications.",
          "order": 1,
          "qid": "S21-Q01"
        },
        {
          "q": "Will radiation change how I think or play music?",
          "gt": "Stereotactic radiosurgery (SRS) delivers a high‑dose, highly focused beam to each lesion, sparing most surrounding brain tissue. In most patients, short‑term side effects are mild—headache, fatigue, or a brief “brain fog.” Long‑term cognitive changes are uncommon, especially when the tumors are small and distant from language or motor areas. If a lesion sits near a region that controls speech or movement, there is a slightly higher risk of subtle deficits, but these are usually reversible or manageable with therapy.\n\nYour ability to think clearly and play piano should remain intact. Keep a regular follow‑up schedule (clinical exam, neuro‑cognitive testing, and MRI) so any changes are caught early. If you notice new memory lapses, difficulty concentrating, or motor issues, let your neuro‑oncology team know right away. With careful monitoring, most patients return to their normal activities—driving, piano, and work—without lasting impact.",
          "order": 2,
          "qid": "S21-Q02"
        },
        {
          "q": "Do I lose my hair in patches?",
          "gt": "Stereotactic radiosurgery (SRS) delivers a very focused dose to the brain lesions and almost never involves the scalp, so patchy hair loss from the SRS itself is highly unlikely. You would only see alopecia if the treatment field accidentally covered part of the scalp, which is rare. However, the systemic therapy you’re on can cause hair loss—many chemotherapies and some targeted agents do. If that happens, it’s usually temporary and the hair regrows once treatment stops or the dose is adjusted. Talk with your oncologist about the specific drugs you’re receiving; they can give you a clearer idea of what to expect and how to manage any hair changes.",
          "order": 3,
          "qid": "S21-Q03"
        },
        {
          "q": "How do you decide which lesions to treat now versus watch?",
          "gt": "**Deciding what to treat now vs. watch**\n\n1. **Size & number** – SRS is most effective for lesions < 3–4 cm and usually ≤ 4–10 lesions.  \n2. **Location** – Tumors near eloquent cortex, brainstem, or optic pathways may be deferred or treated with lower doses to avoid deficits.  \n3. **Symptoms** – Anything causing seizures, focal deficits, or significant edema is a priority.  \n4. **Growth rate** – Rapidly enlarging or newly appearing lesions on serial MRI warrant prompt treatment.  \n5. **Systemic disease** – If your cancer is controlled or you’re on effective systemic therapy, treating all visible lesions can prolong local control. If systemic disease is progressing, you may opt for “watch‑and‑wait” on asymptomatic, small lesions.  \n6. **Patient factors** – Your need to drive and play piano means preserving neuro‑cognitive function is key; we’ll aim for the smallest effective dose and monitor closely.  \n7. **Follow‑up** – MRI every 2–3 months for the first year, then every 6 months, helps catch any new or enlarging spots early.\n\nWe’ll review all these points in a multidisciplinary meeting and tailor the plan to your goals and overall health.",
          "order": 4,
          "qid": "S21-Q04"
        },
        {
          "q": "Does this mean my systemic treatment failed?",
          "gt": "It’s understandable to feel alarmed, but the appearance of a few brain lesions doesn’t automatically mean your systemic therapy has failed. Many cancers can spread to the brain even while the rest of the disease is controlled, because the blood‑brain barrier limits drug penetration. Brain metastases are often treated separately with stereotactic radiosurgery (SRS) while you continue or adjust systemic therapy for the rest of the body. In some cases, the brain lesions may represent a new, limited progression that can be managed locally, while the systemic disease remains stable. Discuss with your oncologist whether your current systemic regimen is still effective elsewhere, or if a change is warranted. The key point is that SRS is a targeted, complementary approach, not a sign that all treatment has failed.",
          "order": 5,
          "qid": "S21-Q05"
        },
        {
          "q": "If a new spot appears later, do we do SRS again?",
          "gt": "If a new lesion shows up, we usually re‑evaluate it on a multidisciplinary team (radiation oncologist, medical oncologist, neurosurgeon). Repeat SRS is often an option for a single, small, well‑targeted new spot, especially if it’s in a safe area and the cumulative dose to surrounding brain tissue is still within tolerance. However, if the new lesion is large, near critical structures, or you have several new spots, we may consider alternative strategies—such as a different SRS plan, whole‑brain radiotherapy, or intensified systemic therapy—to avoid excessive radiation toxicity. Regular MRI follow‑up (every 2–3 months for the first year) helps catch new lesions early and lets us decide the safest, most effective approach.",
          "order": 6,
          "qid": "S21-Q06"
        },
        {
          "q": "What symptoms should make me call immediately?",
          "gt": "If you notice any of the following, call your oncologist or go to the nearest emergency department right away:\n\n- **Severe or worsening headache** that doesn’t improve with usual pain relief, especially if it’s new or different in character.  \n- **Repeated vomiting** (especially if it’s bilious or you can’t keep fluids down).  \n- **New or worsening neurological deficits**: weakness, numbness, difficulty walking, slurred speech, trouble understanding or speaking, or changes in vision (blurred, double, loss of field).  \n- **Seizures** of any kind, even a single episode.  \n- **Sudden confusion, disorientation, or altered mental status** (e.g., drowsiness, agitation, inability to recognize people).  \n- **Any new focal neurological signs** such as facial droop, loss of coordination, or balance problems.  \n\nThese can signal increased intracranial pressure or a complication of the metastases or SRS. Prompt evaluation can prevent serious complications. If in doubt, it’s safest to seek medical attention immediately.",
          "order": 7,
          "qid": "S21-Q07"
        },
        {
          "q": "Can I fly for work next week?",
          "gt": "**Short answer:** In most cases you can fly after stereotactic radiosurgery (SRS), but it’s best to confirm with your oncologist and have a plan for any acute side‑effects or seizure risk.\n\n**Why it’s usually safe**  \n- SRS is a single‑fraction treatment; there’s no “acute radiation reaction” that would make flight hazardous.  \n- The radiation is highly localized, so it doesn’t increase the risk of in‑flight complications.  \n\n**What to check before you go**  \n1. **Seizure precautions** – If you’ve had seizures or are on anti‑seizure meds, bring a copy of your prescription and a brief medical statement for the airline.  \n2. **Side‑effects** – Mild headaches, fatigue, or nausea can occur in the first few days. Stay hydrated, avoid alcohol, and keep a pain‑relief plan ready.  \n3. **Medical clearance** – Some airlines require a short note if you have a serious condition; ask your oncologist for a brief statement if needed.  \n\n**Practical tips**  \n- Take your medication at the usual times.  \n- Wear comfortable clothing and move around during the flight to keep circulation good.  \n- Have a small snack and water on hand.  \n\nIf you’re feeling unusually tired, have a new headache, or notice any neurological changes, contact your oncology team immediately. Otherwise, you should be fine to fly next week.",
          "order": 8,
          "qid": "S21-Q08"
        },
        {
          "q": "Will steroids make me jittery or hungry?",
          "gt": "I’m sorry you’re dealing with so many new changes. Steroids are often used to reduce swelling around brain lesions, and they can indeed affect how you feel. Common side‑effects include:\n\n- **Increased appetite and weight gain** – you may notice a “hunger” that’s hard to resist.  \n- **Jitteriness, anxiety, or mood swings** – especially if the dose is high or taken late in the day.  \n- **Insomnia or trouble sleeping** – which can amplify the feeling of restlessness.\n\nIf you’re experiencing these, let your oncologist know. They can adjust the dose, suggest taking the medication earlier in the day, or add a sleep‑promoting routine. A balanced diet, light exercise, and staying hydrated can help keep the appetite in check. Remember, the goal is to keep the brain swelling under control while minimizing side‑effects, so keep the lines of communication open with your care team.",
          "order": 9,
          "qid": "S21-Q09"
        },
        {
          "q": "How often are MRIs after this?",
          "gt": "After SRS you’ll usually get a baseline MRI right before treatment, then a follow‑up scan about **3 months** later to confirm the lesions are responding. If everything looks good, most clinicians schedule MRIs every **3–6 months for the next 1–2 years**. After that, the interval can be extended to **every 6–12 months** as long as you’re asymptomatic. If new symptoms (headache, seizures, focal deficits) arise, an MRI is ordered sooner. These time points are based on NCCN and ASCO guidelines and help catch any recurrence early while balancing the cost and inconvenience of imaging.",
          "order": 10,
          "qid": "S21-Q10"
        }
      ]
    },
    {
      "id": "S22",
      "title": "Second chances (liver cancer with cirrhosis)",
      "diagnosis": "Hepatocellular carcinoma in the setting of cirrhosis",
      "treatment_plan": "Locoregional therapy (e.g., ablation or embolization) or systemic therapy; transplant evaluation when appropriate; manage liver function",
      "narrative": "I'm 64 with cirrhosis and now a liver tumor. I quit drinking last year. I want to live long enough to walk my daughter down the aisle.",
      "qa": [
        {
          "q": "Am I a transplant candidate, or did I miss that window?",
          "gt": "I’m glad you’re still hopeful—age alone isn’t a barrier.  The key is whether your tumor meets the **Milan criteria** (single ≤5 cm or up to 3 nodules each ≤3 cm) and whether your liver function is adequate (usually Child‑Pugh A or well‑controlled B, MELD < 15–20).  Because you quit drinking a year ago, your fibrosis may be stabilizing, which helps.  \n\nThe next step is a formal transplant evaluation at a center that treats HCC.  They’ll review imaging, labs, performance status, and any comorbidities.  If you’re within criteria, you can be listed; if not, bridging therapies (ablation, TACE) or systemic agents (e.g., atezolizumab‑bevacizumab) can control the tumor while you wait.  \n\nSo you haven’t missed the window—just get evaluated promptly, and we’ll see if you qualify.",
          "order": 1,
          "qid": "S22-Q01"
        },
        {
          "q": "Does treatment hurt my liver more than the cancer does?",
          "gt": "I’m really glad you’re thinking ahead about how to keep your liver healthy while fighting the cancer. In most cases, the goal of treatment is to control the tumor **without** causing more liver damage than the cancer itself.  \n\n- **Locoregional therapies** (radio‑frequency or microwave ablation, trans‑arterial chemo‑embolization, or radioembolization) are designed to target the tumor while sparing the surrounding liver. They can cause temporary inflammation or a small drop in liver enzymes, but the damage is usually limited and reversible.  \n- **Systemic drugs** (e.g., atezolizumab‑bevacizumab or sorafenib) can affect liver function, especially if you already have cirrhosis, but they are chosen based on your liver reserve (Child‑Pugh score).  \n- **Transplant** is the only curative option that removes the damaged liver entirely, but it’s only available if the cancer is small and well‑controlled.\n\nIn short, the treatments are carefully tailored to preserve as much liver function as possible. If you’re in good overall health and your liver function is stable, the benefit of controlling the cancer usually outweighs the potential liver side‑effects. Discuss your specific liver function tests and imaging with your hepatologist and oncologist—they’ll choose the safest, most effective plan for you.",
          "order": 2,
          "qid": "S22-Q02"
        },
        {
          "q": "What if my legs swell and I can’t fit shoes—does that mean it’s all downhill?",
          "gt": "Leg swelling (peripheral edema) is common in cirrhosis and can be caused by low albumin, portal hypertension, or fluid shifts from treatments. It **does not automatically mean the end is near**.  \n- **Check the cause**: a simple sodium‑restricted diet, compression stockings, and a loop diuretic (e.g., furosemide) often reduce swelling.  \n- **Monitor**: if the legs become increasingly puffy, painful, or you develop new abdominal fluid (ascites), let your hepatology/oncology team know right away.  \n- **Reversible**: many patients see significant improvement once liver function is stabilized or after locoregional therapy.  \n- **When to worry**: sudden, rapid swelling, skin changes, or signs of heart failure (shortness of breath, rapid weight gain) warrant urgent evaluation.  \n\nSo, swelling is a treatable symptom—stay in touch with your care team and keep an eye on the pattern.",
          "order": 3,
          "qid": "S22-Q03"
        },
        {
          "q": "Do I have to swear off every celebration forever?",
          "gt": "You don’t have to give up every celebration, but you must keep alcohol out of the picture.  \n- **Alcohol**: Even a single drink can worsen cirrhosis and impair liver function, so abstain completely.  \n- **Other drinks**: Non‑alcoholic beers, sparkling water, or a “mocktail” can let you join in the toast.  \n- **Food & stress**: Heavy, fatty meals or high‑stress events can also strain the liver; keep portions moderate and plan for a calm environment.  \n- **Support**: Let friends and family know you’re avoiding alcohol; they’ll respect your choice and may even offer non‑alcoholic alternatives.  \n\nBy staying alcohol‑free and moderating other lifestyle factors, you can still enjoy meaningful celebrations while protecting your liver and giving yourself the best chance to walk your daughter down the aisle.",
          "order": 4,
          "qid": "S22-Q04"
        },
        {
          "q": "How risky is bleeding during procedures with my platelets low?",
          "gt": "I’m sorry you’re facing this uncertainty. Low platelets do raise the chance of bleeding during liver‑focused procedures, but the risk can be managed. For most percutaneous ablations or trans‑arterial chemo‑embolizations, a platelet count above 50 × 10⁹/L is considered safe; counts below that increase the likelihood of periprocedural hemorrhage and may require platelet transfusion or a temporary platelet‑boosting agent (e.g., thrombopoietin‑receptor agonist). For liver transplant evaluation, a count below 30 × 10⁹/L is usually a contraindication until corrected. Your hepatologist will review your exact numbers, liver function, and the planned procedure to decide whether to transfuse or delay. In short, low platelets do add risk, but with pre‑procedure optimization most patients proceed safely and still have a good chance of a successful outcome.",
          "order": 5,
          "qid": "S22-Q05"
        },
        {
          "q": "If the tumor shrinks, can I get on a transplant list?",
          "gt": "Yes—shrinking the tumor can open the door to transplantation, but it’s not automatic.  Transplant eligibility for hepatocellular carcinoma is governed by strict criteria (e.g., Milan, UCSF, or AFP‑based guidelines) that consider tumor size, number, vascular invasion, and liver function.  If locoregional or systemic therapy reduces the tumor to meet those limits and your liver remains functional enough, you can be evaluated for the transplant list.  The evaluation process is separate and includes imaging, labs, and a multidisciplinary review.  So, a response to treatment that brings the cancer within the accepted window can indeed make you a transplant candidate, giving you a better chance to live long enough to walk your daughter down the aisle.",
          "order": 6,
          "qid": "S22-Q06"
        },
        {
          "q": "What does a bad day look like so my family knows when to act?",
          "gt": "A “bad day” is when any of the following appear or worsen, indicating liver decompensation or tumor‑related complications:\n\n- **Sudden confusion, drowsiness, or disorientation** (hepatic encephalopathy).  \n- **Marked abdominal swelling or pain** that feels like a “fullness” or “pressure.”  \n- **New or worsening jaundice** (yellowing of skin/eyes).  \n- **Unexplained vomiting, especially with blood or coffee‑ground material** (GI bleeding).  \n- **Rapid weight gain or a sudden increase in abdominal girth** (ascites).  \n- **Shortness of breath, wheezing, or a drop in oxygen saturation**.  \n- **Severe, persistent nausea or vomiting that prevents oral intake.**  \n- **Fever, chills, or a sudden drop in blood pressure** (possible infection or sepsis).  \n\nIf any of these occur, call your oncologist or go to the nearest emergency department immediately. Early intervention can prevent irreversible damage and improve outcomes.",
          "order": 7,
          "qid": "S22-Q07"
        },
        {
          "q": "Can I still walk the neighborhood safely?",
          "gt": "It’s absolutely possible to walk safely, but it depends on how your liver is functioning and how your body is coping with the cancer and cirrhosis.  \n- **Check your liver status**: A Child‑Pugh or MELD score, plus a recent ultrasound or CT, will tell your team how much reserve you have.  \n- **Watch for symptoms**: Fatigue, dizziness, abdominal swelling, or confusion are red flags that you should rest or seek medical help.  \n- **Start small**: Begin with short, flat‑ground walks (5–10 min) and gradually increase distance as tolerated.  \n- **Use support**: A walking stick, a supportive friend, or a walker can help if you feel unsteady.  \n- **Avoid high‑risk areas**: Steep slopes, uneven sidewalks, or crowded places can increase fall risk.  \n- **Stay hydrated and avoid alcohol**: Dehydration worsens fatigue and encephalopathy.  \n\nAsk your hepatologist or oncologist for a tailored exercise plan—often a brief graded exercise test can confirm you’re fit for the walk. With careful monitoring, you can safely enjoy the walk down the aisle.",
          "order": 8,
          "qid": "S22-Q08"
        },
        {
          "q": "Will I itch forever?",
          "gt": "Itching (pruritus) in cirrhosis is usually caused by bile salt buildup and other pruritogens that accumulate when the liver can’t clear them. Whether it will persist depends on how well the underlying liver disease and the tumor are controlled.\n\n- **If your liver function improves**—for example, after successful ablation/embolization, systemic therapy that shrinks the tumor, or a liver transplant—most patients notice a marked reduction or complete resolution of itching.  \n- **If cirrhosis remains advanced** and bile flow stays impaired, the itch can be chronic, but it can often be managed with medications such as cholestyramine, rifampicin, naltrexone, or antihistamines, and by treating any cholestasis or portal hypertension.\n\nSo, itching isn’t inevitable forever; it’s highly dependent on how well the liver disease is treated and managed. Discuss pruritus‑specific therapies with your hepatologist or oncologist—they can tailor a plan to help you feel better while you focus on the big day with your daughter.",
          "order": 9,
          "qid": "S22-Q09"
        },
        {
          "q": "How do I keep hope without pretending this isn’t serious?",
          "gt": "I’m glad you’re looking for a realistic way to stay hopeful.  \n1. **Know the plan** – Ask your oncologist to walk you through the exact treatment options (ablation, TACE, systemic therapy, or transplant). Knowing the timeline and expected outcomes turns uncertainty into a concrete roadmap.  \n2. **Stay proactive** – Keep liver‑friendly habits: balanced diet, adequate protein, avoid alcohol, limit sodium, and stay active as your doctor allows.  \n3. **Track progress** – Regular imaging and labs let you see how the tumor responds, so you can adjust treatment early if needed.  \n4. **Support network** – Share your goals (walking your daughter) with family and a counselor; emotional support fuels resilience.  \nHope is realistic optimism—believing in the plan while acknowledging the seriousness keeps you grounded and motivated.",
          "order": 10,
          "qid": "S22-Q10"
        }
      ]
    },
    {
      "id": "S23",
      "title": "Stigma and steel (locally advanced cervical cancer)",
      "diagnosis": "Locally advanced cervical cancer",
      "treatment_plan": "Definitive pelvic radiation with weekly cisplatin and brachytherapy; survivorship sexual health support",
      "narrative": "I'm 37 and a mom of two. The word 'cervical' makes me feel judged. Treatment is radiation with weekly chemo and internal radiation later.",
      "qa": [
        {
          "q": "I feel ashamed telling people what kind of cancer I have. How do I carry this without hiding?",
          "gt": "It’s completely normal to feel uneasy sharing a cancer diagnosis—especially one that carries social stigma. Remember that cervical cancer is a common, treatable disease, not a moral judgment. Here are a few practical ways to manage the conversation:\n\n1. **Choose your circle** – Share first with a trusted friend, partner, or family member who will support you. You can keep the details brief (“I’m dealing with a health issue”) until you’re ready to explain more.\n\n2. **Use neutral language** – If you prefer privacy, say “I have a cancer diagnosis” or “I’m undergoing treatment for a pelvic cancer.” You can add “cervical” later if you feel comfortable.\n\n3. **Set boundaries** – Let people know what you’re comfortable discussing. It’s okay to say, “I’m not ready to talk about it yet” or “I’d rather keep it private.”\n\n4. **Seek support groups** – Online or local groups for cervical cancer survivors can provide a non‑judgmental space to share experiences and coping strategies.\n\n5. **Professional help** – A counselor or social worker can help you navigate disclosure and address feelings of shame.\n\nYou’re not alone, and you deserve support without judgment. Focus on your treatment plan—weekly cisplatin, pelvic radiation, and brachytherapy—and on the fact that you’re taking active steps toward recovery.",
          "order": 1,
          "qid": "S23-Q01"
        },
        {
          "q": "Will sex ever feel normal again?",
          "gt": "I’m really sorry you’re feeling judged—your feelings are valid. After definitive pelvic radiation with cisplatin and brachytherapy, many women experience vaginal dryness, narrowing (stenosis), and sometimes pain during intercourse. These changes can make sex feel different or uncomfortable for months or years. The good news is that most patients do regain a satisfying sexual life with the right support.\n\n**What can help:**\n- **Lubricants & moisturizers** (water‑based, non‑irritating) to reduce dryness.  \n- **Vaginal dilators** (used gradually) to prevent or treat stenosis.  \n- **Pelvic‑floor physical therapy** to improve muscle tone and reduce pain.  \n- **Hormonal therapy** (e.g., low‑dose vaginal estrogen) if you’re not pregnant and it’s safe for you.  \n- **Counseling or sex‑therapy** to address emotional concerns and intimacy issues.  \n\nMany women report that, with these interventions, intercourse feels normal or even more meaningful after treatment. If you’re unsure which options are right for you, discuss them with your oncology team or a pelvic‑floor specialist. You’re not alone, and help is available.",
          "order": 2,
          "qid": "S23-Q02"
        },
        {
          "q": "Do I need a port for the weekly chemo?",
          "gt": "A port (or a PICC line) is usually recommended for weekly cisplatin because it makes each infusion smoother and reduces the risk of vein irritation, infiltration, or infection that can happen with repeated peripheral IVs. It also frees you from having to get a new IV each week, which can be a relief during a busy treatment schedule. If you have good, durable peripheral veins and your oncology team is comfortable with that approach, they may choose to use a peripheral line instead. Discuss with your radiation/medical‑oncology team—most centers will set up a port or PICC for the duration of the weekly chemo to keep the process as easy and safe as possible.",
          "order": 3,
          "qid": "S23-Q03"
        },
        {
          "q": "What if childcare blows up on treatment days?",
          "gt": "If your kids’ care falls through on a treatment day, start with the team that’s already looking out for you.  \n\n1. **Speak to your oncologist or nurse navigator** – they can often shift a radiation session to a day when school is in session or to an early‑morning slot.  \n2. **Ask the hospital social worker** – many centers have a “child‑care assistance” program or can connect you with local respite‑care agencies.  \n3. **Leverage family and friends** – arrange a rotating schedule so you’re never alone during a session.  \n4. **Check employer policies** – most cancer‑care leave policies cover treatment days; a brief note from your oncologist can help.  \n5. **Use after‑school or summer programs** – if treatment falls on a school holiday, see if a nearby program can cover a few hours.  \n\nHaving a backup plan in place reduces stress and lets you focus on your treatment.",
          "order": 4,
          "qid": "S23-Q04"
        },
        {
          "q": "Will I burn or peel from radiation?",
          "gt": "It’s normal to worry about skin changes, but most people who receive pelvic radiation for cervical cancer experience only mild to moderate skin reactions. The first few days to weeks of treatment can cause a pink or red rash (erythema) that may feel itchy or slightly tender. As the skin heals, it can peel or flake—this is a common, self‑limiting response. Severe burns are rare when the dose is delivered with modern techniques and proper shielding.  \n\nTo keep skin comfortable:  \n- Keep the area clean and dry.  \n- Use gentle, fragrance‑free moisturizers after showering.  \n- Wear loose, breathable clothing.  \n- Report any blistering, ulceration, or persistent pain to your radiation team right away.  \n\nWith routine skin care and prompt communication, most patients return to normal skin texture within a few weeks after treatment.",
          "order": 5,
          "qid": "S23-Q05"
        },
        {
          "q": "How do you make sure the internal radiation isn’t traumatic?",
          "gt": "Brachytherapy is a short, well‑controlled procedure, but it can feel uncomfortable. Here’s how to keep it as stress‑free as possible:\n\n1. **Pre‑procedure counseling** – Ask the radiation oncologist to explain the steps, the type of applicator, and what sensations to expect. Knowing the “what” and “why” reduces anxiety.\n\n2. **Pain control** – Most centers use local anesthesia (lidocaine) and sometimes mild sedation. If you’re nervous, request a brief sedative or a “comfort‑drug” (e.g., a low‑dose opioid or gabapentin) to ease the procedure.\n\n3. **Proper positioning and support** – The team will use a vaginal speculum and a small applicator. A gentle, steady approach and a calm, supportive staff can make the experience feel less invasive.\n\n4. **Vaginal dilators** – If you’re uncomfortable with the applicator, a dilator can help keep the canal open and reduce pressure.\n\n5. **Post‑procedure care** – Discuss pain‑management plans, possible side‑effects, and when to seek help. Follow‑up visits give you a chance to voice concerns and adjust comfort measures.\n\n6. **Psychological support** – Consider a brief counseling session or a support group before and after treatment to process emotions and reinforce coping strategies.\n\nBy combining clear communication, adequate pain control, and supportive care, the internal radiation can be a routine part of your treatment rather than a traumatic event.",
          "order": 6,
          "qid": "S23-Q06"
        },
        {
          "q": "Can I keep working, or should I plan leave?",
          "gt": "It’s common to wonder whether you can keep working while on definitive chemoradiation. Weekly cisplatin and pelvic radiation can cause fatigue, nausea, mouth sores, and sometimes short‑term anemia, so many patients need a flexible schedule or a brief break. If your job is desk‑based or allows remote work, you can often continue with short breaks, a lighter workload, or a reduced‑hour week. If you have a physically demanding or high‑stress role, a short leave (e.g., 2–4 weeks) may be wiser to avoid burnout and allow your body to recover.  \n\nTalk to your oncologist and occupational health team about your specific side‑effect profile and job demands. They can help you decide whether a brief leave or a modified schedule is best for you.",
          "order": 7,
          "qid": "S23-Q07"
        },
        {
          "q": "Does this mean I can’t have more children?",
          "gt": "Radiation to the pelvis (with weekly cis‑platin and brachytherapy) will almost certainly damage the ovaries and can lead to premature ovarian failure, especially at age 37. That means natural conception afterward is unlikely, but it isn’t impossible. If you wish to preserve fertility, discuss options **before** treatment starts:  \n\n* **Ovarian transposition** (moving the ovaries out of the radiation field) – can spare some function but isn’t guaranteed.  \n* **Egg or embryo freezing** – viable if you have time to retrieve oocytes; success rates decline with age.  \n\nAfter treatment, pregnancy is possible but carries higher risks (preterm birth, low‑birth‑weight, uterine complications).  Talk with your oncologist and a reproductive specialist to weigh these options and plan accordingly.",
          "order": 8,
          "qid": "S23-Q08"
        },
        {
          "q": "How will you know it worked without surgery?",
          "gt": "After definitive chemoradiation you won’t have a surgical specimen to examine, but we still have several reliable ways to confirm the tumor has responded:\n\n1. **Clinical exam** – A pelvic exam will show a softer, smaller cervix and no palpable mass.  \n2. **Imaging** – MRI or CT scans (often done 4–6 weeks after treatment) compare the pre‑treatment size to the post‑treatment picture. A marked reduction or disappearance of the lesion is a good sign.  \n3. **Biopsy if needed** – If the exam or imaging is equivocal, a small punch biopsy can confirm no residual cancer cells.  \n4. **Follow‑up schedule** – We’ll repeat exams and imaging at 3, 6, 12 months, then yearly.  \n5. **Symptom relief** – Improvement in pain, bleeding, or urinary symptoms also indicates a successful response.\n\nTogether, these tools give us a clear picture that the cancer has been controlled, even without surgery.",
          "order": 9,
          "qid": "S23-Q09"
        },
        {
          "q": "What if the cancer comes back—what’s next?",
          "gt": "If the cancer returns, the next steps depend on where and how soon it comes back.  \n\n**Local recurrence (within the pelvis)** – If it’s limited and you’re still in good health, a **salvage radical hysterectomy with pelvic lymph‑node dissection** can be offered. In some cases, **re‑irradiation** with advanced techniques (e.g., stereotactic body RT) may be considered, but the risk of toxicity is higher.  \n\n**Regional or distant recurrence** – Systemic therapy is the mainstay. A platinum‑based chemotherapy regimen (e.g., carboplatin + paclitaxel) is common. If the tumor expresses PD‑L1, **pembrolizumab** (or other checkpoint inhibitors) can be added. Targeted agents (e.g., bevacizumab) or participation in clinical trials are also options.  \n\nIn every scenario, a multidisciplinary tumor board reviews imaging, prior treatment, and your overall health to tailor the plan. Early detection of recurrence and close follow‑up give the best chance for effective salvage or systemic therapy.",
          "order": 10,
          "qid": "S23-Q10"
        }
      ]
    },
    {
      "id": "S24",
      "title": "Fixing the fence (diffuse large B-cell lymphoma)",
      "diagnosis": "Diffuse large B-cell lymphoma, curative intent",
      "treatment_plan": "R-CHOP every 3 weeks for 6 cycles (or tailored regimen); interim PET after a few cycles",
      "narrative": "I'm 66 and run a small farm. A fast-growing node appeared in my neck. They’re aiming to cure this with chemo.",
      "qa": [
        {
          "q": "Does 'curative intent' really mean cure for someone my age?",
          "gt": "Curative intent means the treatment plan is designed to eradicate the lymphoma, not just control it. For a 66‑year‑old with diffuse large B‑cell lymphoma, many patients achieve long‑term remission with R‑CHOP, especially if you’re otherwise healthy and the disease is localized. Five‑year survival for DLBCL in people 60–69 is roughly 60‑70 % when treated aggressively, and it improves if you respond early on the interim PET scan. Age alone isn’t a definitive barrier; comorbidities, organ function, and how well you tolerate the first few cycles are the real determinants. Discuss your overall health, goals, and any concerns with your oncologist—curative intent is realistic, but it’s personalized to your situation.",
          "order": 1,
          "qid": "S24-Q01"
        },
        {
          "q": "How sick will I be after each cycle—will the animals still get fed?",
          "gt": "R‑CHOP is given every 3 weeks, so you’ll have a 2‑week recovery window between cycles. Most people feel the worst of nausea, vomiting, and fatigue within the first 48–72 hours after a cycle, then gradually improve. Blood‑count drops (especially neutropenia) usually peak around day 7–10; you’ll be advised to avoid crowds and keep a low‑dose antibiotic or growth‑factor if needed. By the time the next cycle starts, many patients are back to normal activity, though you may still feel a bit tired or have mild mouth sores.\n\nPractical tips:  \n- Arrange a helper or use a meal‑prep service for the first week after each cycle.  \n- Keep a simple, protein‑rich diet and stay hydrated.  \n- Use anti‑emetics and oral steroids as prescribed to blunt nausea.  \n- If you’re too weak, ask your oncologist about dose‑reduction or a 2‑week interval.\n\nWith these supports, you can keep feeding the animals and maintain your routine while your body recovers between treatments.",
          "order": 2,
          "qid": "S24-Q02"
        },
        {
          "q": "Will I lose my hair and beard?",
          "gt": "**Hair loss with R‑CHOP**  \nR‑CHOP contains doxorubicin and cyclophosphamide—both drugs that commonly cause hair thinning or loss. Most patients lose scalp hair, eyebrows, eyelashes, and often beard hair during the first few cycles. The degree varies: some people lose almost all hair, others only a few strands.  \n\n**What to expect**  \n- **Timing:** Hair loss usually begins 2–4 weeks after a cycle and peaks around 3–4 weeks.  \n- **Recovery:** After the last cycle, hair typically regrows over 3–6 months, though texture may differ.  \n- **Support:** Wigs, scarves, or beard‑covering options can help you feel comfortable during treatment.  \n\nIf you’re concerned, discuss scalp cooling caps or other supportive measures with your oncology team. They can tailor advice to your specific situation.",
          "order": 3,
          "qid": "S24-Q03"
        },
        {
          "q": "I’m worried about infection from hay dust and barns. Is that a real risk?",
          "gt": "Yes, the immunosuppression from R‑CHOP can make you more vulnerable to infections that are common on farms. Hay dust often contains fungal spores—especially Aspergillus—which can cause invasive aspergillosis in people with low neutrophil counts. Bacterial infections from animals and contaminated food are also possible.  \n\n**Practical steps:**  \n- Avoid dusty barns or wear a well‑filtered mask if you must be there.  \n- Keep your living and work areas clean and dry; use a HEPA filter if possible.  \n- Refrain from consuming raw milk or unpasteurized dairy.  \n- Stay up to date on vaccinations (influenza, pneumococcal).  \n\nIf you develop fever, cough, or other infection signs, contact your oncology team promptly. In high‑risk periods, your doctor may recommend antifungal prophylaxis. These precautions help keep your treatment on track while protecting your health.",
          "order": 4,
          "qid": "S24-Q04"
        },
        {
          "q": "What does the interim PET actually change?",
          "gt": "An interim PET scan is a “check‑in” during your chemotherapy.  \nIt shows whether the lymphoma is shrinking or still active after the first few cycles.  \n\n* **If the PET is negative (no active disease)** – you can often finish the planned 6 cycles, or in some trials even stop early, sparing you extra chemo and its side‑effects.  \n* **If the PET is positive (persistent or new activity)** – the oncologist may change or intensify therapy (e.g., add a different drug, switch to a more aggressive regimen, or plan radiation) or consider a second‑line approach.  \n\nSo the scan doesn’t just confirm the diagnosis; it guides whether you keep the current plan, shorten it, or switch to a different strategy, aiming to maximize cure while minimizing unnecessary treatment.",
          "order": 5,
          "qid": "S24-Q05"
        },
        {
          "q": "Can heart issues happen with this regimen?",
          "gt": "**Yes – the doxorubicin (Adriamycin) in R‑CHOP can affect the heart.**  \n- **Cumulative dose matters:** the risk rises with the total amount of doxorubicin given (≈400 mg/m² is the usual upper limit).  \n- **Age and pre‑existing heart disease increase risk.**  \n- **Monitoring:** most oncologists order a baseline echocardiogram (or MUGA scan) and repeat it every 2–3 cycles or if symptoms appear.  \n- **Protective measures:** dexrazoxane can be used in high‑risk patients, and dose‑adjusted or alternative regimens (e.g., R‑CHOP‑14 or R‑CHOP‑21 with lower cumulative dose) are options.  \n- **Symptoms to watch:** shortness of breath, palpitations, swelling, or fatigue—report them promptly.  \n\nWith routine cardiac surveillance and early intervention, most patients complete R‑CHOP safely. If you have a history of heart disease, discuss cardiology input before starting therapy.",
          "order": 6,
          "qid": "S24-Q06"
        },
        {
          "q": "Will steroids make me edgy and sleepless?",
          "gt": "**Short answer:**  \nYes—prednisone (the steroid in R‑CHOP) can cause mood swings, anxiety, and trouble sleeping, especially at the higher doses used early in treatment.  \n\n**What to expect:**  \n- **Early cycles (first 2–3 weeks):** You may feel more alert or restless, and insomnia is common.  \n- **Later cycles:** The effect usually lessens as the dose tapers.  \n\n**How to manage it:**  \n1. **Timing:** Take the pill in the morning or early afternoon to reduce nighttime wakefulness.  \n2. **Sleep hygiene:** Keep a regular bedtime, avoid caffeine after noon, and create a calm pre‑sleep routine.  \n3. **Talk to your team:** If agitation or insomnia becomes severe, they can adjust the dose or add a short‑acting sleep aid.  \n\nIf you notice significant mood changes or insomnia, let your oncology team know right away—they’ll help you stay comfortable while the treatment works.",
          "order": 7,
          "qid": "S24-Q07"
        },
        {
          "q": "If a cycle is delayed, does that ruin my chance of cure?",
          "gt": "Delaying a cycle can affect the overall intensity of therapy, but it doesn’t automatically mean the cure is lost. R‑CHOP is designed for 3‑week intervals; a short delay (≤ 1–2 weeks) is usually acceptable, especially if it’s due to infection or recovery from toxicity. Significant delays (≥ 3–4 weeks) can give the lymphoma time to grow and may reduce response rates, particularly in aggressive disease. If a delay is unavoidable, your oncologist can consider dose‑adjusted schedules, growth‑factor support, or a shorter interval for subsequent cycles. The key is to keep the treatment as close to the planned schedule as possible and to discuss any postponement immediately with your team. Early, uninterrupted therapy remains the best chance for cure.",
          "order": 8,
          "qid": "S24-Q08"
        },
        {
          "q": "Should I get extra vaccines now?",
          "gt": "I’m sorry to hear about your diagnosis, and I understand you’re looking for ways to protect yourself while you start R‑CHOP. Here’s a practical plan:\n\n| Vaccine | Why it matters | Timing |\n|---------|----------------|--------|\n| **Influenza (annual)** | Reduces flu‑related complications, which can be severe in chemo patients. | Give it as soon as possible—ideally before the first cycle. |\n| **COVID‑19 (booster)** | Even with a weakened immune system, a booster still lowers the risk of severe disease. | If you’re due for a booster, get it now; if you’re not, consider one during the first or second cycle. |\n| **Pneumococcal (PCV15 + PPSV23)** | Prevents invasive pneumococcal disease, which is a common infection in immunocompromised people. | PCV15 first, then PPSV23 8 weeks later; you can start the series before chemo or during the first cycle. |\n| **Shingles (Shingrix)** | Strongly recommended for adults ≥ 50 years; it’s safe during chemo and reduces the risk of post‑herpetic neuralgia. | Give the first dose now; the second dose 2–6 months later. |\n\n**Key points**\n\n1. **Vaccines are still beneficial** even though your immune response may be blunted; the protection they provide outweighs the risk of side effects.  \n2. **Avoid live‑attenuated vaccines** (e.g., MMR, varicella) while on R‑CHOP.  \n3. **Discuss timing with your oncologist**—they can coordinate vaccine administration with your chemo schedule.  \n\nIf you’re unsure about any vaccine or have a history of allergic reactions, let your oncology team know; they can tailor the plan to your needs. Take care, and I wish you a smooth treatment course.",
          "order": 9,
          "qid": "S24-Q09"
        },
        {
          "q": "What happens if it doesn’t respond?",
          "gt": "If the interim PET shows no response (or only partial response) to R‑CHOP, the disease is considered **refractory** or **relapsed**. In that situation we usually:\n\n1. **Switch to a salvage regimen** – common choices are R‑ICE (ifosfamide, carboplatin, etoposide) or R‑DHAP (dexamethasone, high‑dose cytarabine, cisplatin).  \n2. **Add or replace with high‑dose therapy** – many patients then receive high‑dose chemotherapy followed by autologous stem‑cell transplant, which can achieve durable remissions.  \n3. **Consider clinical trials** – newer agents (e.g., CAR‑T cells, bispecific antibodies) are available for relapsed DLBCL.  \n4. **Palliative care** – if aggressive therapy is not feasible or desired, focus shifts to symptom control and quality of life.\n\nEarly identification of non‑response allows us to change strategy before the disease progresses further, improving chances of a cure or long‑term control.",
          "order": 10,
          "qid": "S24-Q10"
        }
      ]
    },
    {
      "id": "S25",
      "title": "Trailhead ahead (metastatic kidney cancer)",
      "diagnosis": "Metastatic renal cell carcinoma",
      "treatment_plan": "Combination immunotherapy or immunotherapy plus targeted therapy; monitor for immune-related side effects",
      "narrative": "I'm 61 and love national parks. I want a plan that lets me keep hiking without ignoring warning signs.",
      "qa": [
        {
          "q": "How do we choose between combinations without wrecking my stamina?",
          "gt": "**Choosing a regimen that preserves your hiking stamina**\n\n1. **Assess your baseline** – Your ECOG performance status, lung function, and any cardiovascular issues dictate how much “extra” fatigue a drug can add.  \n2. **Side‑effect profiles** –  \n   * Nivolumab + ipilimumab* can cause immune‑related fatigue, colitis, and endocrinopathies.  \n   * Pembrolizumab + axitinib* adds hypertension, hand‑foot syndrome, and proteinuria, but often has a more predictable fatigue pattern.  \n3. **Start low, go slow** – If you’re already fatigued, begin with a single‑agent checkpoint inhibitor (e.g., pembrolizumab) and add axitinib only if disease control is inadequate.  \n4. **Monitor early** – Use patient‑reported outcome tools (e.g., PRO‑CTCAE) and check labs every 2–3 weeks. Promptly treat immune‑related events (steroids, antihypertensives) to prevent a cascade of fatigue.  \n5. **Shared decision‑making** – Discuss your hiking goals with your oncologist; a tailored plan that balances efficacy with tolerability is key.  \n\nBy matching drug intensity to your stamina reserve and catching side effects early, you can keep enjoying the trails while fighting cancer.",
          "order": 1,
          "qid": "S25-Q01"
        },
        {
          "q": "What immune side effects should make me stop the trail and call?",
          "gt": "**When to stop the trail and call your oncologist**\n\nIf you develop any of these *serious* immune‑related symptoms, pause hiking and seek care immediately:\n\n| Symptom | Why it matters | Action |\n|---------|----------------|--------|\n| **High fever (≥38 °C)** or chills | Possible sepsis or severe inflammation | Stop treatment, call 911 or your oncology team |\n| **Severe, persistent diarrhea or abdominal pain** | Colitis can lead to dehydration, bleeding | Stop treatment, call your oncologist |\n| **Shortness of breath, chest pain, or cough** | Pneumonitis or myocarditis | Stop treatment, call 911 |\n| **Vision changes, eye pain, or sudden vision loss** | Uveitis or optic neuritis | Stop treatment, call your oncologist |\n| **New or worsening rash with itching, blistering, or swelling** | Severe dermatitis | Stop treatment, call your oncologist |\n| **Unexplained fatigue, weakness, or muscle pain** | Myositis or neuropathy | Stop treatment, call your oncologist |\n| **Signs of endocrine problems** (e.g., sudden weight change, mood swings, low blood pressure, low blood sugar, high blood sugar) | Thyroiditis, adrenal insufficiency | Stop treatment, call your oncologist |\n| **Kidney pain or decreased urine output** | Nephritis | Stop treatment, call your oncologist |\n\n**If you’re unsure**—any new, worsening, or unexplained symptom—stop hiking, rest, and contact your oncology team right away. They’ll decide whether to pause or adjust therapy.",
          "order": 2,
          "qid": "S25-Q02"
        },
        {
          "q": "Can I camp far from hospitals?",
          "gt": "It’s possible to enjoy remote campsites, but you’ll need a safety net.  \n- **Distance to care**: Aim to stay within a 30‑60‑minute drive of a hospital or urgent‑care center. If you go farther, make sure you have a reliable way to reach help (car, helicopter, or a nearby clinic that can call for you).  \n- **Monitoring**: Keep a daily log of temperature, blood pressure, and any new symptoms (rash, diarrhea, shortness of breath, fatigue). Use a phone or smartwatch to track vitals if possible.  \n- **Medications**: Carry all prescribed drugs, an emergency kit, and a list of your treatments and side‑effect warning signs.  \n- **Support**: Arrange for a friend or family member to check in regularly, and keep a local emergency number handy.  \n- **Telehealth**: Have a plan to call your oncologist or a local ER if you notice anything concerning.  \n\nWith these precautions, you can enjoy the parks while staying prepared for any medical needs.",
          "order": 3,
          "qid": "S25-Q03"
        },
        {
          "q": "Will high altitude be a problem?",
          "gt": "High altitude can add extra strain on a body already coping with metastatic kidney cancer and its treatment.  \n- **Cardiovascular & pulmonary load**: VEGF‑inhibitors and some immunotherapies raise blood pressure and can cause heart strain. At altitude the heart works harder to deliver oxygen, increasing the risk of hypertension, arrhythmias, or pulmonary edema.  \n- **Immune‑related pneumonitis**: If you’ve had lung inflammation from checkpoint therapy, lower oxygen levels can worsen symptoms or trigger flare‑ups.  \n- **Acute mountain sickness**: Even healthy people feel fatigue, dizziness, or shortness of breath; these can mask or amplify treatment side‑effects.\n\n**Practical steps**  \n1. **Baseline assessment**: Get a cardiology/ pulmonology review and baseline oxygen saturation.  \n2. **Choose moderate altitudes** (≤ 2,500 m) and allow gradual ascent.  \n3. **Monitor**: Keep a pulse oximeter, watch for new fatigue, cough, or chest pain.  \n4. **Plan for descent**: Have a clear exit strategy and carry medications (e.g., steroids for pneumonitis, antihypertensives).  \n5. **Stay hydrated and avoid alcohol**; keep your treatment schedule intact.\n\nIf you feel any new or worsening symptoms, descend immediately and seek medical care. With careful planning, many people with metastatic RCC can still enjoy hiking at moderate elevations.",
          "order": 4,
          "qid": "S25-Q04"
        },
        {
          "q": "Does diet matter for these meds?",
          "gt": "Yes—what you eat can influence how your immunotherapy and targeted drugs work and how you feel. A balanced, anti‑inflammatory diet (fruits, veggies, whole grains, lean protein, omega‑3s) supports immune health and may ease fatigue and nausea. Keep hydrated and limit alcohol, which can impair liver metabolism of many agents. For VEGF‑targeted drugs that raise blood pressure, moderate sodium and avoid excess salt or high‑fat meals that can worsen hypertension. If you develop colitis or diarrhea from checkpoint inhibitors, a bland, low‑fiber diet (e.g., bananas, rice, toast) can help until symptoms improve. Finally, discuss any supplements or herbal products with your oncologist or a registered dietitian, as some can interfere with drug absorption or metabolism.",
          "order": 5,
          "qid": "S25-Q05"
        },
        {
          "q": "What about blood pressure spikes I’ve heard about?",
          "gt": "Blood‑pressure spikes are most common with the VEGF‑targeted drugs (e.g., sunitinib, pazopanib, axitinib) that are often paired with immunotherapy. They can appear within the first 2–4 weeks and may worsen with exertion or dehydration.  \n\n**What to do:**  \n1. **Check BP regularly**—ideally before and after hikes, and at least twice a week while on therapy.  \n2. **Keep a log** of readings, activity, and any symptoms (headache, dizziness).  \n3. **Stay hydrated** and avoid excessive salt or caffeine.  \n4. **Report any readings > 140/90 mm Hg** (or > 160/100 mm Hg if symptomatic) to your oncology team. They may start or adjust an antihypertensive (e.g., ACE‑I, ARB, calcium‑channel blocker).  \n5. **Adjust hiking intensity** if BP is elevated; rest, shorten the trail, or postpone until controlled.  \n\nEarly detection and treatment keep you safe and let you enjoy the parks.",
          "order": 6,
          "qid": "S25-Q06"
        },
        {
          "q": "Can I still donate blood to the park drives?",
          "gt": "I’m glad you’re thinking about giving back while you’re still active on the trails.  \nBecause you’re receiving immunotherapy (or a combo with targeted therapy) and have metastatic disease, most blood‑bank guidelines defer donors for **at least 3 months after the last dose** of these agents. In addition, active cancer itself is a temporary deferral.  \n\nSo, you’ll likely need to wait until your treatment course is finished and the required deferral period has passed before you can safely donate blood.  Check with your oncology team and the local blood‑bank for the exact timing and any additional criteria.  \n\nIn the meantime, you can still volunteer in other ways—organizing park clean‑ups, leading hikes, or sharing your story with others. Your enthusiasm and experience are invaluable to the community.",
          "order": 7,
          "qid": "S25-Q07"
        },
        {
          "q": "If scans show stable disease, is that a win or just holding pattern?",
          "gt": "**Stable disease = a positive sign, not a “finished” story.**  \nWhen your scans show no new lesions and existing ones haven’t grown, the treatment is effectively holding the cancer in check. That’s a win in the sense that the disease is under control and you can keep living your life—hiking, enjoying the parks, and staying active—while the therapy continues to work.  \n\nHowever, stable disease is still a “holding pattern.” The cancer can still evolve, and side‑effects or new lesions can appear later. Keep regular scans, report any new symptoms (pain, fatigue, swelling, or changes in your usual hiking stamina), and stay in close touch with your oncology team. With vigilant monitoring and a balanced activity plan, you can enjoy the trails while staying on top of the disease.",
          "order": 8,
          "qid": "S25-Q08"
        },
        {
          "q": "What if my joints ache too much to hike?",
          "gt": "I’m sorry to hear how much the joint aches are limiting your hikes. Joint pain is a common immune‑related side effect of checkpoint inhibitors or combined chemo‑immunotherapy. Here’s a practical plan:\n\n1. **Pain control** – Start with acetaminophen or a low‑dose NSAID (e.g., naproxen 250 mg twice daily) if kidney function allows. If pain persists, a short course of oral steroids (e.g., prednisone 10–20 mg/day tapered over 1–2 weeks) can be tried, but only under oncologist guidance.  \n2. **Activity modification** – Replace steep trails with flat, low‑impact routes, or try walking on a treadmill or in a pool. Gentle stretching before and after each walk helps.  \n3. **Supportive measures** – Use compression sleeves, heat packs, or topical NSAIDs.  \n4. **Physical therapy** – A PT can design a strengthening program that protects joints while maintaining endurance.  \n5. **Monitor** – If pain worsens, becomes numb, or you notice swelling, contact your oncology team promptly; they may adjust therapy or add a pain specialist.  \n\nWith these steps, many patients keep hiking safely while managing joint discomfort.",
          "order": 9,
          "qid": "S25-Q09"
        },
        {
          "q": "If this stops working, what’s next?",
          "gt": "If the current combo stops controlling the cancer, the next step is to move to a second‑line regimen that still keeps you active and minimizes side‑effects.  \n\n1. **Switch to a VEGF‑targeted therapy** (e.g., axitinib, cabozantinib, or lenvatinib + everolimus). These drugs are oral, have a manageable side‑effect profile, and many patients maintain their exercise routine.  \n2. **Consider a different immunotherapy** (nivolumab alone or with ipilimumab) if you haven’t used it yet; it can be effective after first‑line failure.  \n3. **Enroll in a clinical trial**—many trials for metastatic RCC focus on novel agents or combinations that may offer benefit while preserving quality of life.  \n4. **Supportive care**: keep a close eye on fatigue, anemia, and bone health; adjust activity levels as needed.  \n\nDiscuss these options with your oncologist, and we’ll tailor the plan so you can keep enjoying the trails.",
          "order": 10,
          "qid": "S25-Q10"
        }
      ]
    },
    {
      "id": "S26",
      "title": "Hope in a cooler (CAR-T for relapsed lymphoma)",
      "diagnosis": "Relapsed/refractory large B-cell lymphoma, candidate for CAR-T",
      "treatment_plan": "Leukapheresis, bridging therapy as needed, lymphodepleting chemo, CAR-T infusion; monitor for CRS/ICANS; caregiver required",
      "narrative": "I'm 59 and my lymphoma came back. They say my own cells can be turned into medicine. I’m hopeful and scared of the side effects I’ve read about.",
      "qa": [
        {
          "q": "How long am I away from home from collection to infusion?",
          "gt": "**Typical timeline (from your first apheresis to the CAR‑T infusion):**\n\n| Step | What happens | Time from the previous step |\n|------|--------------|-----------------------------|\n| **Leukapheresis** | Blood is drawn to collect your T‑cells. | Day 1 |\n| **Manufacturing** | Your T‑cells are engineered, expanded, and tested in a GMP lab. | 1–2 weeks |\n| **Bridging therapy** (if needed) | Short‑course chemo or steroids to keep the lymphoma under control while the product is ready. | 1 week (often overlaps with manufacturing) |\n| **Lymphodepletion** | Cyclophosphamide + fludarabine (or similar) to “make room” for the CAR‑T cells. | 2 days before infusion |\n| **CAR‑T infusion** | The final product is given. | Day 0 |\n\n**Total:** Roughly **3–4 weeks** from the day you start apheresis to the day you receive the CAR‑T cells. Some centers may take a bit longer (up to 5 weeks) if manufacturing or bridging therapy takes extra time. If you’re traveling, plan for a stay of about a month, but you’ll be in close contact with the medical team throughout.",
          "order": 1,
          "qid": "S26-Q01"
        },
        {
          "q": "What does a caregiver actually do, and for how long?",
          "gt": "A caregiver’s role is hands‑on and continuous.  \n**Before the CAR‑T infusion** they help with appointments, transport, and paperwork, and they prepare the home for a short hospital stay (usually 2–4 days).  \n**During the inpatient phase** they monitor your vitals, watch for fever, rash, or neurologic changes, administer medications (antipyretics, steroids, antihistamines) as directed, and keep the medical team informed of any new symptoms.  \n**After discharge** the caregiver stays on‑call for the first 30 days—when cytokine release syndrome (CRS) and immune‑cell–associated neurotoxicity (ICANS) can still flare. They check temperature, blood pressure, and neurologic status, manage side‑effect medications, and coordinate follow‑up visits.  \nBeyond the 30‑day window, routine oncology visits continue (often every 4–6 weeks for the first year). In practice, a dedicated caregiver is most needed for the first month, then less intensive but still present for ongoing monitoring and support.",
          "order": 2,
          "qid": "S26-Q02"
        },
        {
          "q": "What does cytokine release syndrome feel like?",
          "gt": "Cytokine release syndrome (CRS) is the body’s immune‑system “fire alarm” after CAR‑T cells start attacking lymphoma. Most people feel it as a sudden, intense flu‑like flare: high fever (often >38 °C), chills, sweats, and a rapid heart rate. You may also notice low blood pressure, shortness of breath, and a feeling of extreme fatigue or weakness. In some cases, the fever can be accompanied by a rash, nausea, or a headache. If the syndrome is severe, you might experience confusion, agitation, or a sense of “brain fog” (ICANS). The symptoms usually appear within a few days of infusion and can last from a few hours to several days. Careful monitoring—vital signs, blood counts, and a 24‑hour observation period—helps catch and treat CRS early, keeping it manageable.",
          "order": 3,
          "qid": "S26-Q03"
        },
        {
          "q": "What about the brain side effects—will I know if my words tangle?",
          "gt": "**ICANS (CAR‑T neurotoxicity) can affect language, but it’s usually noticeable early.**  \n- **Typical signs:** confusion, difficulty finding words, slurred speech, or sudden changes in tone/clarity.  \n- **Monitoring:** Your team will perform daily neurologic exams and may use quick language tests (e.g., naming a picture).  \n- **When to alert:** If you or your caregiver notice any of the above—especially if it worsens or is accompanied by headache, seizures, or high fever—call the oncology team right away.  \n\nMost ICANS cases respond to prompt treatment (steroids, sometimes tocilizumab) and resolve within days to weeks. Early recognition is key, so keep a simple “word‑tangle” log and report any changes promptly.",
          "order": 4,
          "qid": "S26-Q04"
        },
        {
          "q": "Can I work remotely during all this?",
          "gt": "You can often keep a remote job, but the schedule will need to be flexible.  \n• **Leukapheresis & bridging therapy** – usually outpatient; you can work from home if you feel well, but you’ll need to be available for brief clinic visits.  \n• **Lymphodepleting chemo** – you’ll be in the hospital for a few days; most patients can work remotely during this time if they’re not too fatigued.  \n• **CAR‑T infusion & monitoring** – you’ll stay in the hospital for 5–10 days (sometimes longer) to watch for CRS/ICANS. During this period you’ll likely need to stay home and focus on recovery.  \n\nPlan with your employer: arrange a flexible schedule, use sick leave or a short paid‑time‑off period, and keep a backup plan if you experience severe side effects. If you’re unsure, discuss your work plans with your oncology team—they can advise on safe timing and any restrictions.",
          "order": 5,
          "qid": "S26-Q05"
        },
        {
          "q": "If the cells don’t grow in the lab, then what?",
          "gt": "If the T‑cells you donate fail to expand in the lab, the CAR‑T product can’t be made, so the planned infusion isn’t possible. The manufacturing team will let you know whether a second apheresis (another blood draw) is feasible or if the failure is due to a technical issue that can’t be overcome. If a second collection isn’t an option, the next step is to discuss alternative therapies—such as salvage chemotherapy, targeted agents, antibody‑drug conjugates, or enrollment in another clinical trial. Your oncologist will review all available options and help you decide the best path forward. It’s normal to feel uncertain, but the team will keep you informed and support you through each decision.",
          "order": 6,
          "qid": "S26-Q06"
        },
        {
          "q": "Is infection risk higher after CAR-T?",
          "gt": "Yes—most people who receive CAR‑T therapy have a higher risk of infection, especially in the first few weeks to months after infusion. The lymphodepleting chemotherapy (fludarabine/cyclophosphamide) and the CAR‑T cells themselves can cause profound neutropenia and B‑cell aplasia, leading to low white‑blood‑cell counts and hypogammaglobulinemia. These changes reduce the body’s ability to fight bacteria, viruses, and fungi.  \n\n**What that means for you:**  \n- **Close monitoring** of blood counts and early treatment of fevers.  \n- **Prophylactic antibiotics, antivirals, and antifungals** are often given.  \n- **Immunoglobulin replacement** may be needed if IgG levels fall below 400 mg/dL.  \n- **Vaccinations** (influenza, pneumococcal, COVID‑19) are recommended before therapy and may be repeated afterward, but live vaccines are avoided until immune recovery.  \n\nIf you notice a fever, sore throat, or any new symptoms, contact your team right away. With vigilant care, most patients recover from infections and go on to enjoy the benefits of CAR‑T therapy.",
          "order": 7,
          "qid": "S26-Q07"
        },
        {
          "q": "Will I lose my hair again?",
          "gt": "**Short answer:**  \nCAR‑T cells themselves don’t cause hair loss. The hair‑shedding you’re worried about comes from the lymphodepleting chemotherapy (usually fludarabine + cyclophosphamide) that is given right before the CAR‑T infusion. If you’ve already had that combo, you may lose hair for a few weeks; if you haven’t, you likely won’t. Hair usually regrows within 3–6 months after the chemo ends.  \n\n**What to expect:**  \n- **Timing:** Hair loss usually starts 1–2 weeks after the chemo and peaks around 3–4 weeks.  \n- **Recovery:** Most people see regrowth by 3–6 months; the hair may be a bit finer or different in texture at first.  \n- **Support:** Use gentle hair care, consider wigs or scarves, and talk to your team about scalp cooling if you’re also receiving other chemo.  \n\nIf you’re unsure whether you’ll receive the lymphodepleting regimen, ask your oncologist; they can confirm the exact drugs and schedule.",
          "order": 8,
          "qid": "S26-Q08"
        },
        {
          "q": "How soon will I know if it worked?",
          "gt": "After the CAR‑T infusion you’ll start monitoring right away.  \n**Early signs (within 1–2 weeks):**  \n- Improvement in symptoms (fever, pain, swelling).  \n- A drop in circulating tumor cells or soluble markers (if your lymphoma is measurable that way).  \n\n**Formal assessment (4–6 weeks):**  \n- Imaging (CT/PET) to look for shrinkage of lymph nodes or masses.  \n- If you had bone‑marrow involvement, a marrow aspirate/biopsy is usually done around 6–8 weeks.  \n\nIf the scans and labs show a response, that’s the first concrete evidence that the therapy worked. If not, the team will discuss next steps. Remember, early symptom relief is a good sign, but the definitive “worked” answer comes from the imaging and pathology done a month or so after the infusion.",
          "order": 9,
          "qid": "S26-Q09"
        },
        {
          "q": "If it works, how long can it last?",
          "gt": "I’m glad you’re asking—knowing what to expect can ease a lot of the anxiety. In clinical trials and real‑world data, about 40–60 % of patients with relapsed large B‑cell lymphoma who receive CAR‑T therapy stay in complete remission for 2–3 years, and a smaller but meaningful group—roughly 10–20 %—remain disease‑free for 5 years or more. The exact duration depends on many factors: the specific CAR‑T product, how many prior lines of therapy you’ve had, the biology of your lymphoma, and how well you tolerate the treatment. Even if the disease recurs, subsequent therapies can still be effective. So, while we can’t predict a precise length, many patients enjoy durable remissions that last several years.",
          "order": 10,
          "qid": "S26-Q10"
        }
      ]
    },
    {
      "id": "S27",
      "title": "Semester on hold (acute lymphoblastic leukemia, young adult)",
      "diagnosis": "Ph-negative acute lymphoblastic leukemia in a 24-year-old",
      "treatment_plan": "Multi-phase chemotherapy (induction, consolidation, maintenance); CNS prophylaxis; central line; fertility counseling",
      "narrative": "I'm 24 and in grad school. The schedule looks like a second full-time job. I want to live—and still graduate.",
      "qa": [
        {
          "q": "How much of my semester is realistically salvageable?",
          "gt": "I’m sorry you’re facing this. In a typical ALL protocol the first 4–6 weeks are induction (daily chemo, hospital stays, lots of side‑effects). After that you’ll have 4–6 weeks of consolidation, then maintenance that runs for 2–3 years but is broken into 2–3 week “on” periods followed by 1–2 week “off” breaks.  \n\nFor a single semester (≈15 weeks) you can realistically expect about 6–8 weeks of intense treatment (induction + consolidation) and 4–5 weeks of maintenance “on” time. The remaining 2–3 weeks may be “off” or very light.  \n\nIf your program allows online or recorded lectures, flexible deadlines, and you can arrange a reduced course load or a leave of absence for the first 6–8 weeks, you can salvage roughly 50–60 % of the semester. Discuss a tailored plan with your academic advisor and the oncology team to maximize what you can keep up with.",
          "order": 1,
          "qid": "S27-Q01"
        },
        {
          "q": "Will a central line change how I sleep or shower?",
          "gt": "A central line (usually a PICC or tunneled catheter) can change a few daily habits, but most people adapt quickly.\n\n**Sleeping**  \n- Keep the line out of the way: lie on the opposite side or use a pillow to keep the line from being compressed.  \n- Avoid sleeping on the line itself; a small “line‑friendly” pillow or a rolled towel can help.  \n- If you’re prone to snoring or sleep apnea, the line won’t interfere, but you may need to adjust your mattress or use a head‑up position.\n\n**Showering**  \n- You can shower with the line in place.  \n- Use a waterproof cover or a shower cap to keep the line dry.  \n- Keep the line out of direct water spray; a gentle stream is fine.  \n- Avoid soaking (tub baths) until your doctor clears it.  \n- After showering, pat the line area dry and apply a sterile dressing if instructed.\n\nWith a bit of routine—protecting the line, choosing the right sleeping position, and using a cover while showering—you can maintain most of your normal schedule. If you notice redness, swelling, or pain, contact your oncology team right away.",
          "order": 2,
          "qid": "S27-Q02"
        },
        {
          "q": "How do I handle friends who say 'you don’t look sick' when I’m exhausted?",
          "gt": "It’s normal for chemo‑related fatigue to be “invisible.” When a friend says “you don’t look sick,” try a calm, brief reply that sets the tone for the rest of the conversation. For example: “I appreciate you noticing, but I’m still dealing with a lot of tiredness and brain fog. It’s hard to show it on the outside.” This lets them know you’re not dismissing their observation, but that the illness is real. If they keep pushing, set a gentle boundary: “I’m okay for now, but I need some quiet time to rest.” You can also share a quick fact sheet or a short explanation of how chemotherapy drains energy, so they understand why you’re exhausted. If the comment feels dismissive or hurtful, let them know it’s affecting you emotionally and ask for more supportive ways to help—like checking in, offering to pick up a grocery order, or just giving you space. If the pattern continues, consider talking to a counselor or support group to reinforce healthy boundaries.",
          "order": 3,
          "qid": "S27-Q03"
        },
        {
          "q": "What does 'maintenance' actually feel like?",
          "gt": "Maintenance is the longest, but least “bomb‑shell” part of ALL therapy. After induction and consolidation you’ll be on a schedule of oral or short‑infusion drugs (often weekly or monthly) for 2–3 years. The intensity drops: you’ll have less hair loss, fewer high‑dose chemo spikes, and fewer hospital stays, but you’ll still feel the toll of fatigue, mild nausea, and a heightened infection risk. Blood tests and clinic visits stay frequent—every 2–4 weeks—so you’ll need to juggle appointments with classes. Many patients find that the routine becomes manageable: you can do part‑time work or study, but you’ll need to keep a close eye on side‑effects and communicate with your professors about deadlines. In short, maintenance is a steady grind with intermittent chemo, but it’s the phase where you can gradually return to normal life while staying vigilant.",
          "order": 4,
          "qid": "S27-Q04"
        },
        {
          "q": "Can we preserve fertility without delaying induction?",
          "gt": "I understand how stressful it is to juggle a demanding treatment plan and a grad‑school schedule. The good news is that fertility preservation can often be done **without delaying induction**.\n\n**For men**: a single sperm‑banking visit (usually 1–2 days) is done before the first chemo dose. No delay is needed.\n\n**For women**:  \n- **GnRH‑agonist suppression** (e.g., leuprolide) can be started immediately; it protects ovarian reserve during induction and takes only a few days.  \n- If you want oocytes or embryos, a short stimulation cycle (≈10 days) can be performed concurrently with induction, though it may require a brief pause of a few days—usually not enough to compromise outcomes.\n\nDiscuss these options with your oncologist and reproductive specialist right away; they can tailor the timing to your specific protocol and keep your induction on schedule.",
          "order": 5,
          "qid": "S27-Q05"
        },
        {
          "q": "Do I have to give up my apartment with roommates?",
          "gt": "It’s not a blanket rule that you must leave your apartment.  The key is how low your infection risk is during each phase of therapy.  \n\n**Induction & early consolidation** – when your neutrophil count is <500 /µL, you’re highly neutropenic.  In that window you should avoid crowds, keep the apartment clean, and consider staying in a quieter space (e.g., a single‑room unit or a temporary rental) if you can.  A central line adds a small infection risk, but with proper line care and routine checks you can often stay home.  \n\n**Maintenance** – counts usually recover, and you can resume normal living with standard precautions (hand hygiene, avoiding sick contacts).  \n\nDiscuss a personalized plan with your oncology team; they’ll weigh your infection risk, the apartment’s layout, and your support system.  Many patients keep their roommates and manage safely with clear guidelines.",
          "order": 6,
          "qid": "S27-Q06"
        },
        {
          "q": "What if chemo brain wrecks my studying?",
          "gt": "I’m really sorry you’re facing this. “Chemo‑brain” is common in ALL, especially during induction, but it’s usually temporary and manageable.  \n**What to do now:**  \n1. **Talk to your oncologist** about your concerns; they can adjust medications (e.g., consider dexamethasone taper or add a low‑dose stimulant if appropriate).  \n2. **Get a neuropsychological assessment**—many centers offer brief cognitive testing and tailored strategies.  \n3. **Use practical study aids**: short, frequent study blocks (20–25 min), spaced repetition, audio‑recorded lectures, and visual summaries.  \n4. **Prioritize rest, nutrition, and light exercise**—even a 10‑minute walk can boost cognition.  \n5. **Ask for academic accommodations**: extended deadlines, note‑taking help, or a reduced course load.  \n6. **Seek support**: counseling, peer groups, or a study buddy can reduce stress and keep you on track.  \n\nWith these tools, many patients finish their programs successfully. You’re not alone, and help is available.",
          "order": 7,
          "qid": "S27-Q07"
        },
        {
          "q": "How strict is infection prevention during exams on campus?",
          "gt": "During the most neutropenic phases (usually induction and the first few consolidation cycles), your absolute neutrophil count (ANC) can drop below 500 cells/µL, putting you at high risk for serious infections. In that window, campus exam settings should be treated as “high‑risk” environments: avoid crowded lecture halls, large group study sessions, and any place where you might be exposed to respiratory droplets or contaminated surfaces.  \n\n**Practical steps:**  \n1. **Speak with your oncology team** and the university’s disability services to request remote or proctored exams, or a “low‑contact” exam room.  \n2. **Wear a well‑fit mask** and use hand sanitizer before and after the exam.  \n3. **Limit physical contact**—no hand‑shakes, no touching your face.  \n4. **Stay home** if you develop fever, sore throat, or any infection symptoms.  \n\nIf you’re in a maintenance phase with a higher ANC, the risk is lower but still worth following basic precautions (mask, hand hygiene, avoid sick contacts). Always keep your medical team and school updated on your neutrophil status so accommodations can be adjusted accordingly.",
          "order": 8,
          "qid": "S27-Q08"
        },
        {
          "q": "If a phase is delayed, does it ruin the whole plan?",
          "gt": "Delaying a single phase doesn’t automatically doom the entire protocol, but it does require careful adjustment. In ALL, the induction phase is the most critical for achieving remission; a delay here can increase the risk of relapse. Consolidation and maintenance can usually be postponed a few weeks (often 2–4) without major impact, provided the patient remains in remission and the delay is communicated promptly to the oncology team. The team will re‑evaluate your blood counts, infection status, and overall health, then shift the schedule accordingly—sometimes by shortening the interval between cycles or adding a dose‑adjusted “catch‑up” cycle. The key is to keep the oncologist informed, attend all supportive‑care appointments, and follow any infection‑prevention or dose‑modification recommendations. With timely communication, most patients resume the planned course and still achieve excellent outcomes.",
          "order": 9,
          "qid": "S27-Q09"
        },
        {
          "q": "What’s plan B if remission isn’t complete?",
          "gt": "I’m sorry you’re facing this uncertainty. If the first induction doesn’t achieve a complete remission, the next step is usually a **salvage or “second‑induction”** regimen—often a different combination of drugs (e.g., high‑dose methotrexate, cytarabine, or a newer agent like nelarabine).  \n\nIf that still fails, the standard “plan B” is an **allogeneic stem‑cell transplant** (donor match, haplo‑related, or cord blood) after a conditioning regimen.  For some patients, enrolling in a **clinical trial** that offers novel targeted therapies or immunotherapies (CAR‑T, blinatumomab, or bispecific antibodies) can be an option.  \n\nThroughout, supportive care (infection prophylaxis, transfusions, psychosocial support) is essential. Discuss these options with your oncologist early so you can weigh risks, benefits, and timing while keeping your academic goals in mind.",
          "order": 10,
          "qid": "S27-Q10"
        }
      ]
    },
    {
      "id": "S28",
      "title": "Which way do I pee (muscle-invasive bladder cancer)",
      "diagnosis": "Muscle-invasive urothelial carcinoma",
      "treatment_plan": "Neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy with urinary diversion (ileal conduit or neobladder)",
      "narrative": "I'm 65. They’re removing my bladder after chemo, and I have to choose how I’ll pee for the rest of my life. I want dignity and practicality.",
      "qa": [
        {
          "q": "Is there a way to avoid removing the bladder if chemo works well?",
          "gt": "I’m sorry you’re facing such a big decision. For muscle‑invasive bladder cancer, the standard of care is neoadjuvant cisplatin‑based chemotherapy followed by radical cystectomy. Even if the tumor shrinks dramatically, most oncologists still recommend removal because microscopic disease can remain and recurrence rates are high.\n\nThere is a “bladder‑preserving” approach—trimodality therapy (TURBT + concurrent chemoradiation). It’s only suitable for a small subset of patients who meet strict criteria (e.g., single tumor, no hydronephrosis, good performance status) and requires intensive surveillance and a willingness to accept the risk of future recurrence or the need for a later cystectomy.\n\nSo, while a bladder‑sparing option exists, it’s not a guaranteed escape from cystectomy and is only offered to carefully selected patients. Discuss these options with your surgeon and radiation oncologist to see if you qualify.",
          "order": 1,
          "qid": "S28-Q01"
        },
        {
          "q": "Which diversion lets me travel without constant bathroom scouting?",
          "gt": "Ileal conduit is the diversion that gives you the most freedom when you’re on the move.  \nWith a conduit, a small piece of intestine is fashioned into a tube that carries urine from the kidneys straight into a pouch that you wear on the outside of your body. Because the urine never goes into a bladder‑like reservoir, you don’t have to schedule voiding or hunt for a restroom. The pouch can be emptied or changed discreetly, even while you’re traveling, and it’s generally easier to manage in unfamiliar places.\n\nA neobladder, on the other hand, is a new “bladder” made from bowel that you empty by voiding. It requires regular bathroom visits and can be less convenient when you’re away from home or in a foreign country. If your priority is travel‑friendly convenience, the ileal conduit is usually the better choice.",
          "order": 2,
          "qid": "S28-Q02"
        },
        {
          "q": "Will intimacy be possible after surgery?",
          "gt": "After a radical cystectomy, many men can still have intimate relationships, but the experience often changes. The surgery usually removes the bladder and may cut or stretch the nerves that control erections, so erectile function can be impaired. Nerve‑sparing techniques are sometimes possible, but they’re less common when the cancer is muscle‑invasive. Erectile dysfunction can often be managed with oral medications (PDE‑5 inhibitors), vacuum devices, or, if needed, a penile prosthesis. The urinary diversion (ileal conduit or neobladder) does not directly affect sexual function, but the overall recovery, hormonal changes, and psychological adjustment can influence desire and performance. Discuss these options with your surgeon and a sexual‑health specialist; many patients find ways to maintain a satisfying intimate life with appropriate support and treatment.",
          "order": 3,
          "qid": "S28-Q03"
        },
        {
          "q": "How visible is an external bag under clothes?",
          "gt": "After a cystectomy you’ll carry a small, usually 1‑2 L external pouch (the ileal conduit “bag”) that attaches to the stoma. It sits on the lower abdomen and is about the size of a small backpack. With a well‑fitted, loose‑cut shirt or a tailored jacket it can be largely concealed; the bag’s bulk is most noticeable under tight or sheer fabrics. Many patients choose a low‑profile pouch or a “bag‑in‑bag” system that sits snugly against the body, reducing the silhouette. If you’re concerned about visibility, discuss custom‑cut clothing or a discreet pouch with your surgeon or a stoma nurse—they can recommend designs that blend best with your wardrobe while keeping the bag secure and comfortable.",
          "order": 4,
          "qid": "S28-Q04"
        },
        {
          "q": "Will chemo damage my hearing or nerves permanently?",
          "gt": "Cisplatin, the drug most often used in your neoadjuvant regimen, can affect both hearing and nerves.  \n**Ototoxicity** – high‑dose cisplatin can cause permanent high‑frequency hearing loss, especially if cumulative doses exceed 200 mg/m². Your oncologist will usually perform baseline audiograms and repeat them during treatment; if hearing drops, the dose may be reduced or the drug stopped.  \n**Peripheral neuropathy** – cisplatin can damage sensory nerves, producing tingling, numbness, or weakness. Most neuropathy improves after therapy ends, but in some cases it can persist or worsen with higher cumulative doses.  \n\nAsk your team about hearing tests, nerve‑function monitoring, and any protective agents (e.g., amifostine) that might be offered. Early detection and dose adjustments can reduce the risk of lasting damage.",
          "order": 5,
          "qid": "S28-Q05"
        },
        {
          "q": "Can I swim with a stoma?",
          "gt": "Swimming is generally safe after a cystectomy with an ileal conduit, but it does require a few precautions to keep your stoma and pouch secure and to prevent infection.\n\n**What to do:**\n- **Use a waterproof pouch** that fits snugly over the stoma. Many patients find a pouch with a “seal‑on” or “water‑proof” design works best.  \n- **Check the seal before each swim** and replace the pouch if it feels loose or if you notice any leakage.  \n- **Avoid high‑pressure jets** (e.g., in a whirlpool) that could dislodge the pouch or irritate the stoma.  \n- **Rinse the stoma area with clean water** after swimming and dry gently.  \n- **Watch for redness, swelling, or discharge**—if any of these occur, stop swimming and contact your surgeon or stoma nurse.\n\n**When to pause swimming:**\n- If you have a new stoma or a recent surgery, wait until the incision is fully healed (usually 4–6 weeks).  \n- If you develop a urinary tract infection or any stoma complications, hold off until cleared by your team.\n\nWith a properly fitted pouch and careful hygiene, most people enjoy swimming without problems. If you’re unsure about your specific pouch or stoma, a quick call to your stoma nurse can give you peace of mind.",
          "order": 6,
          "qid": "S28-Q06"
        },
        {
          "q": "What if I can’t pee with a neobladder at first?",
          "gt": "I’m sorry you’re facing this uncertainty. After a neobladder, the first few weeks are a learning curve. It’s common to need a catheter for a few days to a month while the new bladder “settles” and you learn the timing and technique of voiding. If you can’t empty comfortably, the surgeon will keep a catheter in place until the bladder can hold and empty on its own. In some cases, a temporary ileal conduit (external pouch) may be used while the neobladder matures, and you can switch back once you’re able to void reliably. Your team will monitor pressure, residual urine, and kidney function, and adjust the plan promptly—so you’re not stuck with a permanent diversion if it’s avoidable.",
          "order": 7,
          "qid": "S28-Q07"
        },
        {
          "q": "How often are follow-ups after surgery?",
          "gt": "After a radical cystectomy you’ll have a structured follow‑up plan that balances early detection of recurrence with practicality.  \n\n**Typical schedule**  \n- **2–4 weeks post‑op**: wound check, review pathology, discuss diversion care.  \n- **3 months**: physical exam, blood work (CBC, electrolytes, renal function), imaging (CT chest/abdomen/pelvis) and, if you have a neobladder, cystoscopy.  \n- **6 months**: repeat exam, labs, imaging, cystoscopy (neobladder).  \n- **12 months**: same work‑up.  \n- **Annually thereafter**: exam, labs, imaging, cystoscopy (neobladder) or surveillance imaging (conduit).  \n\nIf you develop symptoms or abnormal labs, your team will schedule earlier visits. This routine keeps recurrence detection early while respecting your time and dignity.",
          "order": 8,
          "qid": "S28-Q08"
        },
        {
          "q": "Will I smell or leak?",
          "gt": "After a radical cystectomy you’ll have a urinary diversion that works differently from a natural bladder.\n\n**Ileal conduit** – urine is diverted through a small piece of intestine to a stoma on the abdomen. The stoma is covered with a pouch that you change every 3–4 days. The pouch is designed to contain urine and prevent odor; most people report no noticeable smell. Leakage is rare once the stoma is well‑formed, but you may need to adjust the pouch or use a small “safety” bag if you’re active.\n\n**Neobladder** – a new “bladder” is made from intestinal tissue and connected to the urethra. It can hold urine and be emptied by normal voiding. Some patients experience a mild, transient odor as the bowel tissue adapts, but it usually resolves. Leakage can occur early (especially after the first few months) or if the neobladder is overfilled; regular bladder training and, if needed, a small catheter or “safety” bag can help.\n\nIn both cases, proper hygiene, regular pouch changes, and bladder‑training exercises keep odor and leakage minimal. Discuss any concerns with your surgeon or continence nurse—they can tailor a plan that preserves dignity and practicality for you.",
          "order": 9,
          "qid": "S28-Q09"
        },
        {
          "q": "If pathology shows worse disease than expected, do we have backup options?",
          "gt": "If the final pathology shows more aggressive disease than you and your team expected—such as higher‑grade tumor, invasion beyond the muscularis, positive margins, or lymph node involvement—there are several “backup” options to consider:\n\n1. **Adjuvant chemotherapy** – Most guidelines recommend platinum‑based chemo after cystectomy if nodes are positive or margins are involved.  \n2. **Radiation therapy** – In selected cases (e.g., positive nodes, unresectable residual disease) a radiation boost can be added.  \n3. **Change of diversion** – If you were planning a neobladder but the pathology shows high‑risk features, the surgeon can convert to an ileal conduit intra‑operatively. Conversely, if you had an ileal conduit and the pathology is low‑risk, a continent diversion can be discussed later.  \n4. **Extended lymphadenectomy** – If the surgeon didn’t remove enough nodes, a second operation to retrieve more nodes can be considered.  \n5. **Palliative measures** – For very advanced disease, focus may shift to symptom control and quality of life.\n\nDiscuss these possibilities with your surgical oncologist and medical‑oncology team before the operation so you know what to expect and can make an informed choice about your diversion and follow‑up plan.",
          "order": 10,
          "qid": "S28-Q10"
        }
      ]
    },
    {
      "id": "S29",
      "title": "Swallowing my fear (esophageal cancer)",
      "diagnosis": "Locally advanced esophageal or gastroesophageal junction cancer",
      "treatment_plan": "Neoadjuvant chemoradiation followed by surgery when appropriate; nutrition support",
      "narrative": "I'm 60 and losing weight because food gets stuck. Treatment is chemoradiation and possibly surgery. I want to eat with my family again.",
      "qa": [
        {
          "q": "How do I keep weight on when every bite scares me?",
          "gt": "I’m sorry you’re feeling so scared about eating. Here are practical steps that can help you keep weight and still enjoy meals with family:\n\n1. **Small, frequent bites** – 5–6 tiny bites a time, with a pause to swallow, can reduce the feeling of choking.  \n2. **Soft, high‑calorie foods** – pureed soups, mashed potatoes, yogurt, smoothies, protein shakes, and nut‑butter‑filled bananas. Add a spoonful of peanut butter or a splash of cream to increase calories without extra volume.  \n3. **Temperature & texture** – warm foods are easier to swallow; avoid very hot or very cold items that may trigger pain.  \n4. **Pain & reflux control** – take prescribed anti‑emetics, steroids, or proton‑pump inhibitors as directed; ask your oncologist if a brief trial of a swallowing‑stimulant medication is appropriate.  \n5. **Swallow‑therapy support** – a speech‑language pathologist can teach exercises that strengthen the swallowing muscles and reduce fear.  \n6. **Use a feeding tube if needed** – a percutaneous endoscopic gastrostomy (PEG) can provide nutrition while you recover swallowing function.  \n7. **Emotional support** – talk to a counselor or join a support group; anxiety can amplify the sensation of food “sticking.”  \n\nWith these strategies, you can maintain weight and still share meals with loved ones.",
          "order": 1,
          "qid": "S29-Q01"
        },
        {
          "q": "Will chemoradiation make swallowing worse before it gets better?",
          "gt": "It’s common for the first 2–4 weeks of neoadjuvant chemoradiation to feel like a “second hit” on the esophagus. The radiation and chemotherapy can inflame the lining, causing swelling, pain and a temporary worsening of dysphagia. Most patients notice this peak early in treatment, and once the acute inflammation subsides—usually after the 5–6 week course—swallowing improves as the tumor shrinks.  \n\nTo keep swallowing as comfortable as possible:  \n- Use a soft or pureed diet, small frequent meals, and stay upright after eating.  \n- Take prescribed anti‑inflammatory or pain‑relief meds (e.g., proton‑pump inhibitors, steroids, or oral pain control).  \n- Consider a speech‑language pathologist for swallowing exercises.  \n\nIf swallowing remains difficult, a temporary feeding tube can be placed to maintain nutrition while you recover. Most patients regain adequate oral intake before surgery, so you’ll likely be able to sit at the table with your family again.",
          "order": 2,
          "qid": "S29-Q02"
        },
        {
          "q": "If surgery is needed, will I ever eat normally?",
          "gt": "If your surgeon removes part of the esophagus (esophagectomy) or the junction, the anatomy will change, but most people can return to a normal diet. After surgery you’ll likely need a temporary feeding tube and a liquid or pureed diet for a few weeks while the new connection heals. Swallowing therapy and gradual progression to soft foods are common. In many cases, once the anastomosis is healed, you can resume regular meals—though you might need to avoid very hot, very cold, or very dry foods for a while. Some patients experience mild swallowing discomfort or a “tight” feeling, but with time, most regain comfortable, normal eating. Discuss your specific plan with your surgeon and dietitian to set realistic expectations and a tailored recovery schedule.",
          "order": 3,
          "qid": "S29-Q03"
        },
        {
          "q": "Am I going to choke or aspirate at home?",
          "gt": "It’s understandable to worry about choking or aspiration at home. The risk depends on how severe your dysphagia is after chemoradiation and whether you have a swallowing disorder.  \n\n**What you can do:**\n\n1. **Swallow‑study** – A speech‑language pathologist can assess your swallowing function and give you a safe‑food plan.  \n2. **Diet modifications** – Small, well‑chewed bites; pureed or soft foods; avoid very dry or sticky foods; stay upright for at least 30 min after eating.  \n3. **Hydration** – Sip water slowly; avoid gulping.  \n4. **Monitor** – If you cough, choke, or feel food stuck, stop eating and seek help.  \n5. **Feeding tube** – If your swallow study shows a high aspiration risk, a temporary or permanent tube may be recommended to keep you safe and nourished.  \n\nMany patients recover good swallowing after treatment and can enjoy meals with family. Work closely with your oncology team, dietitian, and speech therapist to tailor a plan that keeps you safe and lets you share meals again.",
          "order": 4,
          "qid": "S29-Q04"
        },
        {
          "q": "Can I still drink coffee or wine?",
          "gt": "I’m sorry you’re dealing with so much right now. During neoadjuvant chemoradiation and after surgery the esophageal lining is very fragile. **Coffee** is acidic and can irritate the inflamed tissue, worsening pain or reflux, so it’s best to avoid it or switch to a low‑acid, decaffeinated version. **Wine** (and alcohol in general) can delay healing, increase reflux, and interact with chemotherapy drugs, so it’s usually recommended to stay away from it while you’re being treated and for a few weeks after surgery. If you miss the taste, try a non‑acidic, non‑alcoholic beverage—like a mild herbal tea, a small glass of white wine (if you’re cleared by your oncologist), or a low‑acid fruit juice. Always check with your oncology team before making changes, and let them know if you’re experiencing discomfort or weight loss.",
          "order": 5,
          "qid": "S29-Q05"
        },
        {
          "q": "How long before I know if surgery is on the table?",
          "gt": "After you finish the chemoradiation, your team will schedule a restaging scan (usually a CT or PET‑CT) about **4–6 weeks later**. That scan tells the oncologist and surgeon how well the tumor has responded and whether the cancer is still resectable. The results are then reviewed at a multidisciplinary tumor‑board meeting. If the response is favorable, the surgeon will plan the operation within the next **2–4 weeks**. So, in practice you can expect a definitive answer about surgery roughly **6–8 weeks after you complete the chemoradiation**. Your care team will keep you updated at each step and will discuss any concerns you have about timing or recovery.",
          "order": 6,
          "qid": "S29-Q06"
        },
        {
          "q": "Do I need to sleep upright forever?",
          "gt": "You don’t have to stay upright forever. During chemoradiation (and sometimes after surgery) sleeping upright or with a wedge helps keep food and acid from backing up, so many patients use a recliner or several pillows for a few weeks to months. Once the esophagus heals and your swallowing improves, you can usually return to a normal sleeping position. If you still feel food getting stuck or have reflux, your surgeon or gastroenterologist can advise a temporary “upright” schedule. Keep monitoring your symptoms, and let your care team adjust the plan as you recover.",
          "order": 7,
          "qid": "S29-Q07"
        },
        {
          "q": "How do you keep me safe from dehydration?",
          "gt": "I’m sorry you’re facing these challenges. Staying hydrated is essential, especially during chemoradiation when mucositis, nausea, and dry mouth can increase fluid loss. Here are practical steps:\n\n1. **Small, frequent sips** – Aim for 4–6 oz (120 ml) every 15–20 min, even if you’re not hungry. Keep a water bottle or glass at your bedside and sip between meals and during breaks.  \n2. **Oral rehydration solutions (ORS)** – Use a commercial ORS or a homemade mix (1 tsp salt + 6 tsp sugar in 1 L water) to replace electrolytes.  \n3. **High‑calorie, liquid supplements** – If you can’t swallow solids, try meal‑replacement drinks (Ensure, Boost) or protein shakes.  \n4. **Monitor signs** – Track weight, urine color (pale yellow is good), and thirst. If urine is dark, you’re dehydrated.  \n5. **Speak with your team** – If oral intake is insufficient, discuss a percutaneous endoscopic gastrostomy (PEG) tube or IV fluids.  \n6. **Avoid diuretics** – Skip caffeine, alcohol, and excess salt until cleared by your oncologist.  \n\nKeep a hydration log and share it with your care team; early intervention can prevent complications and help you enjoy meals with your family again.",
          "order": 8,
          "qid": "S29-Q08"
        },
        {
          "q": "What does a 'good day' look like during treatment so I can plan moments with my spouse?",
          "gt": "A “good day” during chemoradiation is one that balances treatment demands with moments of connection and comfort.  \n\n**Morning** – Start with a light, high‑protein snack (e.g., yogurt with fruit or a protein shake) and hydrate. If you’re scheduled for chemo, bring your spouse to the infusion room; the quiet time can be a chance to talk or simply sit together.  \n\n**Mid‑day** – After treatment, rest for 30–60 min. When you feel ready, have a small, easy‑to‑swallow meal (smoothies, soups, or pureed foods) with your spouse. Use this time to share a favorite song or a short walk if energy allows.  \n\n**Afternoon** – If you’re on a radiation day, the clinic often has a waiting area where you can sit with your partner. Use the break to read a short story or watch a light‑hearted show together.  \n\n**Evening** – Finish with a gentle activity you both enjoy—perhaps a low‑intensity game or a quiet conversation. Keep the focus on small, enjoyable moments rather than long, exhausting sessions.  \n\nBy structuring the day around treatment, rest, and brief shared activities, you preserve energy while maintaining the intimacy you cherish.",
          "order": 9,
          "qid": "S29-Q09"
        },
        {
          "q": "If I can’t face surgery, is there still a path?",
          "gt": "I’m sorry you’re feeling so overwhelmed.  \nIf surgery isn’t an option, you can still pursue **definitive chemoradiation** alone—many patients receive this as a curative‑intent treatment, though the long‑term survival is usually lower than with surgery.  \nFor immediate relief of swallowing problems, **endoscopic stenting** or a **feeding tube** can keep you nourished and improve quality of life.  \nYou can also explore **clinical trials** that test new drug combinations or targeted therapies, and you’ll have a multidisciplinary team (oncology, nutrition, palliative care, and surgery) to help you weigh the risks, benefits, and goals.  \nTalk with your oncologist about these alternatives; they can tailor a plan that keeps you as comfortable and active as possible while still fighting the cancer.",
          "order": 10,
          "qid": "S29-Q10"
        }
      ]
    },
    {
      "id": "S30",
      "title": "Fast and furious (extensive-stage small cell lung cancer)",
      "diagnosis": "Extensive-stage small cell lung cancer",
      "treatment_plan": "Platinum/etoposide chemotherapy with immunotherapy; symptom control; imaging to assess response",
      "narrative": "I'm 63 and this cancer showed up fast. They want to start chemo-immunotherapy now. I need relief and a plan that keeps my days meaningful.",
      "qa": [
        {
          "q": "How quickly might my cough and breathlessness improve?",
          "gt": "I’m sorry you’re dealing with such a rapid onset of symptoms. In many patients with extensive‑stage small cell lung cancer, the first cycle of platinum‑etoposide plus immunotherapy can begin to relieve cough and shortness of breath within **1–2 weeks**—often after the first or second dose. However, the response can be variable; some people notice improvement sooner, while others may need a full 4‑week cycle before symptoms ease.  \n\nIn the meantime, you can use supportive measures that often help quickly: a short course of oral steroids (e.g., prednisone 10–20 mg for a few days), inhaled bronchodilators if you have a history of asthma/COPD, and supplemental oxygen if your blood‑oxygen levels are low.  \n\nKeep your care team updated on any worsening or new symptoms, and try to maintain a routine that allows rest, gentle activity, and time for the things that give you meaning.",
          "order": 1,
          "qid": "S30-Q01"
        },
        {
          "q": "What makes this cancer different from the others I read about?",
          "gt": "Small‑cell lung cancer (SCLC) is a distinct, highly aggressive form of lung cancer that behaves very differently from the more common non‑small‑cell types (NSCLC).  \n\n* **Rapid growth and early spread** – SCLC cells divide quickly (doubling time ~20–30 h) and usually metastasize within weeks of diagnosis, so it is often already “extensive‑stage” when found.  \n* **Neuroendocrine origin** – It arises from neuroendocrine cells, giving it unique biology (e.g., high expression of neuroendocrine markers) and a different pattern of gene mutations.  \n* **Chemo‑sensitivity but quick relapse** – SCLC is initially very responsive to platinum‑etoposide chemotherapy, but most patients relapse within months, limiting long‑term options.  \n* **Limited targeted therapies** – Unlike many NSCLC subtypes that have actionable mutations (EGFR, ALK, etc.), SCLC has few effective targeted drugs; the main advances are adding immunotherapy (PD‑L1 inhibitors) to chemo.  \n\nSo, its speed, early dissemination, distinct biology, and limited long‑term treatments set it apart from other lung cancers.",
          "order": 2,
          "qid": "S30-Q02"
        },
        {
          "q": "Will I be stuck in bed after each cycle?",
          "gt": "It’s normal to worry about the “chemo‑hangover” that can follow each cycle. With a platinum‑etoposide plus immunotherapy regimen, the most common short‑term side effects are fatigue, nausea, and sometimes mild fever or low blood counts. Most patients feel enough energy to get out of bed, walk a few blocks, and return to their usual activities within a week or two. You’ll likely need a few days of rest after each cycle, but you won’t be confined to bed for long. Good nutrition, gentle exercise, and a structured rest‑pacing plan can speed recovery. If you notice prolonged weakness, severe pain, or new symptoms, let your oncology team know right away—they can adjust doses or add supportive meds. Stay in touch with your care team and keep a diary of how you feel after each cycle; that helps tailor the plan to keep your days meaningful.",
          "order": 3,
          "qid": "S30-Q03"
        },
        {
          "q": "Can immunotherapy cause dangerous side effects?",
          "gt": "Yes, immunotherapy can produce serious side effects, though they are relatively uncommon and often manageable with early recognition and treatment. The most notable risks are immune‑related adverse events (irAEs), where the immune system attacks healthy tissues. These can affect the skin (rash, itching), gastrointestinal tract (diarrhea, colitis), liver (hepatitis), endocrine glands (thyroiditis, adrenal insufficiency), lungs (pneumonitis), and, rarely, the heart or nervous system. Symptoms such as new or worsening fatigue, shortness of breath, abdominal pain, or changes in vision or mood should prompt immediate medical attention. Most irAEs respond well to corticosteroids or other immunosuppressants if caught early. Your oncology team will monitor you closely with regular labs and imaging, and will adjust therapy or add supportive care as needed to keep your days meaningful and safe.",
          "order": 4,
          "qid": "S30-Q04"
        },
        {
          "q": "Should I quit smoking now, or is it too late to matter?",
          "gt": "Quitting now is still a powerful choice. Even after a diagnosis of extensive‑stage small cell lung cancer, stopping smoking can:\n\n* **Improve treatment tolerance** – fewer infections, better organ function, and a lower risk of chemotherapy‑related complications.  \n* **Enhance response to therapy** – studies show that patients who quit before or during treatment have higher response rates and longer progression‑free survival.  \n* **Reduce secondary risks** – lower chance of new cancers, heart disease, and lung infections that can shorten life expectancy.  \n* **Boost quality of life** – clearer breathing, less cough, and better energy for meaningful activities.  \n\nThe benefits accrue quickly; even a few weeks of abstinence can lessen side effects and improve outcomes. Talk to your oncologist about a cessation plan—nicotine replacement, counseling, or medications—so you can start today and feel more in control.",
          "order": 5,
          "qid": "S30-Q05"
        },
        {
          "q": "If my brain scan later shows spots, what then?",
          "gt": "If a later brain MRI shows new lesions, it means the cancer has spread to the brain—a common pattern in extensive‑stage small‑cell lung cancer. The next steps usually involve a multidisciplinary discussion with a radiation oncologist, neurologist, and your medical oncologist.  \n\n**Typical approach**  \n1. **Steroids** (e.g., dexamethasone) to reduce swelling if you’re symptomatic.  \n2. **Radiation** –  \n   * **Whole‑brain RT** if many lesions or diffuse disease.  \n   * **Stereotactic radiosurgery** (SRS) for a few, well‑defined spots.  \n3. **Prophylactic cranial irradiation (PCI)** may be offered if you haven’t had it already, especially if the lesions are small or many.  \n4. **Continue systemic therapy** (platinum/etoposide + immunotherapy) if you’re tolerating it, as it can still control extracranial disease.  \n5. **Supportive care** – pain control, rehabilitation, and psychosocial support to keep your days meaningful.\n\nYour team will tailor the plan to the number, size, and symptoms of the spots, balancing effectiveness with quality of life.",
          "order": 6,
          "qid": "S30-Q06"
        },
        {
          "q": "Can I keep my morning walks with my dog?",
          "gt": "It’s usually safe to keep your morning walks, but the key is to listen to your body and adjust as needed.  \n- **Energy & fatigue**: If you feel unusually weak or short‑of‑breath after a dose, shorten the walk or switch to a gentle stroll.  \n- **Infections**: During neutropenia (low white cells) avoid crowded parks or places where you could catch a cold; keep your dog’s vaccinations up‑to‑date.  \n- **Timing**: Many people find a light walk a few hours after chemo or immunotherapy helps with mood and circulation, but if you’re still nauseated or dizzy, wait until you feel steadier.  \n- **Hydration & rest**: Drink plenty of water before and after, and rest if you feel drained.  \nIf you notice new pain, shortness of breath, or fevers, pause the walk and contact your oncology team. Your dog’s companionship is a wonderful support—just pace it with your treatment schedule.",
          "order": 7,
          "qid": "S30-Q07"
        },
        {
          "q": "How long does this treatment last?",
          "gt": "For most patients with extensive‑stage small‑cell lung cancer, the initial “front‑line” course is **4–6 cycles** of platinum/etoposide plus an immune‑checkpoint inhibitor (e.g., atezolizumab or durvalumab).  \n- Each cycle lasts about **3 weeks**, so the whole induction phase takes roughly **12–18 weeks** (3–4 months).  \n- After those cycles, many clinicians continue the immunotherapy as **maintenance** for up to **12 months** or until the cancer progresses or side‑effects become intolerable.  \n\nSo you can expect the first intensive phase to last about 3–4 months, followed by a longer maintenance period that may extend the overall treatment to a year or more, depending on how you tolerate it and how the disease responds. This schedule is designed to give you the best chance of control while preserving as much of your daily life as possible.",
          "order": 8,
          "qid": "S30-Q08"
        },
        {
          "q": "What happens if it grows back fast?",
          "gt": "If the cancer recurs quickly after the initial platinum‑etoposide plus immunotherapy, it usually means the tumor has become resistant to the drugs you just used. In that case the disease can progress rapidly—symptoms such as shortness of breath, pain, or fatigue may worsen, and the cancer can spread to other organs. The next steps are usually a change in systemic therapy: a second‑line regimen such as topotecan, amrubicin, or a newer agent (e.g., avelumab or nivolumab in selected patients) may be offered, sometimes combined with targeted or supportive treatments. Palliative care teams can help manage symptoms and keep your quality of life high. Early discussion with your oncologist about these options and your goals can help you plan the next phase of care.",
          "order": 9,
          "qid": "S30-Q09"
        },
        {
          "q": "How do we protect good days for time with my family?",
          "gt": "I’m sorry you’re facing this. The goal is to keep the days you can spend with family bright and meaningful while you’re on chemo‑immunotherapy. Here are practical steps:\n\n1. **Prioritize symptom control** – Ask your oncologist about early pain, fatigue, and nausea management (e.g., low‑dose opioids, anti‑emetics, short‑acting steroids). Good symptom control lets you stay alert and present.\n\n2. **Schedule care around family time** – Plan infusions and scans on days when family can be present. If possible, use outpatient infusion centers so you can leave the hospital early.\n\n3. **Use “good‑day” buffers** – Keep a small, flexible buffer of days (e.g., a weekend or a holiday) set aside for family visits. If a treatment day falls on a buffer day, ask if the infusion can be moved to a nearby clinic.\n\n4. **Communicate openly** – Let your family know your treatment schedule and how they can help (e.g., bringing meals, arranging transportation). Clear expectations reduce last‑minute stress.\n\n5. **Engage palliative care early** – A palliative team can coordinate symptom management, psychosocial support, and advance care planning, freeing you to focus on quality moments.\n\n6. **Plan small rituals** – Even a 15‑minute chat, a shared meal, or a short walk can create lasting memories. Schedule these during the times you feel strongest.\n\n7. **Use technology** – If you’re too tired to travel, video calls can keep you connected. Ask your care team to help set up a simple, reliable platform.\n\nBy combining proactive symptom control, thoughtful scheduling, and open communication, you can protect the good days you share with your loved ones while staying on track with treatment.",
          "order": 10,
          "qid": "S30-Q10"
        }
      ]
    }
  ]
}